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 Summary 
The need for alternative or supplementary treatments due to the global problem of 
microbial resistance towards conventional antimicrobials may be met by the 
development of novel drugs based on antimicrobial peptides. The antimicrobial peptides 
of interest to this study were the tyrocidines, cyclic decapeptides produced by Bacillus 
aneurinolyticus. Although these antimicrobial peptides were the first natural antibiotic 
to be discovered though a systematic search for antibacterial compounds, information 
regarding their bioactivity, structure-activity relationships, determinants of bioactivity 
and mode of action is limited. The aim of this study was to investigate the antibacterial 
and antiplasmodial activity, as well as to identify determinants of bioactivity 
modulation, of the natural tyrocidine library. 
The study indicated that the tyrocidines exhibit significant activity toward 
Gram-positive bacteria, notably Listeria monocytogenes, and the intraerythocytic 
parasite, Plasmodium falciparum. Both the antilisterial and antiplasmodial activity was 
found to be highly dependent on peptide identity and self-assembly. The antilisterial 
activity of the tyrocidines was shown to be associated with increased self-assembly 
within a membrane-like environment, which suggested that formation of lytic 
complexes within the bacterial membrane may play a crucial role in tyrocidine activity. 
In contrast to the observations for antilisterial activity, the antiplasmodial activity of the 
tyrocidines was shown to be associated with reduced self-assembly within a 
membrane-like environment, which suggested that the antiplasmodial activity of the 
tyrocidines is mediated by a mechanism other than the formation of lytic complexes 
within the target cell membrane.  
In addition to the influence of peptide identity and self-assembly, the bioactivity of the 
tyrocidines was found to be highly sensitive to environmental conditions, notably the 
presence of calcium. The antilisterial activity, as well as the mode of action, of the 
tyrocidines was also found to be highly sensitive to tyrocidine-Ca2+ complexation and 
the concomitant induction of higher-order structures.  Tyrocidine-Ca2+ complexation 
was shown to greatly enhance antilisterial activity and change the mechanism of action 
from a predominantly membranolytic to an alternative, non-lytic mode of action. 
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The results of this investigation suggest that the alternative mode of tyrocidine activity 
may be related to complexation with Ca2+. It is hypothesised that such complexation 
may either (1) promote tyrocidine-DNA complexation, and thus inhibition of 
transcription and/or replication; or (2) interfere with Ca2+ homeostasis, and thus 
influence vital cell functions. 
Overall, it may be hypothesised that tyrocidine activity and mode of action is modulated 
by a critical play-off between self-assembly, cation-complexation and 
membrane-interaction. As these modulators of activity are highly dependent on 
tyrocidine sequence/structure, the wide variety of tyrocidines found in the natural 
complex may allow for optimal interaction with and activity toward a variety of 
microbes.  
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Opsomming 
Die universele probleem van mikrobiese weerstand teen konvensionele antimikrobiese 
middels en die wêreld-wye noodsaaklikheid vir alternatiewe of bykomende behandeling 
mag deur die ontwikkeling van nuwe middels, gebasseer op antimikrobiese peptiede, 
vervul word. Die antimikrobiese peptiede van belang tot hierdie studie is die tirosidiene, 
sikliese dekapeptiede wat deur Bacillus aneurinolyticus geproduseer word. Informasie 
ten opsigte van die tirosidiene se bioaktiwiteit, struktuur-funksieverwantskap, 
determinante van bio-aktiwiteit en meganisme van aksie was beperk, alhoewel hierdie 
peptiede die eerste antimikrobiese peptiede was wat ontdek is deur ‘n sistematiese 
soektog vir antimikrobiese middels. Die doelwit van hierdie studie was die ondersoek 
van antibakteriële and antiplasmodiese aktiwiteit, sowel as om die determinante van 
bio-aktiwiteit modulering van die natuurlike tirosidienbiblioteek te ondersoek. 
Hierdie studie het getoon dat die tirosidiene merkwaardige aktiwiteit teenoor 
Gram-positiewe bakterië, in besonder Listeria monocytogenes het, asook teenoor die 
intra-eritrositiese parasiet, Plasmodium falciparum. Daar is bevind dat beide die anti-
listeriese en antiplasmodiese aktiwiteite hoogs afhanklik is van peptiedidentiteit en 
self-verpakking. Daar is gewys dat die antilisteriese aktiwiteit van die tirosidiene 
geassosieer is met verhoogde self-verpakking in ’n membraanagtige omgewing,   wat ’n 
aanduiding is dat die vorming van litiese komplekse in die bakteriële membraan ’n 
kritiese rol in tirosidienaktiwiteit speel. Kontrasterend tot die waarnemings van 
antilisteriese aktiwiteit, is getoon dat die antiplasmodiese aktiwiteit van die tirosidiene 
geassosieer is met verlaagde self-verpakking in ’n membraanagtige omgewing. Dis ’n 
aanduiding dat die antiplasmodiese aktiwiteit van die tirosidiene gemediëer word deur 
‘n ander meganisme en nie die vorming van litiese komplekse in die teikenselmembraan 
nie.  
Bykomend tot die invloed van peptiedidentiteit en self-verpakking, is daar bevind dat 
die bioaktiwiteit van die tirosidiene hoogs sensitief is vir die omgewing, in besonder die 
teenwoordigheid van kalsium. Daar is ook bevind dat die antilisteriese aktiwiteit, sowel 
as die meganisme van aksie, van tirosidiene hoogs sensitief is vir tirosidien-Ca2+ 
kompleksvorming en die gevolglike induksie van of hoër-orde strukture.  Daar is gewys 
  
vi 
dat tirosidien-Ca2+ kompleksvorming die antilisteriese aktiwiteit drasties verhoog en dat 
die meganisme van aksie verander van ’n oorwegende membranolitiese meganisme na 
’n alternatiewe nie-litiese meganisme van aksie. 
Die resultate van hierdie ondersoek het aangedui dat die alternatiewe meganisme van 
aksie van tirosidienaktiwiteit moontlik verband kan hou met kompleksvorming met 
Ca2+. Die hipotese is dat sodanige kompleksvorming moontlik of (1) tirosidien-DNA 
komplekvorming aanmoedig, en dus transkripsie en/of replikasie inhibibeer of (2) met 
Ca2+ homeostase inmeng, en sodoende lewensnoodsaaklike selfunksies beïnvloed. 
Die algemene hipotese is dat tirosidienaktiwiteit en meganisme van aksie deur ’n 
kritiese spel tussen self-verpakking, katioonkompleksvorming en membraaninteraksie 
gemoduleer word. Die wye verskeidenheid van tirosidiene, wat in die natuurlike 
kompleks gevind word, kan moontlik toelaat vir die optimale interaksie met, en 
aktiwiteit teenoor ’n verskeidenheid van mikrobes, aangesien die aktiwiteitmoduleerders 
hoogs afhanklik is van tirosidien struktuur/volgorde.  
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Preface 
Microbial resistance towards conventional antimicrobials has become a global problem, 
necessitating the search for alternative antimicrobial compounds. The urgent need to 
find alternative or supplementary treatments for infections caused by various resistant 
microbes may be met by the development of novel drugs based on antimicrobial 
peptides and/or their analogues. A group of the first natural antibiotics to be discovered 
in the 1930’s through a deliberate and systematic search for antibacterial compounds, 
namely the tyrocidines (cyclic antimicrobial decapeptides produced by Bacillus 
aneurinolyticus) may potentially be promising candidates as antimicrobials. However, 
the tyrocidines seem to be “the forgotten antibiotic group” and information regarding 
their bioactivity, structure-activity relationships, determinants of bioactivity and mode 
of action is limited. 
This study was initiated to gain more knowledge of the tyrocidines and to explore their 
applicability as potential lead compounds for the development of bio-preservatives and 
novel drugs for the treatment of listeriosis, caused by L. monocytogenes, and malaria, 
caused by blood-borne parasites, such as P. falciparum. In order to develop therapeutic 
agents or bio-preservatives based on the tyrocidines, much insight regarding 
determinants of bioactivity, target interaction, and mechanism of action is required.  
The goal of this study was therefore to elucidate the structural, physicochemical and 
environmental modulators of tyrocidine antimicrobial activity and selectivity. The 
objectives to meet this goal were: 
1. The purification and analysis of tyrocidines from the tyrothricin complex of 
Bacillus aneurinolyticus (Chapter 2); 
2. Spectrophotometric investigation of tyrocidine structure and self-assembly in an 
aqueous and membrane-mimetic environment (Chapter 3);  
3. Structural investigation by homology modelling and physicochemical 
characterisation of the tyrocidines (Chapter 4);  
4. Investigation of the antibacterial activity and structure-activity relationships of 
the tyrocidines towards selected bacterial strains, including the food-borne 
pathogen Listeria monocytogenes (Chapter 5); 
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5. Investigation of the influence of cations, specifically Ca2+, on antilisterial 
activity (Chapter 6); and 
6. Investigation of the antiplasmodial and haemolytic activity, 
structure-activity-selectivity relationships and modulation of the antiplasmodial 
activity of the tyrocidines (Chapter 7). 
The chapters in this thesis were, to some extent, written as independent units so as to 
facilitate future publication. Although this led to some repetition, every attempt was 
made to keep this to a minimum.  
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 Chapter 1 
 Literature Review 
1.1 Introduction 
Food-borne diseases have an extensive impact on both public health and economics 
worldwide, which calls for the development of more effective preventative measures 
and treatments for pathogens such as Listeria, Campylobacter, E. coli and Salmonella 
[1-5]. L. monocytogenes, the causative agent of listeriosis, is estimated to account for 
28% of food-related deaths [1, 3]. L. monocytogenes has become a major concern due to 
the increased incidence of listeriosis, together with the emergence of resistance toward 
antibiotics and disinfectants [1, 2, 6-14]. In addition to the impact of food- and water-
borne diseases on public health and world economy, diseases such as malaria and 
African sleeping sickness (trypanosomiasis), caused by blood-borne parasites such as 
Plasmodium falciparum and Trypanosoma brucei, are responsible for widespread 
morbidity and mortality [15-17], and yet are some of the most neglected diseases 
afflicting mankind.  The endemic proportions of malaria and the rapid emergence of 
antibiotic-resistance in the causative parasite [15, 16, 18] is of great concern and 
requires the development of new treatments. 
The above-mentioned diseases are part of the global problem of microbial resistance 
towards conventional antimicrobials, which necessitates the search for alternative 
antimicrobial compounds [19-21]. Since the adaptive mechanisms of microbes that lead 
to the development of resistance is largely dependent on the type and mechanism of 
action of the antibiotic [22, 23], an entirely new class of antibiotics needs to be 
developed [23, 24]. Desirable attributes of such a new class of antimicrobial agents 
include broad spectrum activity, selective toxicity, rapid killing and reduced likelihood 
of resistance development [23, 25, 26]. A class of compounds that display such 
attributes are the antimicrobial peptides.  
Antimicrobial peptides represent an ancient and conserved part of innate immunity and 
are produced by all forms of life [19, 22, 24, 27-32]. Since the discovery of 
antimicrobial peptides, these compounds have received much research interest for the 
development of novel therapeutic and bio-preservative agents due to the growing 
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problem of microbial resistance to conventional antibiotics [19, 24, 26-29, 31, 33-35]. 
In general, antimicrobial peptides have been found to possess broad spectrum 
antimicrobial activity with targets such as Gram-positive and Gram-negative bacteria, 
fungi, parasites and virally-infected cells [19, 20, 22, 24, 34, 36, 37]. Despite the 
observed broad spectrum activity, the role of the cell membrane in peptide action, 
together with distinct differences between microbial cell membranes and those of 
multicellular plants and animals, allows for selective toxicity [31]. Furthermore, 
antimicrobial peptides differ from conventional antibiotics in so much as their rapid 
lytic mechanism of action prevents the development of resistant pathogenic mutants 
[30, 38]. The broad spectrum antimicrobial activity and mechanism of action implies 
that antimicrobial peptides may serve as invaluable templates for the development of 
novel antimicrobial agents [19, 22, 29, 31]. 
Antimicrobial peptides can be grouped into four broad categories based on their 
secondary structure: linear, α-helical peptides, linear peptides with an extended 
structure, looped structures and conformationally restrained β-sheet peptides (Figure 1) 
[20, 24, 26, 27, 29, 31, 34, 39].  
A B
 
C D
 
Figure 1 Examples of the four major structural classes of antimicrobial peptides 
[from [27]]. (A) α-helical cecropin-melitin hybrid; (B) extended coil 
indolicin; (C) loop bactenecin and (D) β-sheet human defensin-1 [27].   
Tyrocidines, the antimicrobial peptides of interest to this project, together with the 
structurally related loloatins [40, 41], streptocidines [42, 43] and gramicidin S, comprise 
a family of antimicrobial β-sheet cyclic decapeptides, which adopt similar backbone 
conformations/molecular topologies [40-43]. The tyrocidines are found in tyrothricin, a 
secondary metabolite bactericidal complex produced by Bacillus aneurinolyticus [44, 
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45]. Tyrothricin was the “first natural antibiotic to be discovered though a deliberate 
and systematic search for antibacterial compounds” [44, 46] and is composed of two 
groups of peptides: the linear, neutral gramicidins and the cyclic, basic tyrocidines [47-
49]. The primary structures of 28 tyrocidines have been determined [49] (Table 1).  
Table 1 Peptides from the tyrothricin complex of interest in this investigation  
 The peptide sequences [from [49]] are given using conventional one letter 
abbreviations for amino acids, except that ornithine (Orn) is designated by O. 
Lower case abbreviations denote D-amino acid residues. The abundance of the 
tyrocidines is expressed relative to that of tyrocidine C. Peptides marked with 
* were named by our group; ** renamed from tyrocidine E   
Number Identity Abbreviation Sequence Monoisotopic Mr Abundance 
1 Tyrocidine D* TrcD VOLfPYwNQY 1324.7 2.1 
2 Tyrocidine D1* TrcD1 VKLfPYwNQY 1338.7 1.7 
3 - - VOLyPWwNQY 1363.7 <1 
4 Tyrocidine E’* TrcE’ VOLfPFyNQY 1285.7 <1 
5 Tyrocidine E1’* TrcE1’ VKLfPFyNQY 1299.7 <1 
6 Tyrocidine C TrcC VOLfPWwNQY 1347.7 100 
7 Tyrocidine C1 TrcC1 VKLfPWwNQY 1361.7 30 
8 Tryptocidine C TpcC VOLfPWwNQW 1370.7 23 
9 Tryptocidine C1* TpcC1 VKLfPWwNQW 1384.7 2.3 
10 Tyrocidine B’* TrcB’ VOLfPFwNQY 1308.7 14 
11 Tyrocidine B1’* TrcB1’ VKLfPFwNQY 1322.7 5.8 
12 Tyrocidine B TrcB VOLfPWfNQY 1308.7 109 
13 Tyrocidine B1 TrcB1 VKLfPWfNQY 1322.7 44 
14 Tryptocidine B TpcB VOLfPWfNQW 1331.7 26 
15 Tryptocidine B1* TpcB1 VKLfPWfNQW 1345.7 13 
16 Tyrocidine A TrcA VOLfPFfNQY 1269.7 88 
17 Tyrocidine A1 TrcA1 VKLfPFfNQY 1283.7 39 
18 Tryptocidine A TpcA VOLfPFfNQW 1292.7 15 
19 Phenycidine A** PhcA VOLfPFfNQF 1253.8 3.1 
20 Tyrocidine E* TrcE VOLfPYfNQY 1285.7 2.2 
21 Tyrocidine E1* TrcE1 VKLfPYfNQY 1299.7 1.1 
22 - - VOLfPF(?)NQY 1336.7 4.5 
23 - - VKLfPF(?)NQY 1350.7 9.4 
24 Phenycidine B* PhcB VOLfPWfNQF 1292.7 3.7 
25 - - (L/I)OLfPWfNQY 1322.7 1.9 
26 - - (L/I)KLfPWfNQY 1336.7 2.6 
27 - - VOLfP(L/I)fNQY 1325.7 1.2 
28 - - VKLfP(L/I)fNQY 1249.7 <1 
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The secondary structure of tyrocidine A has been shown to adopt an antiparallel 
β-pleated sheet structure [50, 51]. The most abundant tyrocidines have highly conserved 
amino acid sequences (cyclo[f1P2X3x4N5Q6Y7V8X9L10]), differing only by Trp3,4/Phe3,4 
and Lys9/Orn9 mutations (the lower case abbreviations indicate D-amino acid residues). 
Upon its discovery, it was noted that tyrothricin, as well as the isolated tyrocidine 
fraction, exhibit marked bactericidal activity toward both Gram-positive and Gram-
negative bacteria [44, 52]. In addition to the bactericidal activity, the tyrocidines have 
since been shown to possess activity toward the malarial parasite P. falciparum [37].  
 
1.2 The mechanism of action of antimicrobial peptides 
The antimicrobial activity of cationic peptides generally involves electrostatic and/or 
hydrophobic interaction with phospholipid cell membranes, followed by the integration 
of the antimicrobial peptide into the membrane, which leads to increased permeability, 
leakage of cellular components and/or depolarisation of the cell membrane [19, 20, 26, 
29, 33, 34, 39, 53-56]. The most widely accepted models of peptide-induced membrane 
permeability include the barrel-stave [57], torroidal pore [58], carpet [59-61] and 
aggregate-channel [62] models (Figure 2) [20, 26, 39, 63-66]. In short, the barrel-stave 
model [57] proposes that antimicrobial peptides form barrel-like clusters, which line 
amphipathic pores without distorting the lipid bilayer; the carpet model [59, 60] 
suggests that the peptides cover the surface of the target membrane and, above a critical 
concentration, cause the integrity of the membrane to collapse, while below the this 
concentration pores, distorting the lipid bilayer, will form (personal communication 
Y. Shai) in a manner similar to the torroidal pore model [58]; and the aggregate-channel 
model [62] proposes that, once the peptides have inserted themselves into the 
membrane, they associate to form transient, unstructured aggregates that span the 
membrane [20, 65, 66].  
Although the primary mechanism of antimicrobial peptide action is regarded to involve 
target membrane permeabilisation, there has been growing evidence of 
alternative/additional mechanisms [24, 26, 31, 33, 35, 63, 67, 68]. Some membrane 
active antimicrobial peptides, such as magainin 2 [69], PR-39 [70, 71], apidaecin [72], 
protegrin [73] and tachyplesin [74] can cross bacterial inner and outer membranes 
without inducing membrane lysis, which implies that these peptides may be able to 
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target intracellular molecules [20, 33, 53, 58, 63, 67, 75-79]. Indeed, antimicrobial 
peptides, such as pleurocidin [80], PR-39 [71], buforin II [81], and indolicidin [82], 
have been shown to be capable of inhibiting RNA and DNA synthesis, while 
antimicrobial peptides such as attacins [83] and pleurocidin [80] inhibit protein 
synthesis. Other peptides were found to interfere with metabolic processes of microbes, 
inducing selective transcription [84], inhibiting respiration [85], inhibition of enzymes 
[86-88] inhibiting cellular functions by binding to DNA and RNA [74, 81, 89], 
activation of autolysin [68] and altering cytoplasmic membrane septum formation [78, 
82, 90, 91]. The membrane effects may therefore be a manner by which the peptides 
enter the cell to reach alternative targets rather than being related to the cytotoxic effect 
[33, 53, 92]. However, many antimicrobial peptides may possess more than one mode 
of action, acting on both the cell membrane and at internal sites [24, 26, 33, 63, 67, 93]. 
At high enough concentrations, most cationic antimicrobial peptides will lead to severe 
membrane perturbation, while other modes of action/targets may be affected at low 
peptide concentrations [63]. 
 
 
 
 
 
 
 
 
 
 
Figure 2 Cartoons of different models for the mechanism of action of α-helical 
cationic antimicrobial peptides. In all models the peptides associate with 
the membrane and adopt and an amphipathic α-helical structure (orange 
cylinders). Figure reproduced with permission from M. Rautenbach.  
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Valuable insight regarding the mechanism of action of the peptides in this study, the 
tyrocidines, was already gained during the discovery of their antibacterial activity [44]. 
Although the tyrocidines were found to induce lysis of target cells, lysis was shown to 
be a secondary process mediated by the autolytic enzymes of the target cell in response 
to a primary insult [44]. The bactericidal activity was suggested to be a result of 
inactivation of the glucose dehydrogenase system of the bacterial cell [44]. This is 
supported by the observation that the susceptibility of the target organism is related to 
their metabolic activity [44] and that the tyrocidines lead to the loss of oxygen uptake, 
acid production and reducing ability, indicating disruption of metabolic activity [52]. 
The tyrocidines have also been shown to form complexes with DNA in B. brevis, acting 
as a non-specific repressor by inhibiting transcription [94-96], which suggests that they 
may exert their antimicrobial action via a similar mechanism. Furthermore, the 
tyrocidines have been shown to inhibit β-galactosidase and acetylcholinesterase activity 
[97]. It is thus possible that the tyrocidines also act on an intracellular target or targets. 
Further, recent studies conducted by Rautenbach et al. (2007) [37] showed that the 
antiplasmodial activity of the tyrocidines is not a result of explicit lysis of infected 
erythrocytes but rather due to the inhibition of parasite development and life-cycle 
progression in erythrocytes, suggesting that the tyrocidines may also act by a non-
membrane related mechanism of action. The possibility of membrane-related 
mechanism(s) of action should, however, not be dismissed as the tyrocidines have also 
been shown to perturb the barrier properties of dioleoylphosphatidylcholine model 
membranes [98], implying that disruption of membrane integrity may, under certain 
conditions, play a role in tyrocidine activity. Furthermore, research regarding 
gramicidin S (cyclo[VOLfPVOLfP]), a cyclic β-sheet decapeptide with high sequence 
identity with the tyrocidines, has indicated that interaction of this peptide with the outer 
and cell membrane of bacteria induces potassium leakage and destroys the structural 
integrity of the target membrane [99-101]. Alternative modes of action for GS, 
including inhibition of erythrocyte Ca2+-ATPase [102], and Escherichia coli 
cytochrome bd-type quinol oxidase [103] have also been identified. 
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1.3 Modulation of antimicrobial peptide activity  
Irrespective of the precise mechanism of action, the interaction of antimicrobial 
peptides with the target cell membrane is, at least initially, essential for activity [26, 33, 
63, 68, 78, 104-106]. Activity is therefore modulated by the characteristics of both the 
peptide and the target cell [26, 34, 65, 93, 104, 105]. In addition to the role of peptide 
and target cell properties, environmental factors, such as ionic strength and pH may 
modulate the bioactivity of antimicrobial peptides [65, 107]. 
1.3.1 Physicochemical properties of the peptide that modulate bioactivity 
Structural features of the peptides that influence their activity include conformation, 
charge distribution, amphipathicity, hydrophobicity and the relative size of the 
polar/nonpolar face [19, 20, 23, 26, 35, 64, 93, 104, 106-115]. These structural features 
may be related to different stages of a multi-step mechanism of action [108, 109, 116]. 
Initial electrostatic interaction with anionic outer membrane components will be 
modulated by peptide cationicity [26, 35, 108, 109, 115, 117], while peptide 
aggregation at the membrane surface and subsequent permeation into the membrane 
will be modulated by peptide amphipathicity and hydrophobicity [53, 108, 109, 115, 
118-124].  In the case of an intracellular target, the peptide needs to cross the cell 
membrane of the target organism [38, 53], and the mode of interaction between 
antimicrobial peptides and target cell membranes will therefore be a major determinant 
of activity and selectivity [27]. The activity of antimicrobial peptides may thus be 
modulated by altering parameters that are required/dictate the type and/or efficacy of 
interactions involved in the crucial association of the peptide with the target cell 
membrane.  
Information regarding the structure-activity relationships of the tyrocidines is limited, 
especially with regard to antibacterial activity. However, the high structural similarity 
(50% sequence homology and about 100% backbone homology) between gramicidin S 
and the tyrocidines suggests that these peptides are likely to have similar effects on the 
membranes with which they interact and may share similar structure-activity 
relationships. Research involving gramicidin S has indicated that the presence of both 
hydrophobic and basic residues, a defined secondary (β-sheet) structure, amphipathic 
character and a minimal ring size are essential features for antimicrobial activity [99, 
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106, 125-128]. In general, enhanced haemolytic activity is associated with increased 
amphipathicity, increased hydrophobicity, and the presence of a large hydrophobic face 
[93, 125, 127, 129]. Enhanced antibacterial activity is associated with reduced 
amphipathicity and increased hydrophobicity [125, 127]. Although high amphipathicity 
and hydrophobicity is not desirable, optimal amphipathicity and hydrophobicity for 
antimicrobial activity exist, with such optima being species specific [106, 127]. 
As noted for gramicidin S, cyclic conformation is important for the antibacterial activity 
of the tyrocidines [130, 131]. Furthermore, D-Phe4 and Gln6 have been identified as 
potential targets for substitution for improved antibacterial activity and reduced 
haemolytic activity of tyrocidine A [131, 132].  Substitution of the D-Phe4 residue by 
negatively charged D-Glu or D-Asp leads to a loss of antibacterial activity [131], while 
substitution by cationic D-Orn, D-Lys or D-Arg, leads to improved therapeutic indices, 
largely due to reduced haemolytic activity [131, 132]. Substitution of Gln6 by cationic 
Orn, Lys or Arg also leads to greatly improved therapeutic indices, although this is 
largely due to significantly enhanced antibacterial activity and moderately reduced 
haemolytic activity [132]. The enhanced selectivities upon introduction of a cation 
residue in positions 4 or 6 were attributed to preferential interaction with anionic 
phospholipids of bacterial cell membranes relative to interaction with zwitterionic 
phospholipids in eukaryotic cell membranes [131, 132]. Previous investigation of the 
antiplasmodial activity of the tyrocidines by Rautenbach et al. (2007) [37] found a 
strong correlation between the antiplasmodial activity of the tyrocidines and increased 
apparent hydrophobicity and reduced side-chain surface area. 
In addition to the direct modulating effect of the abovementioned biophysical 
properties, these peptide features may also have an indirect influence on activity and 
selectivity by modulating peptide aggregation/self-assembly. The amphipathic nature of 
antimicrobial peptides poses a problem for solubility in an aqueous environment, 
especially for structurally rigid β-sheet peptides [26, 67], which may overcome this 
solubility issue by the formation of multimeric complexes [26, 67]. The tendency/ability 
of antimicrobial peptides to form aggregates/self-assemblies/supramolecular complexes 
are related to their primary structure, conformation, general topology, amphipathicity 
and hydrophobicity [93, 105, 109, 118, 133]. The potential for an equilibrium between 
monomeric peptides and peptide aggregates in aqueous solution may impact membrane 
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interaction and/or transport across biological barriers [54, 65, 118].  
Aggregation/self-assembly in solution may influence the extent of peptide insertion and 
disruption of membrane integrity, decreasing activity [107, 133, 134], whereas multimer 
formation following initial membrane interaction has been suggested to play a key role 
in the cytolytic activity of β-sheet peptides [19, 26, 54, 64].  
The tyrocidines have been found to undergo extensive, stable aggregation/self-assembly 
in aqueous solution [130, 135-139]. Such aggregation/self-assembly was hypothesised 
to be driven by hydrophobic side-chain interactions [130, 135, 136, 138] as it was 
observed to be highly dependent on amino acid sequence, conformation as dictated by 
the ring-structure and proper spatial orientation of the amino acid residues [130, 135, 
139]. 
1.3.2 Target cell properties that modulate bioactivity 
Interpreting the correlations between the biophysical properties and antimicrobial 
activity of the peptides requires consideration of the structure of the cell wall and cell 
membrane of the target cell [93]. Features of the target cell that affect interaction with 
cationic antimicrobial peptides include membrane lipid composition and the presence of 
sterols [26, 104], electrochemical potential [29], and metabolic state [77]. Gram-
positive bacteria have a thick peptidoglycan layer that surround the cell membrane, 
whereas the cell membranes of Gram-negative bacteria are surrounded by a 
peptidoglycan layer as well as an outer membrane composed mainly of lipids, proteins 
and lipopolysaccaride (LPS). The peptides need to pass through these surrounding 
layers in order to reach the cytoplasmic membrane. The presence of anionic 
phospholipids, a highly negative electrochemical gradient and the absence of cholesterol 
promote membrane-peptide interaction [29]. The high anionic phospholipid content 
(mainly phosphatidylglycerol), the high electrical-potential gradient and the lack of 
cholesterol in bacterial membrane therefore provides the basis for antimicrobial peptide 
selectivity [25, 26, 29, 33, 140]. Gramicidin S has been shown to associate more 
strongly with anionic lipid membranes whereas cholesterol inhibits its lytic action [99]. 
Although membrane interaction is generally regarded as being non-specific interaction 
with the phospholipids [141, 142], other membrane targets such as membrane-bound 
proteins/enzymes [143], lipopolysaccaride (LPS) [144-147], lipoteichoic acid (LTA) 
[148], and lipid II [149, 150] have been suggested [26, 33, 97, 103, 144, 151-154]. 
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1.3.3 Environmental modulators of bioactivity 
In addition to the role of peptide and target cell properties in activity modulation, 
environmental conditions are known to influence antimicrobial peptide activity and 
selectivity [19, 20, 31, 32, 65, 68, 107]. Many antimicrobial peptides, such as defensins 
[155-157], dermaseptin [107], lactoferrin [158], bactenecins [85] and nisin [154] lose 
their antibacterial activity under physiological salt and serum conditions [19, 32, 68]. 
The activity of most antimicrobial peptides is reduced by the presence of cations such as 
Na+, Mg2+ and Ca2+ [19, 85, 154-160]. The antimicrobial activities of mouse β-defensin 
[155], insect defensin A [156], and dermaseptin S4 derivatives [107] are inhibited by 
Na+ and divalent cations (Ca2+ and Mg2+) have been found to reduce the activity of 
human neutrophil defensins [157], lactoferrin [158], bactenecins [85] and nisin [154]. 
The inhibition of antimicrobial peptide activity by cations may be due to either 
increased aggregation induced by cations [156, 161], which would decrease the number 
of “active” peptide, or inhibition of membrane-binding, probably by shielding 
electrostatic interaction between the peptide and the target membrane [107, 154, 156]. 
As tyrocidine aggregation/self-assembly is highly dependent on solvent composition 
and the presence of salt [136, 138], the bioactivity of the tyrocidines is likely to be 
affected by serum and/or food components. 
 
1.4 Potential application of antimicrobial peptides 
The broad spectrum antimicrobial activity, rapid mechanism of action and low 
propensity for resistance development suggest that antimicrobial peptides may serve as 
invaluable templates for the development of novel therapeutic agents for bacterial and 
parasitic infections [19, 22, 24, 25, 27, 29-32, 34, 36, 39, 162]. Antimicrobial peptides 
that are currently in clinical, albeit topical, use include the polymyxin, bacitracin, 
tyrothricin and gramicidin S [27-29, 32, 62]. The applications of antimicrobial peptides, 
including ones currently undergoing clinical trials, are summarised in Table 2. 
However, the susceptibility to proteolysis, toxicity, immunogenicity, bioavailability, 
unknown toxicology and pharmacokinetics of antimicrobial peptides may limit their 
therapeutic applicability [20, 32, 34, 39, 162].  
In order to develop novel therapeutic agents or bio-preservatives based on antimicrobial 
peptides, much insight regarding determinants of bioactivity and mechanism of action is 
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required. An understanding of the structure-function relationships and mechanism of 
action may allow for the development of more efficacious molecules with reduced 
toxicity [26, 108, 125, 127]. The development of novel therapeutic also requires 
consideration of several technical difficulties and safety considerations, such as 
sensitivity to physiologically relevant ionic strength and serum conditions, toxicity and 
selectivity; susceptibility to proteolysis; delivery; high production costs; distribution and 
clearance; and immunogenicity [20, 22, 26, 27, 29, 31, 162, 163]. 
 
Table 2 Summary of AMP clinical applications and status [22, 32, 164] 
Compound Parent AMP Application and status Company 
 Polymyxin Wound creams, eye and ear 
drops (In clinical use) 
Generic 
 Gramicidin S Wound creams, eye and ear 
drops (In clinical use) 
Generic 
 Bacitracin Wound creams, eye and ear 
drops (In clinical use) 
Generic 
 Tyrothricin Throat lozenges (in clinical use) Generic 
Omiganin Indolicidin Topical prevention of catheter-
related blood-stream infections 
(Completed phase III trial) 
Migenix, Vancouver, BC 
MBI Indolicidin Topical treatment for acne 
(Phase III trial) 
Microbiologix, Vancouver, BC 
P113 Histatins Mouth rinse for oral candidiasis 
(Passed phase II trial) 
Demegen, PA, USA 
hLF-11 Human lactoferrin Systemic antifungal 
(Completed phase I trials) 
AM-Pharma Holding, BV 
 Nisin Anti-ulcer drug 
Intravaginal contraceptive and 
microbicide 
Applied Microbiology  
Astra Merck 
XMP.629 BPI Topical treatment for acne 
(Failed phase III trial) 
Xoma, Berkeley, CA 
Neuprex BPI Pareteral treatment of pediatric 
meningococcemia 
(Failed phase III trials) 
Xoma, Berkeley, CA 
Iseganan Protegrin Mouth rinse for stomatitis 
(Failed phase III trials) 
Intrabiotics, CA, USA 
Pexiganan Magainin 2 Topical treatment of diabetic foot 
ulcers (Failed Phase III trials) 
Genaera, PA, USA 
 
The broad spectrum antimicrobial activity of the tyrocidines implies that they may be 
promising templates for alternative treatments for infections caused by various resistant 
pathogens. The tyrocidines are, however, also haemolytic and exhibit toxicity toward 
certain human cell lines in vitro [37, 52]. Investigation of tyrocidine structure-activity-
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toxicity relationships, mode of action and sensitivity to physiologically relevant ionic 
strength and serum conditions may thus provide insight regarding their applicability as 
potential lead compounds for development of bio-preservatives and novel drugs for the 
treatment of listeriosis and blood-borne parasites, such as P. falciparum.  
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 Chapter 2 
 
 Purification and analyses of cyclic decapeptides from 
the tyrothricin complex  
 
2.1 Introduction 
Investigation of the structure, biological activity and structure-function relationships of the 
tyrocidines and analogues from the tyrothricin complex requires highly purified fractions. 
Because of the high analogy of the cyclic peptides in the tyrothricin complex, it required 
the design of a purification protocol and the subsequent analyses of the obtained fractions 
in order to ascertain purity and confirm the identity of the peptide(s) present in each 
fraction. Various techniques are available for the isolation, purification and analysis of 
peptides, most notably high-performance liquid chromatography (HPLC) and mass 
spectrometry (MS). HPLC has the advantage of being both a purification and analytical 
tool, which can be used to assess purity. MS provides an indication of purity, allows the 
determination of accurate molecular mass and can be used to determine primary sequence. 
These techniques do, however, have certain limitations and should ideally be used in 
combination in order to deduce purity and confirm identity.  
When designing a protocol for the purification of individual peptides from a complex 
mixture, advantage should be taken of the differences in their physicochemical properties, 
such as charge, mass and hydrophobicity. Reverse-phase HPLC (RP-HPLC), which 
separates compounds based on their differential interaction with a hydrophobic stationary 
phase in the presence of a polar mobile phase, is one of the most powerful techniques for 
the separation of biomolecules, including peptides. Two characteristics of antimicrobial 
peptides that may impede their purification by RP-HPLC include small differences in 
hydrophobicity and amphipathic character. Careful consideration of factors that influence 
RP-HPLC resolution, such as matrix, column dimensions, eluant compositions, the gradient  
 2-2 
profile and temperature, is required in order to separate and purify individual peptides from 
a mixture of peptides that have similar hydrophobicities. The amphipathic character of 
antimicrobial peptides often results in aggregate/complex formation, especially between the 
more hydrophobic peptides. Eluant compositions, method temperature and peptide 
concentration need to be optimised in order to limit such aggregation. 
Mass spectrometry is a powerful technique for the determination of purity, accurate 
molecular mass and sequence information. Time-of-flight electrospray mass spectrometry 
(TOF-ESMS) is commonly used in the analyses of peptides due to its high sensitivity, high 
mass accuracy and ability to generate and observe multiply charged species. TOF-ESMS 
allows for the identification of specific molecular masses in a sample, but does not 
distinguish between different molecules with the same molecular mass. Tandem mass 
spectrometry (MS-MS) can be used to sequence peptides, thus allowing discrimination 
between peptides with identical molecular masses. The most common MS-MS technique 
involves a triple quadrupole combined with electrospray ionisation (ESI), due to its high 
sensitivity and reasonable fragmentation information. The collision-induced dissociation 
(CID) of peptides in ESI-MS results in two classes of fragment ions. Fragments that retain 
their charge on the N-terminal and are cleaved at the C-terminal form fragment types an, bn, 
or cn, whereas the fragments that retain their charge on the C-terminal and are cleaved at 
the N-terminal form fragment types xn, yn or zn (Figure 1) [1, 2]. Peptides commonly 
dissociate to yield the bn and yn product ion series [3]. Determining the primary sequence of 
cyclic peptides using MS-MS is, however, more complicated than that of linear peptides 
due to the variety of possible ring openings that the peptide can undergo prior to 
fragmentation.  
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Figure 1 Fragmentation patterns of a peptide during mass spectrometry 
The possible peptide backbone cleavage sites, and resulting fragment ions, 
are illustrated. The nomenclature of the fragment ions and side-chain ions 
follows that of Roepstorff and Fohlmann [1], as revised by Biemann and 
Martin [2]. (Figure reproduced with permission from M. Rautenbach)  
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2.1.1 Peptides of interest to this study 
The antimicrobial peptides of interest to this study are the tyrocidines, cyclic decapeptides 
found in the fermentation broth of Bacillus brevis [4, 5]. The tyrocidines are found in a 
complex mixture of peptides, known as tyrothricin, which is composed of the cyclic, basic 
tyrocidines and the linear, neutral gramicidins [4, 5]. The tyrocidines and related peptides 
have very high sequence identity, with limited conservative amino acid substitutions 
(Table 1), and therefore have very similar physicochemical characteristics, which 
complicate the purification of the individual peptides. 
Table 1 Peptides from the tyrothricin complex of interest in this investigation 
The peptide sequences are given using conventional one letter abbreviations 
for amino acids, except that ornithine (Orn) is designated by O. Lower case 
abbreviations denote D-amino acid residues. The monoisotopic Mr were 
calculated as the sum of the molecular weights of the constituent amino 
acids.  
 
Identity Abbreviation Sequence Monoisotopic Mr  
     Major natural tyrocidines   
Tyrocidine A TrcA Cyclo-(VOLfPFfNQY) 1269.70 
Tyrocidine A1 TrcA1 Cyclo-(VKLfPFfNQY) 1283.70 
Tyrocidine B TrcB Cyclo-(VOLfPWfNQY) 1308.70 
Tyrocidine B1 TrcB1 Cyclo-(VKLfPWfNQY) 1322.70 
Tyrocidine C TrcC Cyclo-(VOLfPWwNQY) 1347.70 
Tyrocidine C1 TrcC1 Cyclo-(VKLfPWwNQY) 1361.70 
    Minor natural tyrocidines   
Tyrocidine B` TrcB’ Cyclo-(VOLfPFwNQY) 1308.70 
Tyrocidine B1` TrcB1’ Cyclo-(VKLfPFwNQY) 1322.70 
Tryptocidine B TpcB Cyclo-(VOLfPWfNQW) 1331.70 
Tryptocidine C TpcC Cyclo-(VOLfPWwNQW) 1370.70 
Gramicidin S GS Cyclo-(VOLfPVOLfP) 1140.70 
 
The tyrocidines were categorised into two groups based on their prevalence in the 
tyrocidine complex. Tyrocidines A, A1, B, B1, C and C1 are the most prevalent [5] and 
referred to as the major tyrocidines, whereas the less prevalent tyrocidines B` and B1` 
(named in this study) and tryptocidines B and C [5] are designated as the minor tyrocidines. 
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2.2 Materials  
The tyrothricin and gramicidin S was supplied by Sigma (St. Louis, USA). The diethyl 
ether and acetone were supplied by Saarchem (Krugersdorp, RSA). Acetonitrile (ACN1) 
(HPLC-grade, far UV cut-off) and trifluoroacetic acid (TFA, >98%) was supplied by 
Romill Ltd. (Cambridge, UK) and Sigma-Aldrich (St. Louis, USA), respectively. Waters-
Millipore (Milford, USA) supplied the Nova-Pak® C18 (5µm particle size, 60Å pore size, 
150mm X 3.9mm) reverse-phase analytical column and the Nova-Pak® C18 (6µm particle 
size, 60Å pore size, 7.8mm X 300mm) semi-preparative HPLC column. Analytical grade 
water was prepared by filtering water from a reverse osmosis plant through a Millipore 
Milli-Q® water purification system (Milford, USA). 
2.3 Methods  
2.3.1 Purification of the tyrocidines  
The tyrocidines were isolated from the tyrothricin complex from Bacillus aneurinolyticus, 
commercially obtained from Sigma (St Louis, USA), by organic extraction, as described by 
Hotchkiss and Dubos (1941) [4] with some modifications. Briefly, the tyrothricin in dry 
powder form (300 mg) was washed three times with equal volumes ether/acetone (1:1, v/v) 
and the insoluble fraction/precipitate containing the tyrocidines was collected by 
centrifugation and dried under vacuum. The crude tyrocidine complex (obtained from the 
fractionation) was dissolved in acetonitrile/water (1:1, v/v) (20 mg/mL) and purified by 
semi-preparative reverse-phase high performance liquid chromatography (RP-HPLC), 
using a Nova-Pak® C18 (6µm particle size, 60Å pore size, 7.8mm X 300mm) semi-
preparative HPLC column. The chromatographic system, composed of two Waters 510 
pumps, Waters model 440 detector and a WISP 712 auto-sampler, was controlled by a 
MAXIMA software control system and the separation monitored at 254nm. A solvent 
gradient of decreasing polarity, using eluant A (0.1% TFA in water) and eluant B (10% A 
in 90% acetonitrile), at a flow rate of 3 mL/min was created and run at 35°C (Table 2) [6, 
7]. For the semi-preparative RP-HPLC, 100 µL of the crude tyrocidine mixture (20 mg/mL 
in acetonitrile/water, 1:1, v/v) was injected per run. Those fractions of which insufficient 
separation was observed on the semi-preparative column were further purified on a reverse-
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phase analytical C18 Nova-Pak® column (5µm particle size, 60Å pore size, 150mm X 
3.9mm), using the same solvents and gradient program (Table 2) as for the semi-
preparative purifications, but with a flow rate of 1 mL/min. For purification using the 
analytical C18 column, 50 µL of the peptide solution (2 mg/mL in acetonitrile/water, 1:1, 
v/v) was injected per run. 
 
Table 2 HPLC gradient program used for the purification and analyses 
Eluant A was 0.1% TFA in water; eluant B was 10% A in acetonitrile. The 
gradient profile was defined by the Waters gradient control curve type.   
 
Time 
(min) % eluant A % eluant B Curve type 
0.0 50 50  
0.5/1.01 50 50 6 (linear) 
23.0 20 80 5 (curve) 
24.0 0 100 6 (linear) 
26.0 0 100 6 (linear) 
28.0 - - - 
30.0 50 50 6 (linear) 
35.0 50 50 6 (linear) 
              
     
1
 0.5 min for semi-preparative RP-HPLC, 1.0 min for analytical RP-HPLC 
2.3.2 Analysis of the purified tyrocidines 
The collected fractions were subjected to analytical RP-HPLC, time-of-flight electrospray 
mass spectrometry (TOF-ESMS), and tandem mass spectroscopy (MS-MS) in order to 
determine the degree of purity of each fraction and to identify the purified product. The 
same column and conditions as for purification on the analytical RP-HPLC column were 
employed for the analytical RP-HPLC analyses (Table 2). Peptide concentrations used for 
the analytical RP-HPLC analysis were optimised to limit peptide aggregation, and 20 µL 
injection volumes were used. TOF-ESMS and MS-MS analyses were performed using a 
Waters Q-TOF Ultima mass spectrometer fitted with an electrospray ionisation source. For 
TOF-ESMS, 10 µL of each peptide sample (10 µg/mL in acetonitrile/water, 1:1, v/v) was 
injected into the ESMS and subjected to a capillary voltage of 3.5 kV. The source 
temperature and cone voltage was set at 100 ºC and 35 V, respectively. The data was 
collected in positive mode by scanning the first mass analyser (MS1) through m/z = 100–
1999. MS–MS analyses were performed by injecting 30 µL of peptide sample (10 µg/mL in 
acetonitrile/ water, 1:1, v/v) into the mass spectrometer and subjecting the selected 
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molecular species to decomposition at a collision energy of 40 eV. Data was collected in 
MS2 through m/z = 100-1999. 
2.4 Results and Discussion 
Organic extraction of the tyrothricin complex yielded 200 mg (67% yield) of the crude 
tyrocidine complex, which corresponds to the expected yield as tyrothricin is composed of 
gramicidins and tyrocidines in a ratio of approximately 40:60 [4].  
 
Table 3 Summary of the purification data 
The HPLC retention times of the tyrocidines were obtained from the 
analytical HPLC chromatograms of the purified tyrocidines. The observed 
monoisotopic Mr were calculated from TOF-ESMS spectra. The expected 
monoisotopic Mr were calculated as the sum of the molecular weights of the 
constituent amino acids. The percentage purity was calculated from 
analytical HPLC analyses at 254 nm of the purified tyrocidines. The 
percentage yield was calculated as the percentage of the mass of the crude 
tyrocidine complex (200 mg) obtained from organic extraction.  
 
Identity 
HPLC RT 
(min) 
Monoisotopic Mr 
Observed (Expected) 
% Purity 
% Yield  
(Yield, mg) 
Major natural tyrocidines    
TrcA 11.81 1269.70 (1269.70) > 95% 5.8 (11.6) 
TrcA1 11.33 1283.71 (1283.70) > 95% 2.3 (4.5) 
TrcB 9.48 1308.71 (1308.70) > 95% 9.4 (18.8) 
TrcB1 9.24 1322.71 (1322.70) > 95% 4.6 (9.1) 
TrcC 8.31 1347.71 (1347.70) > 95% 13.6 (27.1) 
TrcC1 7.90 1361.75 (1361.70) > 95% 6.1 (12.2) 
Minor natural tyrocidines    
TrcB’ 8.98 1308.70 (1308.70) 94% 0.2 (0.4) 
TrcB1’ 9.72 1322.70 (1322.70) > 95% 0.4 (0.7) 
TpcB 11.33 1331.65 (1331.70) 59%1 2.1 (4.2) 
TpcC 9.63 1370.67 (1370.70) 73%1 0.8 (1.6) 
GS 12.05 1140.72 (1140.70) >95% - 
1
 Purity estimated from ESMS signals 
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During the first round of semi-preparative C18-RP-HPLC, the crude tyrocidine complex 
(Figure 2) was divided into six fractions. Analytical C18-RP-HPLC and TOF-ESMS 
analyses of fraction I indicated the presence of purified (>95%) tyrocidine C1, with a 
RP-HPLC retention time (RT) of 7.90 minutes (Figure 3A). TOF-ESMS spectra indicated 
the singly (m/z = 1362.75) and doubly (m/z = 681.89) charged molecular ion, as well as the 
singly (m/z = 1384.74) and doubly (m/z = 692.88) charged sodium adduct of TrcC1 (Figure 
3B). Fraction II contained purified (>95%) tyrocidine C, with a RT 8.31 minutes (Figure 
4A). The TOF-ESMS spectra of tyrocidine C indicated the singly (m/z = 1348.71) and 
doubly (m/z = 674.87) charged molecular ions, as well as the singly charged sodium adduct 
(m/z = 1370.74) (Figure 4B).  
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Figure 2  Semi-preparative RP-HPLC chromatogram of the tyrocidine mixture 
Semi-preparative C18-RP-HPLC chromatogram indicating the six fractions 
(fractions I to VI) isolated during the first round of semi-preparative 
RP-HPLC purification. 
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Figure 3 Analytical RP-HPLC and TOF-ESMS analysis of purified tyrocidine C1  
A: Analytic C18-RP-HPLC chromatogram of purified tyrocidine C1 at 
500 µg/mL (20 µL injection volume), indicating peptide identity and elution 
time (in minutes). B: TOF-ESMS spectrum of purified tyrocidine C1, 
indicating the monoisotopic peaks and m/z ratios of the singly charged 
molecular ion ([M+H]+), singly charged sodium adduct ([M+Na]+), the 
doubly charged molecular ion ([M+2H]2+) and the doubly charged sodium 
adduct ([M+H+Na]2+). 
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Figure 4 Analytical RP-HPLC and TOF-ESMS analysis of purified tyrocidine C 
A: Analytic C18-RP-HPLC chromatogram of purified tyrocidine C at 
500 µg/mL (20 µL injection volume), indicating peptide identity and elution 
time (in minutes). B: TOF-ESMS spectrum of purified tyrocidine C, 
indicating the monoisotopic peaks and m/z ratios of the singly charged 
molecular ion ([M+H]+), singly charged sodium adduct ([M+Na]+), and the 
doubly charged molecular ion ([M+2H]2+).  
 
Fraction III was found to contain a mixture of TrcB1, TrcB1`, TrcB and TrcB`; fraction IV 
contained TrcB1`, TrcB, TrcB` and TpcC; fraction V contained TrcA1 and TrcA; and 
fraction VI contained TrcA, TrcA1 and TpcB. These fractions were thus subjected to a 
second round of semi-preparative C18-RP-HPLC. Tyrocidine B1, with a RT of 9.24 minutes, 
was successfully purified (>95%) from fraction III (Figure 5A). The TOF-ESMS spectra of 
tyrocidine B1 indicated the singly (m/z = 1323.71) and doubly (m/z = 662.37) charged 
molecular ion, as well as the singly charged sodium adduct (m/z = 1345.71) (Figure 5B). 
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Tyrocidine B (RT = 9.48 minutes) was successfully purified (>95%) from fraction IV 
(Figure 6A) and the TOF-ESMS spectra of tyrocidine B indicated the singly (m/z = 
1309.71) and doubly (m/z = 655.37) charged molecular ion, as well as the singly charged 
sodium adduct (m/z = 1331.72) (Figure 6B). 
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Figure 5 Analytical RP-HPLC and TOF-ESMS analysis of purified tyrocidine B1  
A: Analytic C18-RP-HPLC chromatogram of purified tyrocidine B1 at 
200 µg/mL (20 µL injection volume), indicating peptide identity and elution 
time (in minutes). B: TOF-ESMS spectrum of purified tyrocidine B1, 
indicating the monoisotopic peaks and m/z ratios of the singly charged 
molecular ion ([M+H]+), singly charged sodium adduct ([M+Na]+), and the 
doubly charged molecular ion ([M+2H]2+).  
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Figure 6 Analytical RP-HPLC and TOF-ESMS analysis of purified tyrocidine B 
A: Analytic C18-RP-HPLC chromatogram of purified tyrocidine B at 
200 µg/mL (20 µL injection volume), indicating peptide identity and elution 
time (in minutes). B: TOF-ESMS spectrum of purified tyrocidine B, 
indicating the monoisotopic peaks and m/z ratios of the singly charged 
molecular ion ([M+H]+), singly charged sodium adduct ([M+Na]+), and the 
doubly charged molecular ion ([M+2H]2+).  
 
Tyrocidine B`, TrcB1`, TrcA, TrcA1, TpcB and TpcC, could not be successfully purified by 
semi-preparative C18-RP-HPLC. The semi-preparative fractions containing these peptides 
were therefore further purified using an analytical C18-reverse phase column. Tyrocidine B` 
(RT = 8.98 minutes), was successfully purified (94%), and the TOF-ESMS spectrum 
 2-13 
indicated the singly (m/z = 1309.70) and doubly (m/z = 655.36) charged molecular ion, as 
well as the singly charged sodium adduct (m/z = 1331.71) (Figure 7). Tyrocidine B1` (RT = 
9.72 minutes) was successfully purified (>95%), and the TOF-ESMS spectrum indicated 
the singly (m/z = 1323.70) and doubly (m/z = 662.37) charged molecular ion, as well as the 
singly (m/z = 1345.71) and doubly (m/z = 673.37) charged sodium adduct (Figure 8).   
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Figure 7 Analytical RP-HPLC and TOF-ESMS analysis of purified tyrocidine B` 
A: Analytic C18-RP-HPLC chromatogram of purified tyrocidine B` at 
200 µg/mL (20 µL injection volume), indicating peptide identity and elution 
time (in minutes). B: TOF-ESMS spectrum of purified tyrocidine B`, 
indicating the monoisotopic peaks and m/z ratios of the singly charged 
molecular ion ([M+H]+), singly charged sodium adduct ([M+Na]+), and the 
doubly charged molecular ion ([M+2H]2+).  
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Figure 8 Analytical RP-HPLC and TOF-ESMS analysis of purified tyrocidine B1` 
A: Analytic C18-RP-HPLC chromatogram of purified tyrocidine B1` at 
200 µg/mL (20 µL injection volume), indicating peptide identity and elution 
time (in minutes). B: TOF-ESMS spectrum of purified tyrocidine B1`, 
indicating the monoisotopic peaks and m/z ratios of the singly charged 
molecular ion ([M+H]+), singly charged sodium adduct ([M+Na]+), the 
doubly charged molecular ion ([M+2H]2+) and the doubly charged sodium 
adduct ([M+H+Na]2+). 
 
Difficulty was encountered in the purification of tyrocidines A and A1, with each round of 
purification still showing multiple peaks in analytical RP-HPLC analysis even though TOF-
ESMS analysis indicated purity (Figures 9 and 10). The observed multiple peaks may be 
ascribed to aggregate formation due to the more hydrophobic nature of these peptides. Such 
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aggregation may be reduced if purification and subsequent analyses are performed at 
sufficiently low concentrations (100 µg/mL). Tyrocidine A1, with a retention time of 11.33 
minutes, was successfully purified (>95%), and the TOF-ESMS spectrum indicated the 
singly (m/z = 1284.71) and doubly (m/z = 642.87) charged molecular ion, as well as the 
singly (m/z = 1306.72) and doubly (m/z = 653.87) charged sodium adduct (Figure 9). 
Tyrocidine A (RT = 11.81 minutes) was successfully purified (>95%), and the TOF-ESMS 
spectrum indicated the singly (m/z = 1270.70) and doubly (m/z = 635.87) charged 
molecular ion, as well as the singly charged sodium adduct (m/z = 292.71) (Figure 10). 
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Figure 9  Analytical RP-HPLC and TOF-ESMS analysis of purified tyrocidine A1 
A: Analytic C18-RP-HPLC chromatogram of purified tyrocidine A1 at 
1 mg/mL. B: Analytic C18-RP-HPLC chromatogram of purified tyrocidine 
A1 at 100 µg/mL, indicating peptide identity and elution time (in minutes). 
20 µL injections were used. C: TOF-ESMS spectrum of purified tyrocidine 
A1, indicating the monoisotopic peaks and m/z ratios of the singly charged 
molecular ion ([M+H]+), singly charged sodium adduct ([M+Na]+), the 
doubly charged molecular ion ([M+2H]2+) and the doubly charged sodium 
adduct ([M+H+Na]2+). 
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Figure 10  Analytical RP-HPLC and TOF-ESMS analysis of purified tyrocidine A 
A: Analytic C18-RP-HPLC chromatogram of purified tyrocidine A at 
1 mg/mL. B: Analytic C18-RP-HPLC chromatogram of purified tyrocidine A 
at 100 µg/mL, indicating peptide identity and elution time (in minutes). 
20 µL injections were used. C: TOF-ESMS spectrum of purified tyrocidine 
A, indicating the monoisotopic peaks and m/z ratios of the singly charged 
molecular ion ([M+H]+), singly charged sodium adduct ([M+Na]+), and the 
doubly charged molecular ion ([M+2H]2+). 
 
The purification of the minor tryptocidines (TpcB and TpcC) could not be accomplished 
for, regardless of the number of purifications done, TpcB co-eluted with tyrocidine A 
(Figure 11), and TpcC co-eluted with a tyrocidine with Mr of 1336.69 (LKLfPWfNQY [5]) 
(Figure 12). Such co-elution may be due to association/formation of complexes between 
these tyrocidines.  
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Figure 11 Analytical RP-HPLC and TOF-ESMS analysis of purified tryptocidine B 
A: Analytic C18-RP-HPLC chromatogram of tryptocidine B at 200 µg/mL 
(20 µL injection volume), indicating peptide identity, elution time (in 
minutes), and contaminating peaks. B: TOF-ESMS spectrum of tryptocidine 
B, indicating the monoisotopic peaks and m/z ratios of the singly charged 
molecular ions ([M+H]+), singly charged sodium adducts ([M+Na]+), and 
the doubly charged molecular ions ([M+2H]2+).  
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Figure 12 Analytical RP-HPLC and TOF-ESMS analysis of purified tryptocidine C 
A: Analytic C18-RP-HPLC chromatogram of tryptocidine C at 200 µg/mL 
(20 µL injection volume), indicating peptide identity, elution time (in 
minutes), and contaminating peaks. B: TOF-ESMS spectrum of tryptocidine 
C, indicating the monoisotopic peaks and m/z ratios of the singly charged 
molecular ions ([M+H]+), singly charged sodium adducts ([M+Na]+), and 
the doubly charged molecular ions ([M+2H]2+).  
 
 
In addition to analytical RP-HPLC and TOF-ESMS, MS-MS analyses were performed on 
the purified tyrocidines to confirm their chemical integrity and amino acid sequence. 
MS-MS analysis of cyclic peptides requires initial ring-opening to yield a linear product. 
All the natural tyrocidines in this investigation preferentially opened between the D-Phe1 
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and Pro2 residues, with Pro2 forming the N-terminus (Table 4, Figure 13). Such 
ring-cleavage is consistent with observations that peptide bonds flanking a proline residue 
are particularly susceptible to cleavage [8, 9]. In some cases, ring-openings between Val8 
and Orn9/Lys9 (Table 4; Figure 13) were also observed. For all the natural tyrocidines, 
fragments formed from the D-Phe1-Pro2 ring-opened structure included the complete b2 to 
b9 series (Table 4), with some of these fragments having lost ammonia (-NH3). This loss is 
consistent with previous observations of fragments that contain a lysine, asparagine and/or 
glutamine residue(s) [10]. Some a-ions were also observed, which is consistent with the 
observation that b-ions are susceptible to further degradation [5, 10]. The a2 ion of the 
D-Phe1-Pro2 ring-opened structure was also observed for all the peptides. (See 
supplementary tables SI-1 – SI-10 for fragment assignments and sequences.) These results 
(summarised in Table 4) are consistent with previous research by Tang et al. (1992), which 
indicated initial ring-openings between D-Phe1-Pro2 and Val8-Orn9/Lys9, and predominant 
formation of b-ion, and some a-ion, fragments [5]. 
 
The two minor tyrocidines, TrcB` and B1`, have identical molecular weights to the major 
TrcB (Mr = 1308.70) and B1 (Mr = 1322.70), respectively. These peptides can thus not be 
distinguished based on TOF-ESMS analysis. However, the b2 and a2 ions of these peptides 
have different sequences and MS-MS analysis allowed us to distinguish between TrcB and 
TrcB` as well as between TrcB1 and TrcB1`. The MS-MS spectra of TrcB and TrcB1 
indicated fragments with m/z = 284 and 256, which correspond to the b2 and a2 ions with 
sequence Pro2-Trp3. The MS-MS spectra of TrcB` and TrcB1` indicated fragments with 
m/z = 245 and 217, which correspond to the b2 and a2 ions with sequence Pro2-Phe3. 
 
In addition to the b- and a-ion fragments, internal fragments were identified. Tyrocidines A, 
A1, B and B1 formed three internal fragments, which could have originated from either of 
the initial ring-openings (Table 4), assigned as N5Q6Y7, N5Q6 and F4N5Q6.  Tyrocidines B`, 
B1`, C and C1 formed two of these internal fragments, assigned as N5Q6Y7, and N5Q6, but 
did not form the related W4N5Q6 fragment. This suggests that the peptide bond between 
Phe3/Trp3 and D-Phe4 (TrcA, A1, B and B1) is more labile or more exposed than the peptide 
bond between Phe3/Trp3 and D-Trp4 (Trc C, C1, B` and B1`). Tryptocidine B formed three 
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internal fragments, which could have originated from any of the three initial ring-openings 
(Table 4), assigned as N5Q6W7, N5Q6 and F4N5Q6. Tryptocidine C formed two of these 
internal fragments, assigned as N5Q6W7 and N5Q6, but did not form the related W4N5Q6 
fragment, which further supports the hypothesis that the Trp3-D-Phe4 bond (TpcB) is more 
labile or more exposed than the Trp3-D-Trp4 bond (TpcC).  
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Figure 13 The primary structure of the tyrocidine A 
The amino acid abbreviations in brackets indicated the variable amino acid 
identities in the other tyrocidines (refer to Table 1). The numbering of the 
peptide chain is based on the biological synthesis sequence. The arrows 
indicate peptide bonds (D-Phe1-Pro2; Val8-Orn9; and Orn9-Leu10) 
preferentially broken during initial ring-opening in MS-MS analysis. 
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Table 4  Summary of the MSMS data of the natural tyrocidines  
The predominant fragment ions formed from the linear product of Phe1-Pro2 
and Val8-Orn9/Lys9
 
ring-openings, as well as the internal fragment ions, are 
given. See supplementary tables SI-1 – SI-10 for fragment assignments and 
sequences. 
  
 Phe1-Pro2 Val8-Orn9/Lys9 Internal fragments 
TrcA b2 – b9; a2 b1 N5Q6Y7; N5Q6; F4N5Q6 
TrcA1 b2 – b9; a2; a3; y1 b6 N5Q6Y7; N5Q6; F4N5Q6 
TrcB b2 – b9;  a2 - N5Q6Y7; N5Q6; F4N5Q6; W3 
TrcB1 b2 – b9; a2 - N5Q6Y7; N5Q6; F4N5Q6 
TrcC b2 – b9; a2 b6 N5Q6Y7; N5Q6 
TrcC1 b2 – b9; a2 - N5Q6Y7; N5Q6 
TrcB` b1 – b9; a2; y2 b1, b6 N5Q6Y7; N5Q6 
TrcB1` b1 – b9; a2 - N5Q6Y7; N5Q6W3 
TpcB b2 – b9; a2 b6 N5Q6Y7; N5Q6; F4N5Q6 
TpcC b2 – b9; a2 - N5Q6Y7; N5Q6 
 
2.5 Conclusions 
Our group developed and optimised a RP-HPLC purification methodology [6, 7], which 
allowed purification of the six major tyrocidines (TrcA, A1, B, B1 C and C1) and two minor 
(TrcB` and B1`) tyrocidines and partial purification of two analogous tryptocidines. The 
identity, purity and chemical integrity were confirmed by analytical RP-HPLC, TOF-ESMS 
and MS-MS analyses. In order to purify additional minor tyrocidine-like peptides, such as 
TpcB and TpcC, the purification methodology requires further refinement/development. 
However, this is the first reported study in which eight tyrocidines were purified to >95% 
purity from the natural tyrothricin complex in milligram quantities. The successful 
purification allowed investigation of the physicochemical character (Chapters 3 and 4) and 
bioactivity (Chapters 5-7) of the eight purified tyrocidines.  
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2.7 Supplementary information 
 
Table SI-1  Summary of fragment assignment of the product ions generated by CID of 
tyrocidine A [M+H]+ 
 
m/z 
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated 
Sequence 
1270.67 Phe1-Pro2
 
[trcA]+ 1270.66 P2F3F4N5Q6Y7V8O9L10F1 
1253.66 Phe1-Pro2 trcA -NH3 1253.66 P2F3F4N5Q6Y7V8O9L10F1 
1243.70 Phe1-Pro2 trcA -CO 1242.65 P2F3F4N5Q6Y7V8O9L10F1 
1105.60 Phe1-Pro2 b9 -NH3 1105.56 P2F3F4N5Q6Y7V8O9L10 
1010.54 Phe1-Pro2 b8 1010.51 P2F3F4N5Q6Y7V8O9 
896.45 Phe1-Pro2 b7 896.43 P2F3F4N5Q6Y7V8 
879.42 Phe1-Pro2 b7 -NH3 879.42 P2F3F4N5Q6Y7V8 
797.35 Phe1-Pro2 b6 797.36 P2F3F4N5Q6Y7 
780.35 Phe1-Pro2 b6 -NH3 780.36 P2F3F4N5Q6Y7 
634.31 Phe1-Pro2 b5 634.30 P2F3F4N5Q6 
617.29 Phe1-Pro2 b5 -NH3 617.29 P2F3F4N5Q6 
506.25 Phe1-Pro2 b4 506.24 P2F3F4N5 
406.18 any Internal fragment 406.17 N5Q6Y7 
392.21 Phe1-Pro2 b3 392.20 P2F3F4 
390.18 any Internal fragment 390.18 F4N5Q6 
245.14 Phe1-Pro2 b2 245.13 P2F3 
243.15 any Internal fragment 243.11 N5Q6 
217.14 Phe1-Pro2 a2 217.12 P2F3 
115.09 Val8-Orn9 b1  115.09 O9 
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Table SI-2  Summary of fragment assignment of the product ions generated by CID of 
tyrocidine A1 [M+H]+ 
 
m/z 
observed 
Proposed 
ring opening 
Proposed fragment 
type 
m/z 
calculated 
Sequence 
1284.69 Phe1-Pro2 [trcA1]+ 1284.68 P2F3F4N5Q6Y7V8K9L10F1 
1267.67 Phe1-Pro2 trcA1 -NH3 1267.67 P2F3F4N5Q6Y7V8K9L10F1 
1137.63 Phe1-Pro2 b9 1137.61 P2F3F4N5Q6Y7V8K9L10 
1120.62 Phe1-Pro2 b9 -NH3 1120.63 P2F3F4N5Q6Y7V8K9L10 
1024.54 Phe1-Pro2 b8 1024.53 P2F3F4N5Q6Y7V8K9 
896.46 Phe1-Pro2 b7 896.43 P2F3F4N5Q6Y7V8 
879.42 Phe1-Pro2 b7 -NH3 879.42 P2F3F4N5Q6Y7V8 
797.36 Phe1-Pro2 b6 797.36 P2F3F4N5Q6Y7 
780.36 Phe1-Pro2 b6 -NH3 780.36 P2F3F4N5Q6Y7 
764.33 Val8-Lys9 b6 -NH3 763.44 K9L10F1P2F3F4 
634.31 Phe1-Pro2 b5 634.30 P2F3F4N5Q6 
617.29 Phe1-Pro2 b5 -NH3 617.29 P2F3F4N5Q6 
506.25 Phe1-Pro2 b4 506.24 P2F3F4N5 
489.23 Phe1-Pro2 b4 -NH3 489.23 P2F3F4N5 
406.18 any Internal fragment 406.17 N5Q6Y7 
392.21 Phe1-Pro2 b3 392.20 P2F3F4 
390.19 any Internal fragment 390.18 F4N5Q6 
364.20 Phe1-Pro2 a3 364.19 P2F3F4 
245.14 Phe1-Pro2 b2 245.13 P2F3 
243.15 any Internal fragment 243.11 N5Q6 
217.14 Phe1-Pro2 a2 217.12 P2F3 
120.09 any Internal fragment -CO 120.07 F1 or F3 or F4 
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Table SI-3  Summary of fragment assignment of the product ions generated by CID of 
tyrocidine B [M+H]+   
 
m/z 
observed 
Proposed 
ring opening 
Proposed  
fragment type 
m/z 
calculated 
Sequence 
1309.69 Phe1-Pro2 [trcB]+ 1309.67 P2W3F4N5Q6Y7V8O9L10F1 
1292.68 Phe1-Pro2 trcB -NH3 1292.67 P2W3F4N5Q6Y7V8O9L10F1 
1281.70 Phe1-Pro2 trcB –CO 1281.66 P2W3F4N5Q6Y7V8O9L10F1 
1144.62 Phe1-Pro2 b9 -NH3 1145.60 P2W3F4N5Q6Y7V8O9L10 
1049.53 Phe1-Pro2 b8 1049.52 P2W3F4N5Q6Y7V8O9 
935.47 Phe1-Pro2 b7 935.44 P2W3F4N5Q6Y7V8 
836.37 Phe1-Pro2 b6 836.37 P2W3F4N5Q6Y7 
819.37 Phe1-Pro2 b6 -NH3 819.37 P2W3F4N5Q6Y7 
673.33 Phe1-Pro2 b5 673.31 P2W3F4N5Q6 
545.27 Phe1-Pro2 b4 545.25 P2W3F4N5 
431.22 Phe1-Pro2 b3 431.21 P2W3F4 
406.18 any Internal fragment 406.17 N5Q6Y7 
390.19 any Internal fragment 390.18 F4N5Q6 
284.14 Phe1-Pro2 b2 284.14 P2W3 
256.15 Phe1-Pro2 a2 256.13 P2W3 
243.12 any Internal fragment 243.11 N5Q6 
159.10 any Internal fragment -CO 159.08 W3  
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Table SI-4  Summary of fragment assignment of the product ions generated by CID of 
tyrocidine B1 [M+H]+ 
 
m/z 
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated 
Sequence 
1323.72 Phe1-Pro2 [trcB1]+ 1323.69 P2W3F4N5Q6Y7V8K9L10F1 
1307.69 Phe1-Pro2 trcB1 -NH3 1306.68 P2W3F4N5Q6Y7V8K9L10F1 
1296.70 Phe1-Pro2 trcB1 -CO 1295.68 P2W3F4N5Q6Y7V8K9L10F1 
1176.62 Phe1-Pro2 b9 1176.62 P2W3F4N5Q6Y7V8K9L10 
1159.61 Phe1-Pro2 b9 –NH3 1159.61 P2W3F4N5Q6Y7V8K9L10 
1063.56 Phe1-Pro2 b8 1063.54 P2W3F4N5Q6Y7V8K9 
935.44 Phe1-Pro2 b7 935.44 P2W3F4N5Q6Y7V8 
918.45 Phe1-Pro2 b7 –NH3 918.43 P2W3F4N5Q6Y7V8 
836.37 Phe1-Pro2 b6 836.37 P2W3F4N5Q6Y7 
819.36 Phe1-Pro2 b6 –NH3 819.37 P2W3F4N5Q6Y7 
673.33 Phe1-Pro2 b5 673.31 P2W3F4N5Q6 
545.26 Phe1-Pro2 b4 545.25 P2W3F4N5 
431.22 Phe1-Pro2 b3 431.21 P2W3F4 
406.18 any Internal fragment 406.17 N5Q6Y7 
390.19 any Internal fragment 390.18 F4N5Q6 
284.15 Phe1-Pro2 b2 284.14 P2W3 
256.15 Phe1-Pro2 a2 256.13 P2W3 
243.12 any Internal fragment 243.11 N5Q6 
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 Table SI-5  Summary of fragment assignment of the product ions generated by CID of 
tyrocidine C [M+H]+ 
 
m/z 
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated 
Sequence 
1348.63 Phe1-Pro2 [trcC]+ 1348.68 P2W3W4N5Q6Y7V8O9L10F1 
1331.62 Phe1-Pro2 trcC -NH3 1331.68 P2W3W4N5Q6Y7V8O9L10F1 
1184.61 Phe1-Pro2 b9 -NH3 1184.61 P2W3W4N5Q6Y7V8O9L10 
1088.51 Phe1-Pro2 b8 1088.53 P2W3W4N5Q6Y7V8O9 
957.41 Phe1-Pro2 b7 -NH3 957.45 P2W3W4N5Q6Y7V8 
875.38 Phe1-Pro2 b6 875.38 P2W3W4N5Q6Y7 
844.43 Val8-Orn9 b6 844.45 O9L10F1P2W3W4 
712.31 Phe1-Pro2 b5 712.32 P2W3W4N5Q6 
584.25 Phe1-Pro2 b4 584.26 P2W3W4N5 
470.21 Phe1-Pro2 b3 470.22 P2W3W4 
406.17 any Internal fragment 406.17 N5Q6Y7 
284.14 Phe1-Pro2 b2 284.14 P2W3 
256.14 Phe1-Pro2 a2 256.13 P2W3 
243.10 any Internal fragment 243.11 N5Q6 
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Table SI-6  Summary of fragment assignment of the product ions generated by CID of 
tyrocidine C1 [M+H]+    
 
m/z 
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated 
Sequence 
1362.73 Phe1-Pro2 [trcC1]+ 1362.7 P2W3W4N5Q6Y7V8K9L10F1 
1345.72 Phe1-Pro2 trcC1 -NH3 1345.69 P2W3W4N5Q6Y7V8K9L10F1 
1198.65 Phe1-Pro2 b9 -NH3 1198.62 P2W3W4N5Q6Y7V8K9L10 
1102.58 Phe1-Pro2 b8 1102.55 P2W3W4N5Q6Y7V8K9 
974.49 Phe1-Pro2 b7 974.45 P2W3W4N5Q6Y7V8 
858.51 Phe1-Pro2 b6 -NH3 858.38 P2W3W4N5Q6Y7 
712.33 Phe1-Pro2 b5 712.32 P2W3W4N5Q6 
584.29 Phe1-Pro2 b4 584.26 P2W3W4N5 
470.23 Phe1-Pro2 b3 470.22 P2W3W4 
406.19 any Internal fragment 406.17 N5Q6Y7 
284.15 Phe1-Pro2 b2 284.14 P2W3 
256.10 Phe1-Pro2 a2 256.13 P2W3 
243.10 any Internal fragment 243.11 N5Q6 
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Table SI-7  Summary of fragment assignment of the product ions generated by CID of 
tyrocidine B` [M+H]+ 
 
m/z 
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated 
Sequence 
1309.68 Phe1-Pro2 [trcB`]+ 1309.67 P2F3W4N5Q6Y7V8O9L10F1 
1292.67 Phe1-Pro2 trcB`-NH3 1292.67 P2F3W4N5Q6Y7V8O9L10F1 
1281.70 Phe1-Pro2 trcB` -CO 1281.66 P2F3W4N5Q6Y7V8O9L10F1 
1144.61 Phe1-Pro2 b9 -NH3 1145.60 P2F3W4N5Q6Y7V8O9L10 
1049.54 Phe1-Pro2 b8 1049.52 P2F3W4N5Q6Y7V8O9 
935.45 Phe1-Pro2 b7 935.44 P2F3W4N5Q6Y7V8 
918.42 Phe1-Pro2 b7 -NH3 918.43 P2F3W4N5Q6Y7V8 
836.37 Phe1-Pro2 b6 836.37 P2F3W4N5Q6Y7 
788.39 Val8-Orn9 b6 -NH3 788.43 O9L10F1P2F3W4 
673.32 Phe1-Pro2 b5 673.31 P2F3W4N5Q6 
545.26 Phe1-Pro2 b4 545.25 P2F3W4N5 
431.21 Phe1-Pro2 b3 431.21 P2F3W4 
406.18 any Internal fragment 406.17 N5Q6Y7 
261.17 Phe1-Pro2 y2 261.16 L10F1 
245.13 Phe1-Pro2 b2 245.13 P2F3 
243.14 any Internal fragment 243.11 N5Q6 
217.14 Phe1-Pro2 a2 217.12 P2F3 
115.09 Val8-Orn9 b1 115.09 O9 
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Table SI-8  Summary of fragment assignment of the product ions generated by CID of 
tyrocidine B1` [M+H]+  
 
m/z 
observed 
Proposed 
ring opening 
Proposed  
fragment type 
m/z 
calculated 
Sequence 
1323.69 Phe1-Pro2 [trcB1`]+ 1323.69 P2F3W4N5Q6Y7V8K9L10F1 
1306.68 Phe1-Pro2 trcB1` -NH3 1306.68 P2F3W4N5Q6Y7V8K9L10F1 
1295.72 Phe1-Pro2 trcB1` -CO 1295.68 P2F3W4N5Q6Y7V8K9L10F1 
1176.62 Phe1-Pro2 b9 1176.62 P2F3W4N5Q6Y7V8K9L10 
1159.61 Phe1-Pro2 b9 -NH3 1159.61 P2F3W4N5Q6Y7V8K9L10 
1063.57 Phe1-Pro2 b8 1063.54 P2F3W4N5Q6Y7V8K9 
918.43 Phe1-Pro2 b7 -NH3 918.43 P2F3W4N5Q6Y7V8 
819.36 Phe1-Pro2 b6 -NH3 819.37 P2F3W4N5Q6Y7 
673.32 Phe1-Pro2 b5 673.31 P2F3W4N5Q6 
545.26 Phe1-Pro2 b4 545.25 P2F3W4N5 
431.21 Phe1-Pro2 b3 431.21 P2F3W4 
406.18 any Internal fragment 406.17 N5Q6Y7 
245.13 Phe1-Pro2 b2 245.13 P2F3 
243.14 any Internal fragment 243.11 N5Q6 
217.14 Phe1-Pro2 a2 217.12 P2F3 
159.10 any Internal fragment -CO 159.08 W4 
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Table SI-9  Summary of fragment assignment of the product ions generated by CID of 
tryptocidine B [M+H]+ 
 
m/z 
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated 
Sequence 
1332.68 Phe1-Pro2 [tpcB]+ 1332.69 P2W3F4N5Q6W7V8O9L10F1 
1315.67 Phe1-Pro2 tpcB –NH3 1315.68 P2W3F4N5Q6W7V8O9L10F1 
1304.70 Phe1-Pro2 tpcB –CO 1304.68 P2W3F4N5Q6W7V8O9L10F1 
1167.61 Phe1-Pro2 b9 -NH3 1168.61 P2W3F4N5Q6W7V8O9L10 
1072.54 Phe1-Pro2 b8 1072.54 P2W3F4N5Q6W7V8O9 
958.47 Phe1-Pro2 b7 958.46 P2W3F4N5Q6W7V8 
859.39 Phe1-Pro2 b6 859.39 P2W3F4N5Q6W7 
788.38 Val8-Orn9 b6 788.43 O9L10F1P2W3F4 
673.32 Phe1-Pro2 b5 673.32 P2W3F4N5Q6 
545.26 Phe1-Pro2 b4 545.25 P2W3F4N5 
528.26 Phe1-Pro2 b4 -NH3 528.24 P2W3F4N5 
431.21 Phe1-Pro2 b3 431.21 P2W3F4 
429.19 any Internal fragment 429.19 N5Q6W7 
390.18 any Internal fragment 390.18 F4N5Q6 
284.14 Phe1-Pro2 b2 284.14 P2W3 
256.15 Phe1-Pro2 a2 256.13 P2W3 
243.12 any Internal fragment 243.11 N5Q6 
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Table SI-10  Summary of fragment assignment of the product ions generated by CID of 
tryptocidine C [M+H]+ 
 
m/z 
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated 
Sequence 
1371.70 Phe1-Pro2 [tpcC]+ 1371.70 P2W3W4N5Q6W7V8O9L10F1 
1354.71 Phe1-Pro2 tpcC -NH3 1354.69 P2W3W4N5Q6W7V8O9L10F1 
1207.62 Phe1-Pro2 b9 -NH3 1207.62 P2W3W4N5Q6W7V8O9L10 
1111.56 Phe1-Pro2 b8 1111.55 P2W3W4N5Q6W7V8O9 
997.48 Phe1-Pro2 b7 997.47 P2W3W4N5Q6W7V8 
881.39 Phe1-Pro2 b6  -NH3 881.39 P2W3W4N5Q6W7 
712.33 Phe1-Pro2 b5 712.32 P2W3W4N5Q6 
584.27 Phe1-Pro2 b4 584.26 P2W3W4N5 
470.22 Phe1-Pro2 b3 470.22 P2W3W4 
429.20 any Internal fragment 429.19 N5Q6W7 
284.15 Phe1-Pro2 b2 284.14 P2W3 
256.15 Phe1-Pro2 a2 256.13 P2W3 
243.10 any Internal fragment 243.11 N5Q6 
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 Chapter 3 
 Spectrophotometric investigation of  
tyrocidine structure 
3.1 Introduction 
In order to develop novel therapeutic agents or bio-preservatives based on antimicrobial 
peptides, insight regarding factors that modulate activity is imperative. The bioactivity 
of antimicrobial peptides, including that of the tyrocidines (Chapters 5-7), has been 
shown to be modulated by the peptide conformation [1-9] and self-assembly [3, 10-16]. 
A clearer understanding of the structure-function relationships, modulation of 
bioactivity and mode of action therefore requires investigation of the secondary 
structure and aggregation state/self-assembly of the tyrocidines. Due to the observed 
influence of peptide sequence on bioactivity (Chapters 5 and 7), the influence of the 
variable cationic residue (Orn9 or Lys9) and the variable aromatic dipeptide unit 
(Trp3,4/Phe3,4) on tyrocidine structure and aggregation state/self-assembly is of 
particular interest. Furthermore, as the bioactivity of antimicrobial peptides requires 
interaction with the target cell membrane [10, 17-20], changes in tyrocidine structure 
and/or aggregation state/self-assembly induced in a membrane-mimetic environment 
may advance the understanding of the structure-activity relationships and mode of 
action of the tyrocidines.  
Circular dichroism spectroscopy, which exploits the sensitivity of the chiral properties 
of the peptide bond to secondary structural motifs, is an important tool for studying the 
secondary structure and solvent-induced conformational changes of peptides. 
Tyrocidine A has been shown to adopt an amphipathic type I β-turn/type 
II` β-turn/β-pleated sheet conformation, which is stabilised by four internal hydrogen 
bonds [21, 22]. Previous research by Laiken et al. (1969) indicated that the CD spectra 
of the tyrocidines resemble that of an α-helical structure rather than that of a typical 
β-sheet structure, exhibiting negative ellipticity minima at about 205 and 215 nm [23]. 
Although the far-UV CD spectra of peptides usually arise due to the backbone peptide 
bonds, aromatic amino acid side-chains may contribute significantly and have been 
shown to distort typical CD spectra [24-26]. As previously noted for the structurally 
related peptide gramicidin S, the uncharacteristic CD spectra of the tyrocidines may be 
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attributed to the combined contribution of β-sheet structure, β-turns and aromatic 
residues [6, 23, 27-29]. In addition to the influence of the aromatic amino acids, the CD 
spectra of the tyrocidines have been shown to be influenced by the aggregation state of 
the peptides, which has been shown to be highly dependent on peptide and solvent 
properties [23, 30-34]. In general, peptide self-assembly is influenced by peptide 
properties (conformation, hydrophobicity, amphipathicity and size of the hydrophobic 
and charged surface areas), the environment/solvent (polarity, ionic strength and 
presence of lipids) and the interactions involved (hydrophobic and electrostatic) [7, 35].  
In addition to circular dichroism, fluorescence spectroscopy can be used to study 
peptide conformation, dynamics and intermolecular interactions by investigating 
changes in fluorescence emission maxima as well as fluorescence (quantum) yield. 
Intrinsic fluorophores of the tyrocidines include phenylalanine (Phe), tyrosine (Tyr) and 
tryptophan (Trp). The use of phenylalanine fluorescence is, however, limited to peptides 
that lack tryptophan and tyrosine residues due to its low extinction coefficient and short 
absorption (λex = 260 nm) and emission (λem = 282 nm) wavelengths [36, 37]. The use 
of tyrosine, which is excited at 280 nm and exhibits an emission maximum at 303 nm, 
for studying peptide structure and intermolecular interactions is also limited due the 
relative insensitivity of the phenol group to solvent polarity [37, 38]. Furthermore, Tyr 
exhibits a lower extinction coefficient than Trp and its emission is thus usually 
overshadowed by Trp emission [37, 38]. Tryptophan is the most commonly used 
intrinsic fluorophore for studying peptide structure, dynamics and intermolecular 
interactions due to its large extinction coefficient and the high sensitivity of the indole 
group to the polarity/hydrophobicity of its local environment [36, 37, 39]. In an aqueous 
environment, the indole group of tryptophan exhibits an absorbance maximum at 
295 nm and an emission maximum at 350 nm, while residues in a hydrophobic 
environment emit at shorter wavelengths [37]. Although fluorescence at wavelengths 
greater than 310 nm is usually due to Trp fluorescence, the ionised p-hydroxyphenyl 
moiety of Tyr (tyrosinate) has been shown to fluoresce between 315 and 350 nm [37, 
38, 40]. Deprotonation of tyrosine in the native peptide will lead to ground-state 
tyrosinate, which is excited at both 280 and 295 nm [38, 40], whereas excitation at 
280 nm leads to the formation of excited-state tyrosinate [37, 40]. Fluorescence 
(quantum) yields can be used to assess the relative exposure, orientation and/or local 
environment of the aromatic amino acids, which may allow deductions regarding 
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peptide conformation, intermolecular interactions and state of aggregation. The 
fluorescence yield of Trp, Tyr and tyrosinate is sensitive to the local environment due to 
various quenching mechanisms and resonance energy transfer (RET) [37-40]. 
Quenching of Trp and Tyr fluorescence may occur via a number of molecular 
interactions, including excited-state reactions, molecular rearrangements, ground-state 
complex formation and dynamic/collisional quenching [37]. Resonance energy transfer 
(RET) may occur if the emission spectrum of a fluorophore (donor) overlaps with the 
absorption spectrum of another molecule (acceptor) [37]. Due to the spectral overlap of 
Trp, Tyr, and tyrosinate, RET from Tyr to tyrosinate or Trp, and from tyrosinate to Trp 
is likely to occur [37]. Furthermore, Trp-to-Trp RET can be expected if some of the Trp 
residues exhibit blue-shifted emission [37]. Tyrosinate fluorescence yield is dependent 
on the degree of tyrosine deprotonation, which requires an acceptor that is in close 
enough proximity to allow optimal proton transfer, as well as its degree of motional 
freedom and solvent accessibility [38]. 
3.2 Materials  
Analytical grade ethanol (>99.8%) was supplied by Merck (Darmstadt, Germany), 
2,2,2-trifluoreoethanol (TFE) was supplied by Sigma (St. Louis, USA), and CaCl2 was 
supplied by Saarchem (Krugersdorp, South Africa). Analytical grade water was 
prepared by filtering water from a reverse osmosis plant through a Millipore Milli-Q® 
water purification system (Milford, USA). 
3.3 Methods 
Analytical stock solutions (2.00 mg/mL) of the purified tyrocidines were prepared in 
ethanol:water (1:1, v/v), and diluted to 10 µM in water, 2,2,2-trifluoroethanol (TFE) or 
75 mM CaCl2 (final ethanol concentration was 0.5% v/v). Circular dichroism scans were 
obtained on a Chirascan CD spectrometer (Applied Photophysics, UK) using a 1.00 cm 
quartz cuvette. Three scans were collected between 200 and 250 nm with 0.1 nm steps. 
The spectra of the blank solutions were auto-subtracted. UV-absorbance spectra were 
collected simultaneously with the CD spectra. Fluorescence measurements of the same 
peptide solutions were performed on model RF-5301PC spectrofluorophotometer 
(Shimadzu, Japan). Emission spectra were recorded between 280 and 450 nm, 0.2 nm 
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steps, for excitation at 280 and 295 nm. Slit widths of 5nm were used for both excitation 
and emission, unless otherwise stated. 
This study represents the first comprehensive spectrophotometric comparison of a 
natural tyrocidine library in terms of conformation and self-assembly in different 
solvents. The results presented in this chapter have important implications for tyrocidine 
bioactivity and should therefore be regarded in the context of the structure-activity 
relationships (QSAR studies) as discussed in Chapters 5-7. 
3.4 Results and Discussion 
Interpretation of the spectrophotometric results of the tyrocidines is complicated by both 
the variable aromatic residues and aggregation/self-assembly. The contribution of 
aromatic amino acids to the circular dichroism of proteins and peptides is often 
considered to be negligible due to the low abundance of these residues [37]. However, 
the tyrocidines have a high (40%) aromatic content, which implies that the contribution 
of these residues will be considerable, but different due to varying aromatic 
composition. Although the influence of varying aromatic residue composition may be 
negated by only comparing tyrocidines with identical aromatic content, differences in 
the orientation/exposure/local environment of such residues will also affect their 
contribution to CD spectra. In order to evaluate the contribution of aromatic amino 
acids to the CD spectra, the UV absorbance of the tyrocidines were compared. 
Comparison of the far-UV absorbance spectra of the tyrocidines indicated marked 
differences in absorbance of the tyrocidines from 210 and 230 nm. Although UV 
absorbance in this wavelength region represents the combined absorbance of the peptide 
bonds, phenylalanine, tyrosine and tryptophan, differences in the average absorbance 
between 210 and 230 nm (A210-230) were assumed to be predominantly due to the 
aromatic amino acid side-chains. Although such differences in UV absorbance may be 
related to the influence of concentration, the ionic environment and pH, all the 
tyrocidines were treated in the same manner during purification and preparation and 
their concentration, ionic environment and pH were therefore assumed to be the same. 
The differences in UV absorbance were thus attributed to differences in the 
orientation/exposure/local environments of the aromatic amino acids. The 
orientation/exposure/local environment of the aromatic residues may be influenced by 
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conformational differences and/or differences in the manner of 
association/self-assembly and the size of the prevalent species. 
Diffusion-ordered 2D NMR spectroscopy (DOSY), performed in collaboration with 
Prof Katalin Kövėr (University of Debrecen, Hungary), has indicated that TrcA, TrcC 
as well as gramicidin S form multimeric complexes of between 6 and 10 monomers in 
50% (v/v) D2O/CNCD3 (Personal communication). Furthermore, as discussed in 
Chapter 2, TrcA and A1 tend to form aggregates that cause changes in their HPLC 
profiles at concentrations > 200 µg/mL. Previous research regarding tyrocidine 
aggregation indicted that TrcB forms elongated aggregates in an aqueous environment 
[32]. In an aqueous environment, the tendency for self-assembly is, at least in part, 
dictated by properties of the peptide, such as primary structure, conformation, 
hydrophobicity, amphipathicity and size of the hydrophobic and charged surface areas 
[7, 35], and tyrocidine aggregation is highly dependent on the cyclic conformation and 
proper spatial alignment of the amino acid residues [30, 31]. Variation in self-assembly 
may be due to (1) steric factors as a result of differences in the size/available surface 
area of the polar/charged face of the peptide molecule; (2) differences in hydrophobicity 
or (3) differences in solvent systems. Self-assembly may therefore influence the CD 
spectra directly by leading to ‘apparent’ changes in backbone conformation due to 
differences in the manner of association/self-assembly and/or the size of the prevalent 
species, or by affecting orientation/exposure/local environment, and thus the 
contribution of the aromatic amino acids. 
It is thus assumed in the discussion of the results that some aggregates/higher order self-
assembly structures already exist in solution. The results of the spectroscopic 
investigation are discussed in two parts: spectroscopic investigation of tyrocidine 
structure in an aqueous environment (Part 1) and in trifluoroethanol (TFE), a 
membrane-mimetic environment (Part 2).  
3.4.1 Results and Discussion: Part 1  
3.4.1.1 Circular dichroism of the tyrocidines in an aqueous environment 
The CD spectra of the tyrocidines in an aqueous environment exhibited two negative 
bands at approximately 205 and 216 nm, which may be attributed to β-turn and β-sheet 
structure, respectively [23, 27, 29]. The shape and ellipticities of these bands are, 
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however, influenced by the aggregation state of the peptides, as well as the aromatic 
amino acids [23, 24]. Previous investigators have used spectral shapes, characterised by 
the ratio of the negative ellipticity minima (θ205/θ216), as an indication of differences in 
backbone conformation [7, 26]. Although such ratios are expected to provide 
information regarding the backbone conformation of monomeric peptides, 
self-assembly to form higher-order structures are also expected to influence the spectral 
shape. As the tyrocidines have been shown to form multimeric complexes in an aqueous 
environment [30-32](this study), differences between the negative minima at 205 and 
216 nm, as well as spectral shape, are most probably more related to different 
aggregation states (manner of association/self-assembly and the size of the prevalent 
species) than differences in peptide backbone conformation.  
 Comparison of the CD spectra of the Orn9- and Lys9-containing peptides (Figures 1 - 3) 
indicated marked differences in the ellipticity at 205 and 216 nm (Table 1). 
Orn9-containing TrcC exhibited enhanced θ205 and θ216 relative to Lys9-containing 
TrcC1, whereas all the other Orn9-containing tyrocidines (TrcB, B` and A) exhibited 
reduced θ205 and θ216 relative to their Lys9-containing counterparts (TrcB1, B1` and A1).  
These changes in θ205 and θ216 may be due to (1) changes in backbone conformation, (2) 
different contributions of the aromatic amino acids and/or (3) differences in aggregation 
state. Comparison of the spectral shapes indicated that the Orn9- and Lys9-containing 
peptides exhibit similar θ205/θ216, which suggests that the tyrocidines adopt similar 
backbone conformations/higher-order structure. However, the θ205/θ216 of tyrocidines 
containing a Phe3 residue (TrcA, A1, B’, B1’) was slightly lower than those with a Trp3 
residue (TrcC, C1, B, B1), due to the θ205 > θ216 of the Trp3-containing tyrocidines, while 
those with a Phe3 exhibited a θ205 < θ216 (Table 1). These results may indicate that a 
larger population of the Phe3 containing tyrocidines may have stable β-pleated sheets, 
possibly due higher order structures/aggregates, in an aqueous environment. This is 
supported by the Raman scattering, which indicates the presence of aggregates/higher 
order structures, observed for all the Phe3 containing peptides (see discussion later) and 
the changes in HPLC profiles (discussed in Chapter 2).  
Comparison of the average UV absorbance of the natural tyrocidines (Figures 1 - 3) 
indicated significant differences in A210-230 of the Orn9- and Lys9-containing peptides 
(Table 1). Orn9-containing TrcC exhibited greater A210-230 than Lys9-containing TrcC1, 
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whereas all the other Orn9-containing tyrocidines (TrcB, B` and A) exhibited lower 
A210-230 than their Lys9-containing counterparts (TrcB1, B1` and A1). Such differences in 
A210-230, which are indicative of differences in the orientation/exposure/local 
environments of the aromatic amino acids, imply that the change in θ216 may, at least in 
part, be due to different contributions by the aromatic residues. Although differences in 
the orientation/exposure/local environments of the aromatic amino acids may be due to 
conformational differences related to the Orn9/Lys9 content, such differences are more 
likely to be related to differences in the manner and/or extent of self-assembly of the 
tyrocidines in aqueous solution.  
In addition to the influence of Orn9/Lys9 content, comparison of the far-UV absorbance 
and CD spectra of tyrocidines B, B`, B1 and B1` allowed evaluation of the influence of 
the variable aromatic dipeptide unit (Trp3,4-D-Phe3,4) on the structure and aggregation 
state of the tyrocidines in an aqueous environment. The CD spectra of TrcB and B1 
(Trp3-D-Phe4) exhibited greatly enhanced ellipticities at 205 and 216 nm, as well as 
significantly greater θ205/θ216 ratios, relative to TrcB` and B1` (Phe3-D-Trp4), 
respectively (Table 1, Figure 2). Although these differences may be related to different 
backbone conformations, different aggregation states and contributions of the aromatic 
amino acids are more likely. Previous studies [41], as well as homology modelling 
(Chapter 4), have indicated that the aromatic residues of the dipeptide unit are located 
on opposite sides of the peptide structure. The relative positioning of the aromatic 
residues may lead to differences in the manner and/or extent of self-assembly as the 
spatial alignment of the amino acid residues influence tyrocidine 
aggregation/self-assembly [30, 31]. Comparison of the UV absorbance spectra indicated 
that the A210-230 of TrcB and B1 is significantly greater than that of TrcB` and TrcB1` 
(Table 1, Figure 2), respectively, which suggests that the orientation/exposure/local 
environments of the aromatic amino acids are different. Such differences may be due 
the direct influence of the relative positioning of the aromatic residues and/or 
differences in the manner and/or extent of self-assembly. It should, however, be noted 
that reduced ellipticity and A210-230 of TrcB` and B1` may also be related to loss of 
peptide due to formation of large aggregates settling out of solution.  
In addition to the negative ellipticity minima at 205 and 216 nm, an additional negative 
band was observed for tyrocidines C and C1 (231 nm) and tyrocidines B` and 
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B1` (225 nm). Laiken et al. (1969) previously attributed this band to the influence of Trp 
[23]. It is plausible to attribute this negative band to the influence of D-Trp4, as 
tyrocidines C, C1, B` and B1` all contain this residue and tyrocidines that lack D-Trp4 do 
not exhibit negative bands in this wavelength region. These bands may, however, also 
be due to red-shifted ellipticity of the β-sheets as a result of hydrogen bonding within 
the assembly. 
Table 1 Influence of the tyrocidine sequence on UV absorbance and CD spectra 
of the tyrocidines in an aqueous environment (Ellipticities (θ) are given 
in degree.cm2.dmol-1 ± SEM of three determinations) 
  A210-230 θ205 θ216  θ205/θ216 
TrcC 0.269 -6.6 ± 0.22 -5.8 ± 0.11  1.1 ± 0.026 
TrcC1 0.249 -5.6 ± 0.054 -5.4 ± 0.098  1.0 ± 0.025 
TrcB 0.159 -6.7 ± 0.17 -5.8 ± 0.070  1.2 ± 0.040 
TrcB1 0.213 -9.9 ± 0.087 -8.7 ± 0.35  1.2 ± 0.037 
TrcB` 0.096 -3.0 ± 0.16 -3.5 ± 0.16  0.85 ± 0.048 
TrcB1` 0.165 -4.0 ± 0.046 -4.4 ± 0.046  0.92 ± 0.012 
TrcA 0.130 -8.3 ± 0.11 -9.1 ± 0.18  0.92 ± 0.0077 
TrcA1 0.203 -12.2 ± 0.082 -12.9 ± 0.027  0.94 ± 0.077 
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Figure 1 (A) CD and (B) far-UV absorbance spectra of tyrocidines C and C1 in 
an aqueous environment. Spectra of the Orn9-containing peptides are 
represented by solid lines; spectra of Lys9-containing peptides are 
represented by dotted lines. Each CD spectrum is depicted by a Lowess 
fit line (20 point smoothing window) for an average of triplicate 
determinations. UV spectra are the average of triplicate determinations. 
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Figure 2 (A) CD and (B) far-UV absorbance spectra of tyrocidines from the 
B-group in an aqueous environment. Spectra of the Orn9-containing 
peptides are represented by solid lines; spectra of Lys9-containing 
peptides are represented by dotted lines. Spectra of tyrocidines B and B1 
(Trp3-D-Phe4) are indicated by black lines; spectra of tyrocidines B` and 
B1` (Phe3-D-Trp4) are indicated by red lines. Each CD spectrum is 
depicted by a Lowess fit line (20 point smoothing window) for an 
average of triplicate determinations. UV spectra are the average of 
triplicate determinations. 
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Figure 3 (A) CD and (B) far-UV absorbance spectra of tyrocidines A and A1 in an 
aqueous environment Spectra of the Orn9-containing peptides are 
represented by solid lines; spectra of Lys9-containing peptides are 
represented by dotted lines. Each CD spectrum is depicted by a Lowess 
fit line (20 point smoothing window) for an average of triplicate 
determinations. UV spectra are the average of triplicate determinations. 
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3.4.1.2 Fluorescence spectrophotometry of the tyrocidines in an aqueous 
environment 
Tryptophan-containing tyrocidines 
Emission spectra for λex 280 and λex 295 of tyrocidines C, C1, B and B1 exhibited emission 
maxima at 350 nm, while tyrocidines B` and B1` exhibited emission maxima at 345 nm. 
Fluorescence emission for λex 280 represents the combined contribution of Tyr, 
ground-state tyrosinate, excited-state tyrosinate and Trp. Tyr emission (λmax at 303 nm), 
however, is not observed due to the Trp emission dominating the spectra and/or due to 
energy transfer from the Tyr to the Trp residues and/or formation of tyrosinate. Trp is 
expected to be the predominant source of emission for λex 295 as the contribution of 
ground-state tyrosinate is expected to be small or negligible. The additional peaks 
observed at 311 nm (λex 280) and 330 nm (λex 295) for TrcB` and B1` are probably due to 
light (Raman) scattering as a result of increased quenching, suspended particulate, 
aggregation or self-assembly structures [37].  
The influence of Orn9→Lys9 substitution on Trp fluorescence was evaluated by 
comparing the emission spectra of the Orn9- and Lys9-containing tyrocidines. The 
fluorescence emission spectra of tyrocidines C and C1 (Trp3-D-Trp4) indicated a 
decrease in Trp emission (fluorescence yield) for Lys9-containing TrcC1 (Figure 4), 
whereas tyrocidines B and B1 (Trp3) and tyrocidines B` and B1` (Trp4) indicated an 
increase in Trp emission for the Lys9-containing TrcB1 and B1` (Figure 5). Trp 
fluorescence yield is influenced by quenching, which may occur via ground-state 
complex formation, excited-state reactions and/or dynamic/collisional quenching [37]. 
Although excited-state electron transfer is likely to be the major quenching mechanism 
in peptides, ground-state interactions may become more significant if the indole moiety 
is surrounded by functional groups [39]. The aggregation state of the tyrocidines is 
therefore expected to have a significant influence on fluorescence emission and the Trp 
quenching may, at least in part, be due to ground-state complex formation due to 
self-assembly. Excited-state reactions that may contribute to the observed quenching of 
Trp fluorescence include excited-state electron transfer to the peptide backbone and the 
amide groups of Asn and Gln, and/or excited-state proton transfer from the ε-amino 
group of Lys and the phenol group of Tyr [37, 39]. As quenching is influenced by both 
proximity and orientation [37, 39], Orn9/Lys9 content may lead to different degrees of 
quenching by favouring different aggregation states. Different aggregation states may 
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also lead to differences in the solvent accessibility of the indole group, which will 
influence the degree of dynamic/collisional quenching by water molecules. Increased 
Trp quenching in the presence of Lys9 (as seen for TrcC1) may thus be due to increased 
solvent accessibility of the indole moiety of Trp3 and/or Trp4, enhanced excited-state 
proton transfer from the Lys9 or Tyr7 side chains and/or enhanced excited-state electron 
transfer to the Asn5 or Gln6 side chains. Increased Trp quenching in the presence of 
Orn9 (as seen for TrcB and B`) may be due to increased solvent accessibility of the 
indole moiety of Trp, enhanced excited-state proton transfer from the Orn9 or Tyr7 side 
chains and/or enhanced excited-state electron transfer to the Asn5 or Gln6 side chains.  
Comparison of the fluorescence emission spectra of tyrocidines B, B`, B1 and B1` 
(Figure 5) indicated that Trp3 and Trp4 exhibit different emission maxima, as well as 
different fluorescence yields (Table 2). Trp3 (TrcB and B1) exhibited emission maxima 
at 350 nm, whereas Trp4 (TrcB` and B1`) exhibited blue-shifted emission at 345 nm. 
Furthermore, Trp3 (TrcB and B1) exhibited greater fluorescence yield than Trp4 (TrcB` 
and B1`). These results may also be explained by peptide self-assembly in an aqueous 
environment. The blue-shifted emission of Trp4 (TrcB` and B1`) suggests that this 
residue is located in a more hydrophobic environment than Trp3 (TrcB and B1). Self-
assembly may lead to reduced fluorescence yield of Trp4 by ground-state complex 
formation within the assembly. Alternatively, self-assembly may increase the proximity 
of nearby quenchers such as the peptide backbone, the amide groups of Asn and Gln, 
the ε-amino group of lysine and/or the phenol group of Tyr. 
Fluorescence difference spectra, which are obtained by subtracting the emission spectra 
for λex 295 from the emission spectra for λex 280, represent the contribution of Tyr energy 
transfer and tyrosinate to the emission for λex 280 (Table 2; Figures 4 and 5).  The relative 
contribution of Tyr/tyrosinate was found to be much greater than expected, which 
suggests that the Trp residues of the tyrocidines are quenched to a great extent and/or 
the fluorescence yield of Tyr/tyrosinate is enhanced by environmental factors. As 
discussed above, quenching of Trp fluorescence is expected to be enhanced by self-
assembly due to ground-state complex formation and/or enhanced proximity to 
quenchers that favour excited-state reactions.  Enhanced Tyr/tyrosinate fluorescence 
may also be related to self-assembly as Tyr/tyrosinate residues in a hydrophobic 
environment (decreased solvent accessibility) exhibit enhanced fluorescence yield [38, 
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40]. As seen for Trp fluorescence, the contribution of Tyr/tyrosinate to fluorescence 
emission of the Trp-containing tyrocidines is influenced by the Orn9/Lys9 content. The 
fluorescence emission spectra of TrcC versus C1 exhibited a decrease in the contribution 
of Tyr energy transfer and/or tyrosinate emission for Lys9-containing TrcC1 (Figure 4), 
whereas tyrocidines B versus B1 and TrcB` versus B1` indicated an increase in the 
contribution of Tyr energy transfer and/or tyrosinate emission for the Lys9-containing 
TrcB1 and B1` (Figure 5). As the efficiency/extent of resonance energy transfer (RET) 
between Tyr and Trp is dependent on the proximity of these side-chains [37], changes in 
the contribution of Tyr may be due to different aggregation states and/or changes in the 
orientation of the Trp and/or Tyr7 side-chains due to Orn9/Lys9 content. Changes in the 
contribution of tyrosinate may be related to different degrees of tyrosinate formation 
and/or differences in the local environment of the Tyr7 residue. Tyrosinate formation 
requires proton transfer from the excited- or ground-state phenolic moiety to an 
acceptor that is in close enough proximity to allow optimal proton transfer [38]. Lys 
residues are expected to be suitable proton acceptors for tyrosinate formation, while 
water, the amide groups of the peptide chain, Gln or Asn are not expected to promote 
protolysis [38, 40]. The Lys9/Orn9 amino-groups may thus affect tyrosinate formation 
directly due to different proton accepting abilities. Alternatively, the Orn9/Lys9 content 
may influence the motion and/or solvent accessibility of the phenolic moiety, as 
restricted motion and/or reduced solvent accessibility has been shown to enhance 
tyrosinate fluorescence (quantum) yield [38].  
In addition to the influence of Orn9/Lys9 content, inversion of the dipeptide unit also 
influenced the contribution of Tyr energy transfer and/or tyrosinate emission. For the 
Orn9-containing peptides, TrcB and B’, decreased contribution of Tyr energy transfer 
and/or tyrosinate emission was observed for TrcB` (contains a Trp4). In contrast, for the 
Lys9-containing TrcB1 and B1’, increased contribution of Tyr energy transfer and/or 
tyrosinate emission was observed for TrcB1 (contains a Trp3). Such differences are 
likely to be related to different aggregation states, which may lead to differences in the 
proximity of the Trp and Tyr residues, differences in formation of tyrosinate and/or 
differences in the solvent accessibility of tyrosinate. 
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Table 2 Influence of tyrocidine sequence on fluorescence emission of the 
Trp-containing tyrocidines in an aqueous environment (Fluorescence 
values are given in arbitrary units ± SEM of three determinations) 
 λex 280 λex 295 Difference spectra 
 λem max 350 λem max 350 λem max 350 
TrcC 699 ± 16 280 ± 5.9 420 ± 12 
TrcC1 434 ± 30 192 ± 2.1 242 ± 28 
TrcB 269 ± 8.8 117 ± 0.90 152 ± 7.9 
TrcB1 415 ± 2.7 170 ± 1.5 246 ± 4.0 
TrcB` 181 ± 4.321 54 ± 0.821 127 ± 3.51 
TrcB1` 381 ± 1.61 111 ± 1.41 271 ±1.31 
 
 1
 The emission maxima of TrcB` and B1` are blue-shifted to 345 nm. 
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Figure 4 Fluorescence emission spectra of the L-Trp-D-Trp-containing 
tyrocidines in an aqueous environment. (A) Excitation at 280 nm 
represents the combined emission of Trp and Tyr; (B) excitation at 
295 nm represents the emission of Trp; whereas the (C) difference 
spectra represent the contribution of Tyr and/or tyrosinate emission. 
Spectra (average of triplicate determinations) of the Orn9-containing 
TrcC are represented by solid lines; spectra (average of triplicate 
determinations) of Lys9-containing TrcC1 are represented by dotted lines.  
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Figure 5 Fluorescence emission spectra of the tyrocidines from the B-group, 
containing both Phe and Trp in the aromatic dipeptide moiety, in an 
aqueous environment.  (A) Excitation at 280 nm represents the combined 
emission of Trp and Tyr; (B) excitation at 295 nm represents the 
emission of Trp; whereas the (C) difference spectra represent the 
contribution of Tyr and/or tyrosinate emission. Spectra of the 
Orn9-containing peptides are represented by solid lines; spectra of 
Lys9-containing peptides are represented by dotted lines. Spectra 
(average of triplicate determinations) of tyrocidines B and B1 
(Trp3-D-Phe4) are indicated by black lines; spectra (average of triplicate 
determinations) of tyrocidines B` and B1` (Phe3-D-Trp4) are indicated by 
red lines. 
 
Tyrocidines that lack tryptophan residues 
The emission spectra for λex 280 for the TrcA and A1 exhibited emission maxima at 
305 nm, which may be attributed to Tyr fluorescence. Comparison of the fluorescence 
emission spectra indicated an increase in Tyr emission (fluorescence yield) for 
Lys9- containing TrcA1 (Table 3; Figure 6). As discussed above, such increased Tyr 
fluorescence yield may be due to differences in aggregation state leading to differences 
in the hydrophobicity of the local environment of the phenolic moiety, or differences in 
the proximity of the Tyr residues to quenching groups. In addition to Tyr fluorescence 
TrcA and TrcA1 also exhibited a shoulder at 340 nm (for λex 280), which may be 
attributed to the combined contribution of ground- and excited-state tyrosinate. 
Emission spectra for λex 295 of tyrocidines A and A1 exhibited emission maxima at about 
350 nm, which may be attributed to ground-state tyrosinate fluorescence. The shoulders 
observed at 330 nm may be attributed to light (Raman) scattering [37], and are probably 
due to the presence of higher order structures. The contribution of excited-state 
tyrosinate could be determined from difference spectra (λmax at 340 nm) (Table 3; 
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Figure 6). TrcA1 exhibited greater tyrosinate emission than TrcA, which may be related 
to different degrees of tyrosinate formation and/or differences in the local environment. 
It is possible that the Lys9 residue of TrcA1 acts as a better proton acceptor for 
tyrosinate formation than the Orn9 residue of TrcA. Alternatively, the Orn9/Lys9 content 
may influence the motion and/or solvent accessibility of the phenolic moiety, due to 
differences in aggregation state.  
Table 3 Influence of Orn9→Lys9 substitution on fluorescence emission of the 
Trp-lacking tyrocidines in an aqueous environment. (Fluorescence 
values are given in arbitrary units ± SEM of three determinations) 
 λex 280 λex 295 Difference spectra 
 λem max 305 λem max 340 λem max 350 λem max 305 λem max 340 
TrcA 62 ± 2.1 53 ± 3.1 24 ± 1.2 60 ± 2.0 31 ± 2.3 
TrcA1 95 ± 1.5 75 ± 2.0 32 ± 0.38 92 ± 1.5 45 ± 1.3 
 
300 325 350 375 400 425 450
0
20
40
60
80
100
A
Wavelength (nm)
Fl
u
o
re
sc
en
ce
 
( λλ λλ
ex
 
28
0)
300 325 350 375 400 425 450
0
5
10
15
20
25
30
35
B
Wavelength (nm)
Fl
u
o
re
sc
en
ce
 
( λλ λλ
ex
 
29
5)
300 325 350 375 400 425 450
0
25
50
75
100
C
Wavelength (nm)
Fl
u
o
re
sc
en
ce
 
( λλ λλ
e
x
 
28
0-
29
5)
 
Figure 6 Fluorescence emission spectra of tyrocidines A and A1 in an aqueous 
environment (A) Excitation at 280nm represents the combined emission 
of Tyr and tyrosinate; (B) excitation at 295 represents the emission of 
tyrosinate; whereas the (C) difference spectra represent the emission of 
Tyr. Spectra (average of triplicate determinations) of the Orn9-containing 
peptides are represented by solid lines; spectra (average of triplicate 
determinations) of Lys9-containing peptides are represented by dotted 
lines. 
 
Summary and Conclusions: Part 1 
With the assumption that aggregates/higher order self-assembly structures already exists 
in solution, differences in the negative ellipticities (θ205 and θ216), UV absorbance and 
fluorescence of the Orn9- and Lys9-containing tyrocidines suggest that the variable 
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cationic residue influences the manner/extent of self-assembly of the tyrocidines, as 
well as the orientation/exposure/local environments of the aromatic amino acids, in an 
aqueous environment. Differences in the negative ellipticities (θ205 and θ216), spectral 
shapes (θ205/θ216), UV absorbance and fluorescence of tyrocidines B, B`, B1 and B1` 
suggest that the relative positioning of the aromatic residues in the variable aromatic 
dipeptide moiety also influences the manner/extent of self-assembly of the tyrocidines, 
as well as the relative orientation/exposure/local environments of the aromatic amino 
acids, in an aqueous environment.  Such differences may be explained by the 
segregation of the two residues in the aromatic dipeptide moiety on opposite faces of 
the molecule. The results also suggest that self-assembly is likely to involve shielding of 
the aromatic residue in position 4 from the aqueous environment (as indicated by the 
blue-shifted emission of Trp4), while the aromatic residue in position 3 remains exposed 
to the polar solvent environment. Furthermore, the lower θ205/θ216 and increased Raman 
scattering exhibited by the Phe3-containing tyrocidines suggest that these peptides may 
form more/larger higher-order structures that the Trp3-containing tyrocidines. 
3.4.2 Results and Discussion: Part 2  
2,2,2-Trifluoroethanol has been shown to stabilise β-turn and β-sheet structures and is 
commonly used as a membrane-mimetic solvent as it induces peptide structures similar 
to those produced by membrane environments [6, 28, 42, 43]. As the bioactivity of 
antimicrobial peptides requires interaction with the target cell membrane [10, 17-20], 
insight regarding the mode of action may be gained by investigation of changes in 
tyrocidine structure/aggregation state induced by a membrane-mimetic environment. 
Furthermore, insight regarding the structure-activity relationships may be gained by 
evaluation of the influence of primary sequence on peptide structure/aggregation state in 
a membrane-mimetic environment. 
3.4.2.1 Changes in tyrocidine structure/aggregation state induced by a 
membrane-mimetic environment  
Inducibility of secondary structure and higher order structures was evaluated by 
comparing the UV absorbance and CD spectra of the tyrocidines in an aqueous and 
membrane-mimetic environment. Comparison of the CD spectra in a 
membrane-mimetic and aqueous environment (Table 4; Figures 7 - 9) indicated 
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significant differences in ellipticity and spectral shape. The negative ellipticity minima 
observed at 205 and 216 nm in an aqueous environment were slightly blue-shifted to 
204 and 214 nm, respectively. This shift was accompanied by the loss of resolution of 
the 214 nm minima. Furthermore, with the exception of TrcA1, TFE led to enhanced 
negative ellipticities, as well as a significant increase in the ratio of the ellipticity 
minima (θ204/θ214) (Table 4). The CD spectra of the structurally related gramicidin S 
(Figure 10) also exhibited significantly enhanced θ204 and θ214, accompanied by a loss of 
resolution of the negative minima at 219 nm observed in an aqueous environment. The 
enhanced ellipticities may be due to increased association by intermolecular hydrogen 
bonding and/or increased intramolecular hydrogen bonding in a membrane-mimetic 
environment. The enhanced ellipticities and change in θ204/θ214 may be thus attributed to 
the induction of higher-order structures that differ from those formed in an aqueous 
environment in the manner of association, degree of hydrogen bonding and/or size of 
the prevalent species.  
Differences between the CD spectra are also expected to be related to differing 
contributions of the aromatic amino acids due to changes in their 
orientation/exposure/local environment. This is supported by the observation that, with 
the exception of TrcA1, the average UV absorbance (A210-230) is significantly greater in 
TFE than in water. The differences in orientation/exposure/local environment of the 
aromatic residues are probably due to changes in aggregation state (both the manner of 
association and size of the prevalent species). The reduced UV absorbance and negative 
ellipticities observed for TrcA1 may be related to its increased state of aggregation and 
settling of the larger aggregates out of solution. 
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Table 4 Change in UV absorbance and CD spectra of the tyrocidines induced in 
a membrane-mimetic environment. The average UV absorbance, 
negative ellipticities (θ204 and θ214) and the ellipticity ratios (θ204/θ214) of 
the tyrocidines in TFE are given. The average UV absorbance, negative 
ellipticities (θ205 and θ216) and the ellipticity ratios (θ205/θ216) of the 
tyrocidines in water are given in parentheses. (Ellipticities (θ) are given 
in degree.cm2.dmol-1 ± SEM of three determinations) 
 
 A210-230 
 θ204 
(θ205) 
θ214 
(θ216) 
 θ204/θ214 
(θ205/θ216) 
TrcC 
0.571 
(0.249) 
 -22.1 ± 0.5 
(-6.6) 
-12.7 ± 0.74 
(-5.8) 
 1.7 ± 0.117 
(1.1) 
TrcC1 
0.465 
(0.269) 
 -17.1 ± 0.36 
(-5.6) 
-10.2 ± 0.86 
(-5.4) 
 1.7 ± 0.168 
(1.0) 
TrcB 
0.261 
(0.159) 
 -15.8 ± 0.38 
(-6.7) 
-10.5 ± 0.48 
(-5.8) 
 1.5 ± 0.038 
(1.2) 
TrcB1 
0.448 
(0.213) 
 -23.1 ± 1.4 
(-9.9) 
-15.5 ± 0.75 
(-8.7) 
 1.5 ± 0.155 
(1.2) 
TrcB` 
0.205 
(0.096) 
 -10.8 ± 0.42 
(-3.0) 
-6.5 ± 0.85 
(-3.5) 
 1.7 ± 0.167 
(0.85) 
TrcB1` 
0.252 
(0.165) 
 -10.4 ± 0.44 
(-4.0) 
-6.3 ± 0.52 
(-4.4) 
 1.7 ± 0.160 
(0.92) 
TrcA 
0.172 
(0.130) 
 -14.3 ± 0.48 
(-8.3) 
-12.8 ± 0.48 
(-9.1) 
 1.1 ± 0.078 
(0.92) 
TrcA1 
0.188 
(0.203) 
 -7.8 ± 0.47 
(-12.2) 
-9.1 ± 1.1 
(-12.9) 
 0.86 ± 0.062 
(0.94) 
GS 
0.115 
(0.116) 
 -36.4 ± 0.98 
(-12.0) 
-25.7 ± 0.94 
(-16.0) 1 
 1.4 ± 0.083 
(0.75)1 
1
 Negative ellipticity minimum at 219 nm; ellipticity ratio θ205/θ219 
The CD spectra in an aqueous and membrane-mimetic environment also exhibited 
significant differences between 220 and 240 nm. For tyrocidines C and C1 
(Trp3-D-Trp4), the negative band observed at 231 nm in water was either lost or 
blue-shifted to 225 nm, and the negative ellipticity of this band was significantly 
enhanced. TrcB and B1 (Trp3), which do not exhibit a negative band in this wavelength 
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 region in water, exhibited a shoulder at 225 nm, while the negative band observed at 
225 nm in water for TrcB` and B1` (Trp4) was significantly enhanced. The 
tryptophan-lacking tyrocidines A and A1 exhibited an additional negative band at 222 
nm, which corresponds to the shoulder seen in the UV absorbance spectra. These 
changes may be related to differing contributions of the aromatic amino acids due to 
re-orientation of and/or differences in exposure/local environment of the aromatic 
side-chains. However, these changes may also be related to β-sheet/stack formation and 
increased intermolecular hydrogen bonding as would be expected in self-assembling 
structures.  
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Figure 7 (A) CD and (B) UV absorbance spectra of tryptophan-containing 
tyrocidines C and C1 in an aqueous and membrane-mimetic 
environment. Spectra in an aqueous environment (water) are represented 
by solid lines; spectra in TFE are represented by dotted lines. The spectra 
of TrcC are indicated in black; the spectra of TrcC1 are indicated in red. 
Each CD spectrum is depicted by a Lowess fit line (20 point smoothing 
window) for an average of triplicate determinations. UV spectra are the 
average of triplicate determinations. 
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Figure 8 CD and UV absorbance spectra of tryptophan-containing tyrocidines of 
the B-group in an aqueous and membrane-mimetic environment. (A) CD 
and (B) UV absorbance spectra of TrcB and B1; (C) CD and (D) UV 
absorbance spectra of TrcB` and B1`. Spectra in an aqueous environment 
(water) are represented by solid lines; spectra in TFE are represented by 
dotted lines. The spectra of TrcB and B` are indicated in black; the 
spectra of TrcB1 and B1` are indicated in red. Each CD spectrum is 
depicted by a Lowess fit line (20 point smoothing window) for an 
average of triplicate determinations. UV spectra are the average of 
triplicate determinations. 
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Figure 9 (A) CD and (B) UV absorbance spectra of tryptophan-lacking 
tyrocidines A and A1 in an aqueous and membrane-mimetic environment. 
Spectra in an aqueous environment (water) are represented by solid lines; 
spectra in TFE are represented by dotted lines. The spectra of TrcA are 
indicated in black; the spectra of TrcA1 are indicated in red. Each CD 
spectrum is depicted by a Lowess fit line (20 point smoothing window) 
for an average of triplicate determinations. UV spectra are the average of 
triplicate determinations. 
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Figure 10 (A) CD and (B) UV absorbance spectra of gramicidin S in an aqueous 
and membrane-mimetic environment. Spectra in an aqueous environment 
are represented by solid lines; spectra in TFE are represented by dotted 
lines. Each CD spectrum is depicted by a Lowess fit line (20 point 
smoothing window) for an average of triplicate determinations. UV 
spectra are the average of triplicate determinations. 
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3.4.2.2 The influence of the variable amino acids on tyrocidine structure 
in a membrane-mimetic environment 
Comparison of the CD spectra of the Orn9- and Lys9-containing tyrocidines indicated 
differences in θ204 and θ214, but similar θ204/θ214 ratios. As seen in an aqueous 
environment, Orn9-containing TrcC exhibited enhanced negative ellipticity relative to 
Lys9-containing TrcC1, while Orn9-containing TrcB exhibited reduced negative 
ellipticity relative to Lys9-containing TrcB1 (Figures 7 and 8). These differences are 
probably related to the orientation/exposure/local environment of the aromatic amino 
acids as a result of differences in the aggregation state favoured by the Orn9/Lys9 
content. In contrast, similar CD spectra were observed for tyrocidines B` and B1` 
(Figure 8), which suggests that the cationic residue does not influence the aggregation 
state or orientation/exposure/local environment of the aromatic amino acids of these 
peptides in a membrane-mimetic environment. Differences between the CD spectra of 
TrcA and A1 (Figure 9) may also be related to differences in aggregation state, although 
the generally reduced negative ellipticity of TrcA1 may have been influenced by other 
factors, such as the settling out of larger self-assembled structures. Comparison of the 
CD spectra of tyrocidines B, B`, B1 and B1` in a membrane-mimetic environment 
indicated generally reduced negative ellipticity for tyrocidines B` and B1`, as well as 
differences in θ204/θ214 (Figure 8). These differences are probably related to differences 
in the manner and/or extent of self-assembly due to the different relative positioning of 
the aromatic residues of the dipeptide unit. Furthermore, the Trp-containing tyrocidines 
(TrcC, C1, B, B1, B` and B1`) exhibited θ204 > θ214, and significantly greater θ204/θ214 
ratios, than the Trp-lacking tyrocidines (TrcA and A1), which may be indicative of 
greater hydrogen bonding and therefore more/larger higher-order structures. 
Summary and Conclusions: Part 2 
The results presented in Part 2 suggest that TFE induces significant changes in the 
self-assembly state, hydrogen bonding and the orientation/exposure/local environment 
of the aromatic amino acids. As peptide self-assembly is influenced by the 
environment/solvent, the manner of association of the tyrocidines, as well as the size of 
the predominant species, in TFE, which is considered a membrane environment mimic, 
is expected to differ from that in water.  Furthermore, self-assembly of the tyrocidines 
in an aqueous environment is probably driven by hydrophobic interactions, whereas 
other interactions, such as hydrogen bonds, are expected to drive self-assembly in TFE, 
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as TFE disrupts the hydrophobic interactions involved in aggregation [7]. Visual 
observation indicated that tyrocidine C1 (the least hydrophobic peptide) formed a small 
number of large, fibre-like structures just after addition to TFE, which dispersed after 
mixing. It was hypothesised that the other tyrocidines would also form such structures, 
albeit too small to be seen. β-sheet peptides are likely to form superstructures upon 
membrane interaction [10] and induction of large higher-order structures of the 
tyrocidines in the presence of TFE is supported by the enhanced negative ellipticities, 
which are indicative of intermolecular interaction (self-assembly) and structural 
stabilisation [7]. The enhanced negative ellipticity at around 204 nm and the fact that 
TFE facilitates hydrogen-bond formation [42, 43] suggests that the higher-order 
structures formed in the presence of TFE are stabilised by intermolecular hydrogen 
bonding. The manner in which peptide conformation, amphipathicity and available 
surface area will influence self-assembly in TFE is also expected to be different from 
that in water. In an aqueous environment, the hydrophobic regions of the peptides will 
associate in order to shield them from the polar solvent. In contrast, the hydrophobic 
portions of the peptide are expected to be exposed in TFE, with preferential shielding of 
the polar regions from the solvent. Differences in the contribution of the aromatic amino 
acids around 230 nm also suggest differences in the arrangements of peptide molecules 
within the higher-order structures, resulting in increased exposure of the aromatic 
residues. The enhanced negative ellipticity around 230 nm was most pronounced for 
tyrocidines B` and B1`, which further supports the hypothesis of increased exposure of 
Trp4 in TFE (Trp4 is “buried” in water induced self-assembly). Unfortunately, due to the 
high Raman scattering and fluorescence quenching by TFE, fluorescence spectroscopy 
could not be applied to evaluate structural changes in a membrane environment. 
 
An additional important observation is that the changes observed for the Trp-containing 
tyrocidines differ significantly from the changes seen for tyrocidines A and A1. The 
Trp-containing tyrocidines exhibited greatly enhanced θ204 and less dramatically 
enhanced θ214, which gives rise in the large increase in θ204/θ214. These results correlate 
strongly with the results for GS (Figure 10), which showed greatly enhanced negative 
ellipticity at 205 nm, less dramatically enhanced θ216, and significantly increased 
θ205/θ216. The conformational changes of the Trp-containing tyrocidines upon membrane 
interaction may therefore be similar to that of GS. In contrast, the θ205 and θ216 of trcA 
are enhanced to more similar extents, leading to a less pronounced change in θ205/θ216. 
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TrcA1 exhibited reduced θ205 and some reduction of θ216, which may be related to the 
self-assembly state and/or precipitation. These results indicated that the conformational 
changes of the Trp-lacking tyrocidines upon target membrane interaction may differ 
significantly from that of the Trp-containing tyrocidines and GS. 
3.5 Conclusions  
Several deductions could be made from the CD, UV absorbance and fluorescence 
results. First, the variable cationic residue (Orn9/Lys9) and aromatic dipeptide unit 
(Phe3,4/Trp3,4) probably influences the manner and/or extent of tyrocidine self-assembly 
in an aqueous and membrane-mimetic environment. The results suggest that, in an 
aqueous environment, the Phe3-containing tyrocidines exhibit greater 
self-assembly/β-sheet stability than the Trp3-containing tyrocidines, while the 
Trp-containing tyrocidines exhibit greater self-assembly/ β-sheet stability than the 
Trp-lacking tyrocidines in a membrane-mimetic environment. Second, the manner 
and/or extent of self-assembly in an aqueous and membrane-mimetic environment 
differ, probably due to different driving forces for association. Last, the Trp-containing 
and Trp-lacking tyrocidines exhibit differences in the manner and/or extent of 
self-assembly induced by a membrane-mimetic environment.   
The observed differences in self-assembly of the various tyrocidines may be due to the 
differences in physicochemical properties, such as amphipathicity, hydrophobicity and 
size (Chapter 4). Furthermore, differences in self-assembly of the various tyrocidines in 
aqueous solution and a membrane environment are likely to influence the bioactivity 
(Chapters 5 and 7), and possibly the mode of action (Chapters 6 and 7), of the 
tyrocidines. 
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 Chapter 4 
 Homology modelling and physicochemical 
characterisation of the tyrocidines 
 
4.1 Introduction 
Physicochemical properties of antimicrobial peptides that influence their biological 
activity and selectivity include conformation, size, amphipathicity, hydrophobicity, and 
charge distribution [1-6]. In addition to these physicochemical properties, studies 
involving the activity of cyclic β-sheet antimicrobial peptides, such as gramicidin S [7-
12] and tachyplesin [5], have revealed that the relative positioning of the basic residues 
and the maintenance of a critical balance in amphipathic character are essential for 
antimicrobial activity. In order to determine the role of tyrocidine structure in activity 
modulation and analyse the structure-activity (toxicity) relationships (QSA(T)R), the 
three-dimensional structure and physicochemical characteristics of the tyrocidines must 
be elucidated. Furthermore, self-assembly influences the bioactivity of antimicrobial 
peptides [3, 5, 13-18] and the tendency/ability of antimicrobial peptides to form 
aggregates/self-assemblies is related to their primary structure, conformation, general 
topology, amphipathicity and hydrophobicity [10, 16, 17, 19, 20]. As the primary 
sequence of the tyrocidines was shown to influence self-assembly in both aqueous and 
membrane-mimetic environments (Chapter 3), the relationship between tyrocidine 
self-assembly and physicochemical descriptors of hydrophobicity/amphipathicity and 
size are of particular interest. The physicochemical and self-assembly descriptors, as 
well as the correlations between them, described in this chapter are of particular 
significance to the structure-activity relationships discussed in Chapters 5-7. 
4.2 Methods  
4.2.1 Homology modelling of the tyrocidines and gramicidin S 
A low energy model of TrcC, using 2D-NMR NOE constraints, was generated in a 
collaborative study with the group of Prof. Graham Jackson (University of Cape Town). 
Homology modelling using the low energy model of TrcC as starting structure of 
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gramicidin S (GS) and the five other major tyrocidines was done by M. Rautenbach 
using YASARA 9.10.5© software [21, 22]. TrcB’ and trcB1’ was mutated from low 
energy structures of TrcA and TrcA1, respectively. Mutated structures were subjected to 
a number of 200 fs YASARA molecular dynamic (MD) simulations at 298 K, followed 
by in vacuo energy minimisations using the NOVA force field [22]. Low energy 
structures were subjected to MD simulations for 400 fs at 333 K, followed by NOVA 
minimisation in order to test whether the structures have reached global minima. It was 
assumed that local or global energy minima had been reached once consecutive 
simulation runs, followed by energy minimisations yielded structures with similar 
energy minima and structures. Ten low energy structures (average RMSD<1) of each 
peptide were used to evaluate the secondary structure, intramolecular hydrogen bonding 
and physicochemical parameters, including solvent accessible  volume (SAV) and 
solvent accessible surface area (SASA) with YASARA 9.10.5©. 
4.2.2 Physicochemical characterisation 
Basic physicochemical properties that describe hydrophobicity, amphipathicity, 
conformation and size were determined in vitro by analytical RP-HPLC analysis 
(Chapter 2), circular dichroism (CD) (Chapter 3), calculated using theoretical 
parameters and in silico using models from homology modelling. Theoretical molecular 
descriptors of hydrophobicity/amphipathicity included hydropathy, lipophilicity (L), 
and amphipathicity (Q/L). Theoretical hydropathy and lipophilicity were calculated as 
the sum of the hydropathy indices [23] and lipophilicity parameters (piFP) [24, 25] of the 
constituent amino acids, respectively. Theoretical amphipathicity was calculated as the 
ratio of overall charge (Q) to overall lipophilicity (L). The theoretical molecular 
descriptors of size and charge included theoretical side-chain surface area (SCSA) and 
theoretical molecular volume, calculated as the sum of the side-chain surface areas and 
volumes of the constituent amino acids [24], respectively. The in silico conformational 
dependent parameters, calculated from the low energy structures of the tyrocidines 
using YASARA software, included solvent-accessible surface area (SASA) and solvent 
accessible volume (SAV). In vitro descriptors of conformation were calculated from CD 
parameters: θ205/θ216 in water (θ205/θ216, water); θ204/θ214 in TFE (θ204/θ214, TFE); and change 
in θ205/θ216 from water to TFE (∆ θ205/θ216, water→TFE). Correlations between the various 
physicochemical parameters were investigated by performing linear or exponential 
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regression analysis using GraphPad Prism® 4.00 (GraphPad Software, San Diego, 
USA). 
4.3 Results and Discussion 
4.3.1 Homology modelling of the tyrocidines and gramicidin S 
A low energy model of TrcC, generated by using 2D-NMR NOE constraints (model 
courtesy of G. Jackson), was used as the basic structure for the homology modeling of 
GS and the tyrocidines. Validation of the homology modelling experiments in this study 
was done by M. Rautenbach who obtained exceptional correspondence of the GS 
structure (GS was mutated from a low energy TrcC model) to the known GS structure 
[8, 26-31] (Figure 1). GS adopts an anti-parallel β-sheet/β-turn structure with four 
hydrogen bonds which is amphipathic due to sequestration of the cationic Orn side 
chains and D-Phe rings on the hydrophilic face and the four hydrophobic Leu and Val 
side-chains on the non-polar face [8, 26-31]. The low energy structures of the GS 
homology model adopted the known antiparallel β-sheet structure composed of 
Val3-Orn4-Leu5 and Val8-Orn9-Leu10 and connected by two β-turns composed of 
D-Phe1-Pro2 and D-Phe6-Pro7
.
 The β-sheet in the GS validation model is also stabilised 
by the known four internal hydrogen bonds: Val3-NH-O-Leu10, Leu10-NH-O-Val3, Leu5-
NH-O-Val8, and Val8-NH-O-Leu5. The low energy structures of GS also indicated that 
the hydrophobic Leu and Val side-chains are located on the non-polar face of the 
molecule, whereas the D-Phe and cationic Orn side-chains are located on the polar face, 
leading to a highly amphipathic structure. However, in addition to the backbone amide-
carbonyl hydrogen bonds, some of the GS models showed hydrogen bonds between the 
δ-amide group of Orn4-RNH-O-Pro2 and Orn9-RNH-O-Phe1, as well as different D-Phe 
and Orn rotamers [32] (results not shown).  
Comparison of the low energy TrcC model with the GS structure showed good 
backbone homology, with two corresponding hydrogen bonds in the conserved VOLPF 
pentapeptide moiety (Figure 1). Previous research concerning TrcA structure indicated 
that this peptide adopts a type I β-turn/type II` β-turn/β-pleated sheet conformation in 
solution [33].  Six residues of the backbone (Val8-Orn9-Leu10 and Phe3-D-Phe4-Asn5) 
form an antiparallel β-pleated sheet structure, which is joined at one end by a type I 
β-turn composed of Gln6-Tyr7, and a type II` β-turn composed of D-Phe1-Pro2 at the 
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other end [33, 34]. It has been proposed that the β-sheet moiety is stabilised by four 
internal hydrogen bonds, analogous to GS (Figure 1), that form between 
Phe3-NH-O-Leu10, Leu10-NH-O-Phe3 and Val8-NH-O-Asn5 and Asn5-NH-O-Val8 [34]. 
All the tyrocidines modelled exhibited similar backbone conformations and the 
secondary structures and hydrogen-bonding observed for these low energy structures 
correspond to the proposed structures of Gibbons et al. (1975) [34] and Kuo et al. 
(1980) [33] (Figures 2 and 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Low energy molecular models of gramicidin S and tyrocidine C. The known 
molecular structure of gramicidin S (top (clear) figure, from 
Jelokhani-Niaraki et al. (2008) [35], corresponds well with the molecular 
model obtained in this study (middle panel). The low energy model of TrcC 
(bottom panel) shows high backbone homology to the gramicidin S model. 
GS and TrcC models courtesy of M. Rautenbach. 
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Molecular dynamic (MD) simulations run on the TrcC structure showed the exceptional 
rigidity of the β-sheet backbone structure (Figure 2, data courtesy of M Rautenbach). 
The β-sheet is composed of Val8-Orn9-Leu10 and X3-D-X4-Asn5, where X denotes Trp 
or Phe. The two strands of the β-sheet are joined by two β-turns composed Gln6-Tyr7 
and D-Phe1-Pro2. However, in contrast to the four hydrogen bonds that Gibbons et al. 
(1975) [34] predicted in Trc A, all the low energy tyrocidine structures only displayed 
three internal hydrogen bonds (Phe3-NH-O-Leu10, Leu10-NH-O-Phe3 and Val8-NH-O-
Asn5) stabilising the β-sheet structure.  Only TrcB1 exhibited the formation of Asn5-NH-
O-Val8
 
internal hydrogen bond (Figure 3). The Trc homology models also indicated that 
the Trp4 amino group of tyrocidines C, C1, B` and B1` participate in a hydrogen bond 
with the backbone carboxyl group of Gln6 (Figure 3). In contrast, the Trp3 amino-groups 
do not participate in any hydrogen bonds in the homology models.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Overlay of 30 low energy structures of TrcC to show the rigidity of the 
backbone structure. The original NOE constrained TrcC structure was 
subjected to a number of 200 ps YASARA MD simulations at 298 K and 
minimised with the NOVA forcefield (data courtesy of M Rautenbach).  
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The homology modelling also indicated that, unlike GS, TrcC does not contain 
segregated hydrophobic and polar sides (Figures 1 and 2). Instead, an aromatic residue 
extends from each face of the peptide. An important observation is that the aromatic 
residues of the variable dipeptide unit extent to opposite sides of the tyrocidine 
structure, with residue 3 (Phe3/Trp3) extending to one side while residue 4 (Phe4/Trp4) 
and the cationic residue (Orn9/Lys9) extend toward the opposite side (Figure 3). Such 
segregation of the variable aromatic residues may have important implications for 
tyrocidine self-assembly and membrane interaction. 
4.3.2 Physicochemical characterisation and correlation between the 
physicochemical properties of the tyrocidines 
The in vitro, theoretical and in silico physicochemical properties of the tyrocidines that 
describe hydrophobicity, amphipathicity and size are summarised in Table 1. 
Investigation of correlations between the various physicochemical parameters may 
provide an indication of the accuracy of the theoretical descriptors, as well as the extent 
to which conformation and self-assembly influence the true parameters. In interpreting 
correlations between the physicochemical properties, it is important to consider the 
manner in which the parameters were determined as this will determine which peptide 
properties are taken into consideration.   
RP-HPLC retention time, which is representative of apparent hydrophobicity/solution 
amphipathicity, is determined in vitro and the influence of conformation and 
self-assembly are thus inherently taken into consideration. In contrast, the theoretical 
descriptors of hydrophobicity/amphipathicity and size only consider the amino acid 
content, reflecting the combined contribution of the constituent amino acids without 
considering the influence of conformation or self-assembly. 
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Figure 3  Low energy molecular models of the tyrocidines showing the β-sheet structure 
as a ribbon and the side chains of the variable amino acids. Low energy 
models of the six major tyrocidines are courtesy of M. Rautenbach 
A A1
B
B’
C1C
B1’
B1
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The in silico parameters determined from the homology models take the conformation 
of the peptides into consideration and should thus provide a more accurate estimate of 
available surface area/volume than the theoretical parameters. It should, however, be 
kept in mind that the modelling was done in vacuo, which influence the results as the 
peptides may assume different conformations in solution. Furthermore, the in silico 
parameters do not take self-assembly into account and could differ significantly from 
the “true” available surface area/volume of the tyrocidines in an aqueous solution.  
All the physicochemical parameters of the tyrocidines and gramicidin S given in Table 
1 were correlated with each other (in vitro/in silico with theoretical; in vitro with in 
silico, in vitro with in vitro). Only correlations with R2> 0.80 were considered for 
inclusion in this study. 
Investigation of correlations between in vitro RP-HPLC retention time and theoretical 
hydropathy, lipophilicity and amphipathicity indicated that the tyrocidines may be 
categorised into two distinct groups based on their Lys9/Orn9 content. The results 
indicated linear relationships (R2 > 0.88), but with a constant difference between curves 
representing the Lys9-containing (tyrocidines A1, B1, B1` and C1) and Orn9-containing 
(tyrocidines A, B, B` and C) peptides (results not shown). RP-HPLC retention time and 
theoretical amphipathicity (Q/L) exhibited the best correlation with R2-values of 0.92 
and 0.98 for the Orn9- and Lys9-containing tyrocidines, respectively (Figure 4A). The 
required segregation of the Orn9- and Lys9-containing tyrocidines suggests that the 
conformations and/or self-assembly of the two groups are significantly different so as to 
influence their true solution amphipathicity to different extents. However, homology 
modelling indicated similar backbone conformations for the Orn9- and Lys9-containing 
tyrocidines (Figures 2 and 3). 
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Table 1  Summary of the physicochemical parameters of the tyrocidines and gramicidin S The theoretical molecular descriptors were 
calculated from the peptide sequences [36] and documented amino acid properties [23-25].  
 
Parameter Type TrcA TrcA1 TrcB TrcB1 TrcC TrcC1 TrcB’ TrcB1’ GS 
HPLC RT1 (minutes) In vitro 11.81 11.33 9.48 9.24 8.31 7.90 8.98 9.72 12.05 
Hydropathy2 Theoretical 24.0 23.1 23.7 22.8 23.4 22.5 23.7 22.8 29.2 
Lipophilicity3 Theoretical 9.55 8.16 10.01 8.62 10.47 9.08 10.01 8.62 11.66 
Q/L4 Theoretical 0.105 0.123 0.100 0.116 0.096 0.110 0.100 0.116 0.172 
Side-chain surface area5 (SCSA, Å2) Theoretical 721.9 741.4 750.8 770.3 779.7 799.2 750.8 770.3 648.2 
Molecular volume6 (Å3) Theoretical 1582.2 1609.2 1620.1 1647.1 1658.0 1685.0 1620.1 1647.1 1501.8 
Solvent accessible surface area7 (SASA, Å2) In silico 1199 1208 1217 1231 1267 1269 1277 1253 1170 
Solvent accessible volume7 (SAV, Å3) In silico 2680 2715 2741 2777 2833 2854 2808 2801 2606 
θ205/θ216 in water In vitro 0.92 0.94 1.15 1.14 1.15 1.03 0.85 0.92 0.75 
θ204/θ214 in TFE In vitro 1.11 0.93 1.51 1.49 1.74 1.68 1.67 1.67 1.42 
change in θ205/θ216 from water to TFE In vitro 21.39 -1.21 31.52 30.28 52.10 63.83 95.85 82.02 89.10 
  
1
 From analytical HPLC chromatograms of purified peptides (Chapter 2). 
  2
 Sum of hydropathy indices [23] of constituent amino acids. 
  3 Sum of lipophilicity parameters (piFP) [24, 25] of constituent amino acids. 
  4
 Theoretical amphipathicity expressed as ratio between overall charge (Q) and overall lipophilicity (L).  
  5
 Sum of side-chain surface areas [24] of constituent amino acids. 
  6 Sum of residue volumes [24] of constituent amino acids; volume of Orn = volume of Lys – methylene (27Ǻ3)  
  7
 In silico determination from homology models (average of 10 low energy models).
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One difference between the models of the Orn9- and Lys9-containing tyrocidines is the 
participation of the Orn δ-amino group in a backbone hydrogen bond in most of the low 
energy models, while only a few models indicated such participation of the Lys ε-amino 
group (Figure 3). It is thus most likely that the Orn9/Lys9 content of the tyrocidines 
influences the extent of self-assembly (size of self-assembly structures) and/or the 
orientation of the peptide molecules within the higher-order structures. The influence of 
conformation and/or self-assembly on solution amphipathicity is further illustrated by 
the different HPLC retention times of TrcB versus B’ and TrcB1 versus B1’ (Table 1). 
These peptides have identical amino acid compositions, varying only in sequence due to 
inversion of the aromatic dipeptide unit (Phe/Trp3-D-Phe/D-Trp4). Although homology 
modelling indicated similar backbone conformations, the aromatic side-chains of the 
dipeptide unit were shown to extend to opposite sides of the molecule (Figure 3). The 
relative positioning of the aromatic residues within the variable dipeptide unit may thus 
influence the solution amphipathicity (HPLC retention time) directly due to varying 
exposure of the aromatic residues, and/or indirectly due to differences in the extent or 
manner of self-assembly.  
Investigation of correlations between theoretical and in silico molecular descriptors of 
size indicated a poor correlation (R2 = 0.52) between theoretical side-chain surface area 
and in silico solvent-accessible surface area, which confirms that the influence of 
peptide conformation on available surface area is sequence-dependent. In contrast, a 
linear relationship (R2 = 0.82) was observed between theoretical molecular volume and 
in silico solvent-accessible volume (Figure 4B), indicating that the peptide 
conformation influences the volume of the various tyrocidines in a similar 
manner/extent. The influence of conformation on accessible surface area and volume is 
further illustrated by the different solvent-accessible surface areas and 
solvent-accessible volumes of TrcB versus B’ and TrcB1 versus B1’ (Table 1), which 
may be attributed to the influence of the relative positioning/orientation of the aromatic 
residues of the variable dipeptide unit.   
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Figure 4  Linear correlations between molecular descriptors of A. amphipathicity 
(HPLC RT and theoretical Q/L) and B. size (theoretical volume and in 
silico determined solvent accessible volume).  
 
 
Inverse linear correlations were observed between HPLC retention time and in silico 
molecular descriptors of size (Figure 5), which, as previously noted by Rautenbach et 
al. (2007) [37], imply that larger peptides may have a weaker interaction with the C18 
matrix. However, correlations between in silico solvent-accessible surface area and 
HPLC retention required segregation of the Phe3- (R2 = 0.997) and Trp3- (R2 = 0.95) 
containing tyrocidines. The required segregation based on Phe3/Trp3 content suggest 
that the solvent-accessible surface areas of the Phe3- and Trp3-containing tyrocidines 
may differ sufficiently so as to lead to differences in the size of the self-assembly 
structure in an aqueous solution and/or orientation of peptide molecules within the 
self-assembly structure. However, the extent and/or manner of self-assembly is less 
sensitive to differences in the solvent-accessible volume of the Phe3- and 
Trp3-containing tyrocidines as indicated by the linear correlation (R2 = 0.88) observed 
when peptides are not segregated (Figure 5B).  
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Figure 5  Linear correlations between molecular descriptors of solution 
amphipathicity (HPLC retention time) and size A. solvent-accessible 
surface area and B. solvent-accessible volume).  
 
4.3.3 Correlation between the physicochemical and CD parameters of 
the tyrocidines 
Circular dichroism ellipticity ratios were chosen as indicators of backbone conformation 
and self-assembly (different size assemblies and/or different orientation of molecules 
within the assembly) in an aqueous (θ205/θ216) and membrane-mimetic (θ204/θ214) 
environment. The change in ellipticity ratio from water to TFE (∆ θ205/θ216, water→TFE) 
was chosen as an indicator of induction of secondary structure and self-assembly in a 
membrane environment. As self-assembly is, at least in part, dictated by 
physicochemical characteristics of the tyrocidines, correlations between self-assembly 
and molecular descriptors of hydrophobicity/amphipathicity and size are expected. 
No clear correlations were observed between HPLC retention time, solvent-accessible 
surface area, solvent-accessible volume and θ205/θ216 in an aqueous environment. 
However, the identity of residue 3 was found to be an important determinant of the 
θ205/θ216 in water, with the Trp3-containing tyrocidines (TrcC, C1, B and B1) exhibiting 
greater θ205/θ216 (ranging between 1.0 and 1.2) in water than the Phe3-containing 
tyrocidines (TrcA, A1, B` and B1`) (ranging between 0.85 and 0.94) (Table 1). As 
discussed in Chapter 3, greater θ205/θ216 in an aqueous environment is related to lower 
θ216, which is indicative of reduced β-sheet structure. The greater θ205/θ216 of the 
Trp3-containing tyrocidines may thus imply reduced self-assembly of the 
Trp3-containing tyrocidines in an aqueous environment. Such differences in the 
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tendency for self-assembly of Trp3- and Phe3-containing tyrocidines may be related to 
the influence of differing solvent-accessible surface areas (refer to Figure 4).  
A negative linear correlation was observed between θ204/θ214 in TFE and HPLC 
retention time (R2 = 0.81) (Figure 6). As greater θ204/θ214 in TFE is generally associated 
with enhanced θ204, which is indicative of increased hydrogen bonding and 
self-assembly (refer to Chapter 3), these results suggests that increased solution 
amphipathicity is associated with reduced β-sheet structure/self-assembly in TFE. 
Furthermore, the Trp-containing tyrocidines exhibited greater θ204/θ214 in TFE than the 
Trp-lacking tyrocidines (Figure 6). The greater θ204/θ214 of the Trp-containing 
tyrocidines may thus imply that the presence of Trp (irrespective of position) leads to 
enhanced β-sheet structure/self-assembly induction in TFE.  
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Figure 6  Correlations between molecular descriptors of solution amphipathicity, 
size and conformation/self-assembly. Ellipticity ratio θ204/θ214 in TFE 
versus (A) HPLC retention time and (B) in silico solvent-accessible 
surface area.  
 
Positive linear correlations were observed between the θ204/θ214 in TFE and 
solvent-accessible surface area of the Phe3- (R2 = 0.86) and Trp3- (R2 = 0.87) containing 
tyrocidines. The required segregation of the Phe3- and Trp3-containing tyrocidines 
indicated that the identity (possibly due to its solvent-accessible surface area) of residue 
3 is an important determinant of the tendency for self-assembly in TFE. 
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Linear correlations were also observed between the Trc changes in CD ellipticity ratio 
from water to TFE (∆ θ205/θ216 water→TFE), HPLC retention time and solvent-accessible 
surface area when the peptides were segregated based on their Phe3/Trp3 content (Figure 
7). Negative linear correlations were observed between ∆ θ205/θ216 water→TFE and HPLC 
retention times of the Phe3- (R2 = 0.87) and Trp3- (R2 = 0.97) containing tyrocidines 
(Figure 7A), which implies that increased solution amphipathicity is associated with 
reduced inducibility of secondary structure/self-assembly.  
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Figure 7  Correlations between molecular descriptors and change in ellipticity 
ratio from water to TFE. Change in ellipticity ratio θ205/θ216 from water 
to TFE versus (A) HPLC retention time, and (B) in silico 
solvent-accessible surface area. 
Positive linear correlations were observed between ∆ θ205/θ216 water→TFE and 
solvent-accessible surface areas of the Phe3- (R2 = 0.90) and Trp3- (R2 = 0.87) 
containing tyrocidines (Figure 7B), which implies that increased solvent-accessible 
surface area is associated with enhanced inducibility of secondary 
structure/self-assembly. The required segregation of the Phe3- and Trp3-containing 
tyrocidines indicated that the identity of residue 3 is an important determinant of 
inducibility of secondary structure/self-assembly in TFE. Furthermore, the identity of 
residue 4 was found to be an important determinant of inducibility of secondary 
structure/self-assembly, with the Trp4-containing tyrocidines (TrcC, C1, B and B1) 
exhibiting greater change in θ205/θ216 than the Phe4-containing tyrocidines (TrcA, A1, B` 
and B1`) (Table 1). 
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4.4 Conclusions 
Correlations between in vitro, in silico and theoretical molecular descriptors indicated 
that the three-dimensional conformation, extent and/or manner of self-assembly of the 
tyrocidines influence both the true solution amphipathicity and available surface 
area/volume. The influence of the cationic residue on true solution amphipathicity, the 
sequence-dependence of solvent-accessible surface area and the influence of 
conformation on solvent-accessible surface area suggest that the theoretical descriptors 
do not provide an accurate reflection of the physicochemical character of the tyrocidines 
in solution. Although the theoretical molecular descriptors may be used to perform 
QSAR analyses, these results suggest that in vitro and in silico physicochemical 
parameters should be used as far as possible.  
Correlations between in vitro solution amphipathicity (HPLC retention time) and in 
silico descriptors of size suggested that the solvent-accessible surface areas of the Phe3- 
and Trp3-containing tyrocidines may differ sufficiently so as to lead to differences in 
amphipathicity, the manner and/or extent of self-assembly. This hypothesis is supported 
by correlations observed between in vitro solution amphipathicity (HPLC retention 
time) and CD-derived descriptors of conformation/self-assembly in an aqueous 
environment, which suggested reduced self-assembly of the Trp3-containing tyrocidines 
relative to Phe3-containing tyrocidines. Correlations between in vitro solution 
amphipathicity, in silico solvent-accessible surface area and CD-derived descriptors of 
conformation/self-assembly in TFE (membrane-mimetic environment) suggested that 
decreased solution amphipathicity and greater solvent-accessible surface area is 
associated with enhanced β-sheet structure/self-assembly. Furthermore, the presence of 
Trp (irrespective of position) was found to be associated with enhanced β-sheet 
structure/self-assembly in TFE. Correlations between in vitro solution amphipathicity, 
in silico solvent-accessible surface area and CD-derived descriptors of inducibility of 
conformation/self-assembly suggested that decreased solution amphipathicity and 
greater solvent-accessible surface area is associated with enhanced inducibility of 
secondary structure/self-assembly. However, it may also indicate that increased solution 
amphipathicity may lead to an increased loss of peptide due to the formation of large 
structures in TFE. Furthermore, greater inducibility of secondary 
structure/self-assembly was seen for the Trp4-containing tyrocidines (TrcC, C1, B and 
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B1) than the Phe4-containing tyrocidines (TrcA, A1, B` and B1`).  However, this result 
may also indicate that the Phe4-containing tyrocidines may already be approaching 
maximal self-assembly in an aqueous solution, leading to lower observed inducibility of 
secondary structure/self-assembly in TFE. 
Overall, the results illustrate the importance of the variable cationic residue and 
aromatic dipeptide unit in peptide conformation and/or self-assembly. The identity of 
residue 3 was found to be an important determinant of β-sheet structure/self-assembly in 
both an aqueous and membrane-mimetic environment, while the identity of both 
residues 3 and 4 are important determinants of inducibility of secondary 
structure/self-assembly. 
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The necessity for the development of a new class of antimicro-
bial agents is underlined by the rapid emergence of microbial
resistance to classical antibiotics.1 Over the past two decades,
antimicrobial peptides have been considered as candidates for
development of therapeutic agents and bio-preservatives.1 The
broad spectrum antimicrobial activity, selectivity, speed of action,
and reduced likelihood of resistance development toward antimi-
crobial peptides implies that these compounds may serve as
invaluable templates for the development of novel therapeutic
agents.1
Almost 70 years ago Dubos and Hotchkiss2 found potent antimi-
crobial activity in the fermentation broth of Bacillus brevis, now
classiﬁed as Bacillus aneurinolyticus. This activity was due to a
diverse group of antimicrobial peptides collectively known as the
tyrothricin complex, which is composed of the basic, cyclic tyroci-
dines and neutral, linear gramicidins.2,3 Tyrothricin was one of the
ﬁrst antibiotics in clinical use, albeit as topical antibiotic.4 The pri-
mary structures of 28 tyrocidines and analogues have been deter-
mined,3 and a study by Gibbons et al.5 suggests that these cyclic
decapeptides assume antiparallel b-pleated sheet structures. The
tyrocidines contain one of the pentapeptide repeats of gramicidin
S, Val-Orn-Leu-Pro-D-Phe. In some tyrocidines the Orn residue is
substituted with Lys (Table 1, Fig. 1).3 The other ﬁve residues in
the tyrocidines differ only by conservative substitutions in the aro-
matic dipeptide unit.3 In some of the minor tyrocidines thell rights reserved.
x: +27 21 8085863.aliphatic residues in the gramicidin S pentapeptide, Val and Leu,
are substituted by other aliphatic residues. In the tyrocidine-like
peptides the invariable Tyr is substituted with Trp (tryptocidines)
or Phe (denoted as phenicidines by our group).3 The tyrocidines
are known to possess broad spectrum antimicrobial activity
toward Gram-positive and Gram-negative bacteria6 and parasites,
notably the malarial parasite Plasmodium falciparum.7 Since the
antibacterial studies early last century on the tyrocidine mixture,
only a few follow up molecular and activity studies were
conducted. These studies mostly involved investigation of the
structure3,5,8,9 and aggregation properties9–11 of the tyrocidines,
generation of synthetic analogue libraries,12,13 and the antiplasmo-
dial activity of the major tyrocidines.7
We decided to revisit the natural antimicrobial peptide library
of tyrocidines and focused on the six major tyrocidines (Table 1)
and their structure–activity relationships, with the food-borne
pathogen, Listeria monocytogenes, as one of the bacterial targets.
L. monocytogenes is the causative agent of listeriosis, a severe
disease with high hospitalisation and case fatality rates.14 As with
many pathogenic microbes, the development of resistance of L.
monocytogenes to antibiotics poses a major problem with the
severity of listeriosis, in addition to the economic impact of big
product recalls, necessitating the development of preventative
measures to control the spread of L. monocytogenes.14 Nisin, a
bacteriocin produced by lactic acid bacteria, was the ﬁrst antibiotic
peptide to be approved as a bio-preservative for the control of food
spoilage organisms, including L. monocytogenes.15 Unfortunately,
nisin-resistant Listeria strains have already been identiﬁed,16
necessitating the development of alternative preservatives and
treatments.
Table 1
Summary of the puriﬁcation and characterisation data of the eight tyrocidines in this study
Identity Abbreviation Sequence HPLC tR (min) Monoisotopic Mr observed (expected)
Tyrocidine A TrcA Cyclo-(VOLfPFfNQY) 11.81 1269.64 (1269.70)
Tyrocidine A1 TrcA1 Cyclo-(VKLfPFfNQY) 11.33 1283.71 (1283.70)
Tyrocidine B TrcB Cyclo-(VOLfPWfNQY) 9.48 1308.66 (1308.70)
Tyrocidine B1 TrcB1 Cyclo-(VKLfPWfNQY) 9.24 1322.69 (1322.70)
Tyrocidine C TrcC Cyclo-(VOLfPWwNQY) 8.31 1347.67 (1347.70)
Tyrocidine C1 TrcC1 Cyclo-(VKLfPWwNQY) 7.90 1361.69 (1361.70)
Gramicidin S GS Cyclo-(VOLfPVOLfP) 12.05 1140.72 (1140.70)
The HPLC retention times of the six natural tyrocidines and two synthetic tyrocidines were obtained from analytical HPLCs of the puriﬁed tyrocidines; the observed
monoisotopic weights were calculated from ESMS spectra of the puriﬁed peptides; the expected monoisotopic weights were calculated as the sum of the molecular weights of
the constituent amino acids. The percentage purity of all the puriﬁed tyrocidines was >95%, as calculated from analytical HPLC analyses at 254 nm. Standard one letter
abbreviations are used for the amino acid residues, except for ornithine that was denoted as O. D-residues are given in lower case letters. The underlined residues highlight the
variable cationic residue and variable aromatic dipeptide unit.
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Figure 1. The primary structure of the cyclic depapeptide antibiotic, tyrocidine A.
Standard three letter abbreviations are used for the amino acid residues, except for
ornithine that was denoted as Orn. Amino acid abbreviations in brackets indicates
the variable amino acid identities in the other tyrocidines (refer to Table 1 for
detail). The numbering of the peptide chain is based on the biological synthesis
sequence.
5542 B. M. Spathelf, M. Rautenbach / Bioorg. Med. Chem. 17 (2009) 5541–5548The tyrocidines may be promising templates for alternative
treatments for various bacterial infections, especially as bio-preser-
vatives or as ‘last-resort’ chemotherapeutic agents. In order todevel-
op the tyrocidines into therapeutic agents or bio-preservatives,
insight regarding their structure–activity relationships and mecha-
nism of action is imperative. An understanding of the structure–
function relationships may allow for the development of more
efﬁcacious molecules, improved selectivity and reduced toxicity,
as well as provide insight regarding the mechanism of action and
possible resistance. Therefore, the aims of this study were to purify
the major tyrocidines found in the tyrothricin complex, determine
the relative activities of the different tyrocidines towardGram-posi-
tive bacteria, in particular L. monocytogenes, and Gram-negative
bacteria, and quantify any correlation between the structural char-
acteristics and the activities of these peptides.
2. Materials
The tyrothricin (from B. aneurinolyticus), gramicidin S, triﬂuoro-
acetic acid (TFA, >98%) and Corning Incorporated cell culture clus-
ter, non-pyrogenic polypropylenemicrotiter plates was supplied by
Sigma (St. Louis, USA). The microtiter plates (NuncTM-ImmunoMaxisorp) and culture dishes were supplied by AEC Amersham
(Johannesburg, South Africa) and Lasec (Cape Town, South Africa),
respectively. The diethyl ether, acetone, butan-1-ol, acetic acid,
propan-2-ol, agar powder, NaCl and disodium EDTA were supplied
by Saarchem (Krugersdorp, South Africa). Acetonitrile (ACN)
(HPLC-grade, far UV cut-off) and was supplied by Romill Ltd
(Cambridge, UK). Biolab Diagnostics (Midrand, South Africa) sup-
plied the tryptone, yeast extract and tryptone soy broth (TSB), brain
heart infusion broth (BHI) and BHI agar. Bovinemilk casein andwas
supplied by Fluka Chemicals (Buchs, Switzerland). TheNa2HPO4 and
KH2PO4 and ethanol (>99.8%) were supplied by Merck (Darmstadt,
Germany). Capital Enterprises (Hillcrest, South Africa) supplied the
KCl. Waters-Millipore (Milford, USA) supplied the Nova-Pak C18
(5 lm particle size, 60 Å pore size, 150 mm  3.9 mm) reverse-
phase analytical column and the Nova-Pak C18 (6 lm particle size,
60 Å pore size, 7.8 mm  300 mm) semi-preparative HPLC column.
Analytical grade water was prepared by ﬁltering water from a
reverse osmosis plant through a Millipore Milli-Q water puriﬁca-
tion system (Milford, USA).
3. Methods
3.1. Peptide puriﬁcation and characterisation
The six major tyrocidines were isolated from commercially
obtained tyrothricin. The crude fractionation was performed by
organic extraction, as described by Hotchkiss and Dubos (1941),2
with somemodiﬁcations. Brieﬂy, the tyrothricin in dry powder form
waswashed three timeswith equal volumes ether/acetone (1:1, v/v)
and the insoluble fraction/precipitate containing the tyrocidines
was collected by centrifugation and dried under vacuum. The tyroc-
idines in the tyrocidine fraction were subsequently puriﬁed by
reverse-phase high performance liquid chromatography (RP-HPLC),
according to the methods described by Rautenbach et al. (2007).7
The collected fractions were subjected to analytical RP-HPLC,7
time-of-ﬂight electrospraymass spectrometry (TOF-ESMS), and tan-
demmass spectroscopy (MS–MS) inorder todetermine thedegreeof
purity of each fraction and to identify the puriﬁed product. TOF-
ESMS and MS–MS analyses were performed using a Waters Q-TOF
Ultima mass spectrometer ﬁtted with an electrospray ionisation
source. For TOF-ESMS, 10 lL of each peptide sample (10 lg/mL in
acetonitrile/water, 1:1, v/v) was injected into the ESMS and sub-
jected to a capillary voltage of 3.5 kV. The source temperature and
cone voltage was set at 100 C and 35 V, respectively. The data was
collected in positive mode by scanning the ﬁrst mass analyser
(MS1) through m/z = 100–1999. MS–MS analyses were performed
by injecting 30 lL of peptide sample (10 lg/mL in acetonitrile/
water, 1:1, v/v) into the mass spectrometer and subjecting the
selected molecular species to decomposition at a collision energy
of 40 eV. Data was collected in MS2 throughm/z = 1001999.
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Micrococcus luteus NCTC 8340 and Escherichia coli HB101 were
cultured, using normal sterile techniques, from freezer stocks on
Luria broth agar (1 g tryptone, 0.5 g yeast extract, 1 g NaCl, 2 g agar
in 100 mL water) at 37 C for 48 and 24 h, respectively. Selected
colonies were cultured overnight at 37 C in Luria broth (10 g tryp-
tone, 5 g yeast extract, 10 g NaCl in 1 L water) and TSB (30 g TSB in
1 L water), respectively. The overnight cultures were sub-cultured
in TSB at 37 C to an OD620 of 0.6. L. monocytogenes B73 and L. mon-
ocytogenes B73-MR1 were cultured from freezer stocks on BHI agar
at 37 C for 24 h. Selected colonies were cultured overnight at 37 C
in BHI broth (37 g in 1 L water). The overnight cultures were sub-
cultured in BHI broth at 37 C to an OD620 of 0.4 for use in lytic
experiments and dose–response assays.
3.3. Lytic activity
Mid-log phase cultures (OD620 of 0.4) of L. monocytogenes B73
were diluted to OD620 of 0.2 (6  108 CFUs). The cell suspension
(90 lL) were pipetted into microtiter plates and 10 lL peptide
solution was added. Plates were prepared as for the broth microdi-
lution assays (see below) and peptides were made up to a known
analytical concentration (approximately 10 lM) in ethanol/water
(1:1, v/v). The growth (in absence of peptide) and reduction of opti-
cal density (in presence of peptide) of L. monocytogenes B73 was
monitored over time at 595 nm using a Biorad microtiter plate
reader. Percentage lysis was calculated according to Eq. 1:
% lysis
¼100 100ðA595 of wellAverageA595 of backgroundÞ
AverageA595 of growthwellsAverageA595 of background ð1Þ
The initial lytic rate (% lysis/min) was determined as the slope of the
linear regression on % lysis versus time (up to 60 min), performed
using GraphPad Prism 3.01 and 4.00 (GraphPad Software, San
Diego, USA).
3.4. Antibacterial activity determinations
The dose–responses of E. coli, M. luteus and L. monocytogenes
toward the six puriﬁed tyrocidines were determined using broth
microdilution assays.17,18 The six puriﬁed tyrocidines were dis-
solved in ethanol:water (1:1, v/v) to concentrations of 2.00 mg/
mL. Doubling dilution series (using ethanol:water (1:3, v/v) for
E. coli and M. luteus; and growth medium for L. monocytogenes)
were then constructed in polypropylene microtiter plates. Suspen-
sions for the broth microdilution assays were prepared by diluting
the sub-cultures in TSB (E. coli and M. luteus) or BHI broth (L. mon-
ocytogenes) to an OD620 of 0.2. The broth microdilution assays17,18
were performed in 96-well microtiter plates that were sterilised
with 70% isopropanol and blocked with sterile 0.5% casein in
Dulbecco’s phosphate buffered saline (PBS)19 prior to use. After
the addition of the peptides, the microtiter plates were incubated
at 37 C for 16 h, after which the light dispersion of each well
was spectrophotometrically determined at 595 nm using a Biorad
microtiter plate reader.
The light dispersion was used to calculate percentage growth
inhibition (Eq. 2) as described by Rautenbach et al. (2006).20
%growth inhibition
¼100 100ðA595 of wellAverageA595 of backgroundÞ
AverageA595 of growthwellsAverageA595 of background ð2Þ
Dose–response curves were plotted using GraphPad Prism 3.01
and 4.00 (GraphPad Software, San Diego, USA). The dose–response
data was analysed by performing non-linear regression andsigmoidal curves (with variable slope and a constant difference of
100 between the top and bottom plateau) were ﬁtted.20 The sigmoi-
dal curves were ﬁtted according to Eq. 3:20
Y ¼ bottomþ ðtop bottomÞ
1þ 10log IC50Activity slope
ð3Þ
Top and bottom is deﬁned as the percentage inhibition observed in
the presence of high peptide concentrations and in the absence of
peptide, respectively; log IC50 refers to the x-value denoting the
response halfway between the top and bottom (represents the con-
centration of peptide required to induce 50% growth inhibition);
and the activity slope, which is related to the Hill slope, deﬁnes
the slope of the curve. ICmax, related to the maximum inhibitory
concentration (MIC), was calculated from the x-values at the inter-
cept between the slope and the top plateau, as described by Du Toit
and Rautenbach (2000).18
3.5. QSAR analyses
The relationship between the antibacterial activity and different
physicochemical properties of the six puriﬁed tyrocidines was
analysed. The molecular properties that were considered include
analytical HPLC retention time [this study], theoretical lipophilic-
ity,21,22 theoretical side-chain surface area22 and mass-over-charge
(m/z) ratio [this study]. The HPLC retention times of the six tyroc-
idines were obtained from the analytical HPLC chromatograms of
the puriﬁed tyrocidines. The theoretical parameters, lipophilicity
(pFP),21,22 and side-chain surface area (SCSA),22 of each peptide
was calculated as the sum of the parameters of all the constituent
amino acids of the particular peptide. Them/z ratios were obtained
from TOF-ESMS spectra (Fig. 1). The correlations between the
molecular descriptors and the antibacterial activity of each peptide
were analysed by performing non-linear regression and ﬁtting a
fourth order polynomial equation using GraphPad Prism 3.01
and 4.00 (GraphPad Software, San Diego, USA). Optimal molecular
descriptors were calculated by determining the minimum turning
points of the ﬁtted polynomial equations from the theoretical
curve data.4. Results and discussion
4.1. Puriﬁcation and characterisation
The six major tyrocidines were successfully isolated and puri-
ﬁed to >95% purity as determined with analytical HPLC analyses
at 254 nm. The chemical purity and integrity, in terms of expected
molecular mass, of the isolated tyrocidines was conﬁrmed by TOF-
ESMS (Table 1, Fig. 2). The primary sequence of each of the isolated
tyrocidines was conﬁrmed with MS–MS studies (results not
shown). For more detail on the HPLC and ESMS analyses of the
puriﬁed peptides refer to Supplementary data.
4.2. Lytic activity
The lytic effect of the crude tyrocidine mixture and the puriﬁed
tyrocidines on cultures of L. monocytogenes B73 was investigated in
order to verify previous studies.6 Incubation of L. monocytogenes
B73 with the crude tyrocidine mixture and puriﬁed tyrocidines
led to total loss of light dispersion over approximately 2 h, which
suggest a membrane-lytic mechanism of action. The initial lytic
rates were found to be the similar (about 1.6% per minute) for
the six tyrocidines and gramicidin S. The lysis half life was
±30 min and ±60% lysis was found after 60 min for the six tyroci-
dines (Table 2). Gramicidin S, however, differed from the tyroci-
dines in that the % lysis after an hour was signiﬁcantly different
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Figure 2. (A) A representative analytical HPLC chromatogram of the crude
tyrocidine mixture on a C18 matrix. The HPLC retention times in minutes of the
six major tyrocidines are given and unlabelled elution peaks represent the minor
tyrocidines. (B) TOF-ESMS spectrum in positive mode of the crude tyrocidine
mixture showing the isotope peaks and monoisotopic m/z ratios for the singly
charged species ([M+H+], in bold) and singly charged sodium adducts ([M+Na]+) of
the six major tyrocidines.
Table 2
Summary of the lytic activity parameters determined for the eight tyrocidines toward
L. monocytogenes B73
Peptide % Lysis/min ± SEM (n)a % Lysis at
60 min ± SEM (n)
Lysis half life – 95%
conﬁdence levels (min)
Trc mix 1.53 ± 0.038 (12) 67 ± 2.1 (10) 28.9–32.5
TrcA 1.62 ± 0.047 (12) 59 ± 1.7 (12)* 32.3–34.0
TrcA1 1.47 ± 0.026 (6) 62 ± 0.77 (6) 32.2–34.5
TrcB 1.53 ± 0.062 (8) 64 ± 0.95 (8) 28.8–30.5
TrcB1 1.68 ± 0.061 (7) 63 ± 1.5 (7) 29.6–31.7
TrcC 1.48 ± 0.067 (7) 66 ± 2.8 (7) 31.2–33.9
TrcC1 1.55 ± 0.063 (7) 60 ± 2.0 (6)* 27.5–30.4
GS 1.61 ± 0.042 (9) 70 ± 1.9 (9)* 38.5–42.8
Lytic experiments were done with 12.5 lg/mL for the tyrocidine mixture and 10 lM
for the puriﬁed tyrocidines and gramicidin S. Each value represents the mean of at
least two biological repeats, with four technical repeats per assay ± SEM.
a R2 values for the ﬁts of all the linear regression lines are >0.99.
* Gramicidin S lysis is signiﬁcantly different from TrcA (P < 0.001) and TrcC1
(P < 0.05).
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Figure 3. Representative dose–response curves of (A) crude tyrocidine mixture and
(B) puriﬁed tyrocidine A toward the different bacterial strains. Each data point
represents the mean of at least 3 biological repeats, with 3–5 technical repeats per
assay ± standard error of the mean (SEM). The sigmoidal dose–response curves
ﬁtted the experimental data with R2-values of >0.99.
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longer lysis half life (Table 2).
4.3. Antibacterial activity
Inorder to investigatehowthe lytic activityof the tyrocidinemix-
ture (tyrothricin with the gramicidins removed) and puriﬁed tyroc-
idines translated into antibacterial activity, we determined their
ability to induce growth inhibition of E. coli and M. luteus, model
Gram-negative and Gram-positive representatives, respectively.
Toward M. luteus, tyrothricin and the tyrocidine mixture had IC50values of 3.5 ± 0.49 lg/mL and 3.9 ± 0.04 lg/mL, respectively. Even
at concentrations as high as 200 lg/mL for the tyrocidine mixture
as well as the puriﬁed tyrocidines, 50% inhibition toward E. coli
was not reached (Fig. 3). The observed selectivity of the tyrocidines
may be a result of the differing cell walls of Gram-positive and
Gram-negative bacteria.23 We therefore focussed our studies of the
puriﬁed tyrocidines on Gram-positive bacteria.
M. luteus, as well as two strains of pathogenic Gram-positive bac-
terium, L. monocytogenes B73 and B73-MR1,were sensitive to all the
tyrocidines. A previous study conducted by Rautenbach et al.
(2006)20 indicated the necessity of at least two activity parameters
to characterise dose-dependence and activity. We therefore chose
IC50 (concentration that gives 50% growth inhibition) and ICmax
(maximal inhibitory concentration, which is related to minimum
inhibitory concentration or MIC)18,20 for characterising the activity
of the tyrocidines and identifying activity trends.When considering
IC50 and ICmax values towardM. luteus, the activity sequences were
(TrcB1, TrcC, TrcB, TrcC1) > TrcA > TrcA1 and (TrcB1, TrcC,
TrcB) > TrcC1 > (TrcA, TrcA1), respectively (tyrocidines in parenthe-
ses gave statistically similar activities) (Table 3). When considering
IC50 and ICmax values toward L. monocytogenes B73, the activity
sequences were (TrcB1, TrcC1, TrcC, TrcB) > TrcA > TrcA1 and
TrcC > (TrcB1, TrcB) > TrcC1 > TrcA > TrcA1, respectively (Table 3,
Fig. 4). When considering IC50 toward L. monocytogenes B73-MR1,
the activity sequence was (TrcB1 > TrcC > TrcC1 > TrcB > TrcA >
TrcA1), but only the most active (TrcB1 and TrcC) and least active
(TrcA and TrcA1) tyrocidines differed statistically in their activities
(Tables 3 and 4, Fig. 4). When considering ICmax values toward L.
Table 3
Summary of the antibacterial activity parameters of tyrothricin, the tyrocidine mixture, the eight puriﬁed tyrocidines and Gramicidin S toward three Gram-positive bacterial
strains
Peptide M. luteus NCTC 8340 L. monocytogenes B73 L. monocytogenes B73-MR1
IC50 ± SEM (n) ICmax ± SEM (n) IC50 ± SEM (n) ICmax ± SEM (n) IC50 ± SEM (n) ICmax ± SEM (n)
Trt 3.5 ± 0.49 (3) 6.3 ± 0.10 (3) 12 ± 0.80 (3) 21 ± 0.10 (3) 9.7 ± 0.53 (3) 29 ± 0.68 (3)
Trc mix 3.9 ± 0.04 (3) 5.7 ± 0.11 (3) 13 ± 1.2 (6) 23 ± 0.63 (6) 7.9 ± 0.84 (3) 14 ± 0.30 (3)
TrcA 22 ± 0.19 (3) 70 ± 1.3 (3) 13 ± 0.49 (7) 25 ± 0.54 (7) 9.9 ± 0.36 (3) 16 ± 0.29 (3)
TrcA1 26 ± 2.0 (4) 72 ± 2.4 (4) 18 ± 0.94 (3) 38 ± 1.0 (3) 10 ± 1.4 (3) 16 ± 0.32 (3)
TrcB 6.5 ± 0.07 (3) 9.9 ± 0.13 (3) 10 ± 0.46 (7) 15 ± 0.41 (7) 7.7 ± 0.59 (3) 12 ± 0.28 (3)
TrcB1 4.2 ± 0.26 (5) 8.9 ± 0.13 (5) 8.1 ± 0.19 (3) 15 ± 0.47 (3) 6.7 ± 0.24 (3) 10 ± 0.21 (3)
TrcC 6.4 ± 0.59 (4) 9.0 ± 0.17 (4) 9.5 ± 0.73 (6) 13 ± 0.32 (6) 7.0 ± 0.25 (3) 11 ± 0.21 (3)
TrcC1 7.3±0.96 (4) 15 ± 0.36 (4) 9.3 ± 0.25 (3) 22 ± 0.54 (3) 7.5 ± 0.43 (3) 16 ± 0.21 (3)
GS 6.7 ± 0.48 (10) 31 ± 0.46 (10) 6.6 ± 0.06 (4) 11 ± 0.20 (4) 3.9 ± 0.25 (3) 6.2 ± 0.078 (3)
The values of tyrothricin and tyrocidine mixture are given in lg/mL (top two rows) and those of the puriﬁed tyrocidines and gramicidin S are given in lM. Each value
represents the mean of n biological repeats (number of repeats in brackets), with 3–5 technical repeats per assay ± SEM.
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Figure 4. Comparison between the activity of the tyrocidines and gramicidin S
towards the leucocin A-sensitive L. monocytogenes B73 and leucocin A resistant L.
monocytogenes B73-MR1. Parameter data are given in Table 2. According to the
Newman-Keuls multiple comparison test the IC50 values of only TrcA, TrcA1 and GS
were signiﬁcantly different (*P > 0.01; **P > 0.001) and the ICmax values of all the
peptides were signiﬁcantly different (#P > 0.05; ##P > 0.001).
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TrcC > TrcB > (TrcC1, TrcA, TrcA1) (Table 3). Overall, the resultsTable 4
Summary of the P-values from Newman-Keuls multiple comparison test on the bacterial
TrcA TrcA1 TrcB
IC50 ICmax IC50 ICmax IC50 ICma
TrcA1 0.01
0.001 0.001
ns ns
TrcB 0.001 0.001 0.001 0.001
0.001 0.001 0.001 0.001
ns 0.001 ns 0.001
TrcB1 0.001 0.001 0.001 0.001 ns ns
0.001 0.001 0.001 0.001 ns ns
0.05 0.001 0.05 0.001 ns 0.00
TrcC 0.001 0.001 0.001 0.001 ns ns
0.001 0.001 0.001 0.001 ns 0.01
0.05 0.001 0.05 0.001 ns 0.05
TrcC1 0.001 0.001 0.001 0.001 ns 0.01
0.01 0.001 0.001 0.001 ns 0.00
ns ns ns ns ns 0.00
GS 0.001 0.001 0.001 0.001 ns 0.00
0.001 0.001 0.001 0.001 0.01 0.00
0.001 0.001 0.001 0.001 0.01 0.00
Accurate P-values are smaller than maximum value given in table. The ns denotes a P-va
value L. monocytogenes B73 and the bottom value L. monocytogenes B73-MR1.showed that antimicrobial activity is modulated by properties of
both thepeptide and the target cell. Refer to Tables3 and4 for details
on activity parameters and statistical analyses.
For each tyrocidine, the different target cells were found to have
varying sensitivities. Only the activities toward the two listeria
strains were compared as identical cell size and initial inoculate
could be assumed. For all tested tyrocidines and gramicidin S, L.
monocytogenes B73-MR1, a highly-resistant mutant of B7323 was
shown to be more sensitive than L. monocytogenes B73, a leucocin
A-sensitive wild-type meat-isolate (Fig. 4).24 In particular, a signif-
icantly lower (P < 0.001 for all peptides, with the exception of TrcC
at P < 0.05) ICmax (‘MIC’) is necessary to inhibit the resistant strain
(Fig. 4). The different activities toward the two listeria strains may
be ascribed to different membrane structures. Resistance mecha-
nisms associated with L. monocytogenes B73-MR1 include
increased membrane ﬂuidity25 and increased positive charge of
the cell wall and cell membrane.26 In general, the presence of
anionic phospholipids, a highly negative electrochemical gradient
and the absence of cholesterol promote membrane–peptide inter-
action.1,27 The increased ﬂuidity and decreased anionicity of the
cell wall and membrane of L. monocytogenes B73-MR1 would thus
be expected to interfere with the hydrophobic and electrostatic
interactions of cationic peptides.25 The opposite was, however,growth inhibition parameters (Table 3)
TrcB1 TrcC TrcC1
x IC50 ICmax IC50 ICmax IC50 ICmax
1
ns ns
ns 0.05
ns 0.05
ns 0.001 ns 0.001
1 ns 0.001 ns 0.001
1 ns 0.001 ns 0.001
1 ns 0.001 ns 0.001 ns 0.001
1 ns 0.001 0.01 0.01 0.05 0.001
1 0.01 0.001 0.01 0.001 0.01 0.001
lue >0.5. In each cell, the top value represents the P value for M. luteus, the middle
Table 5
Summary of selected physicochemical parameters of the six major tyrocidines
Peptide HPLC tR
(min)
R lipophilicity R side-chain
surface area (ÅA
0
)
m/z
TrcA 11.81 9.55 721.9 1269.64
TrcA1 11.33 8.16 741.4 1283.71
TrcB 9.48 10.01 750.8 1308.66
TrcB1 9.24 8.62 770.3 1322.69
TrcC 8.31 10.47 779.7 1347.67
TrcC1 7.90 9.08 799.2 1361.69
GS 12.05 11.66 648.2 1140.70
HPLC retention times and m/z values were obtained from the analytical HPLC
chromatography and ESMS analysis of the puriﬁed tyrocidines, respectively. The
theoretical hydropathies, lipophilicities and side-chain surface areas were calcu-
lated as the sum of all the hydropathy indices,41 lipophilicity parameters (pFP),22
and side-chain surface areas,22 respectively, of the constituent amino acids.
5546 B. M. Spathelf, M. Rautenbach / Bioorg. Med. Chem. 17 (2009) 5541–5548observed for the tyrocidines, with higher activity found toward L.
monocytogenes B73-MR1. This may be related to the manner by
which the tyrocidines associate with the target cell membrane
and/or their mechanism of action. Although the precise mechanism
of action of antimicrobial peptides is not fully understood, it is
generally believed that these peptides are membrane-active.28–36
This theory is supported by the physicochemical characteristics
of antimicrobial peptides; the rapid, concentration-dependent
action; and the observed toxicity toward higher eukaryotic
cells.35,37,38 We were able to show that the tyrocidines act, at least
in part, via a membrane-lytic mechanism of action. The observa-
tion that the different tyrocidines exhibit similar lytic rates (%
lysis/min) but different activities in terms of growth inhibition (IC-
max), however, suggests that lysis is not the only factor leading to
cell death/growth inhibition. The tyrocidines have also been shown
to interfere with the glucose metabolism of Gram-positive bacte-
ria,6 and the reduced glucose consumption rate of L. monocytogenes
B73-MR123,25 may render it more susceptible to the tyrocidines.
The difference in activity toward the two listeria strains may thus
also be related to metabolic differences.
4.4. QSAR analyses
Our results showed that all the tested tyrocidines exhibit similar
lytic activity, butdiffered in their growth inhibitionactivity (Tables2
and 3). The lytic results indicated that lytic activity is not highly
dependent on the identity of the cationic residue or the identity of
residues in thearomaticdipeptideunit. Investigationof growth inhi-B
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Figure 5. QSAR relationships of the six major tyrocidines showing curves ﬁtted to fourth
ICmax values versus (A) HPLC tR on a C18 matrix (gramicidin S was included in the dataset
lipophilicity, (C) theoretical total side-chain surface area, and (D) mass-over-charge ratio
technical repeats per assay ± SEM.bition, however, indicated that there are, unlike for lytic activity,
marked differences between some IC50 and most ICmax values of
the various tyrocidines (Tables 3 and4). This suggests that the tyroc-
idines may have an alternative/additional mechanism of action or
target and that there are structural prerequisites for such mecha-
nism(s) of action and/or interaction with an alternative target(s).
To elucidate the role of structural parameters in modulating
bacterial growth inhibition, we used the theoretical hydropathy,
lipophilicity, side-chain surface area (SCSA), and mass-over-charge
ratio (m/z) as well as HPLC retention time (tR, reﬂecting solution
amphipathicity) in the analyses of qualitative structure activity
relationships (QSAR) (Table 5, Fig. 5). ICmax values were chosen as8.0 8.5 9.0 9.5 10.0 10.5
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as depicted by the arrow and curves shown with dotted lines), (B) theoretical total
(m/z). Each data point represents the mean of at least 3 biological repeats, with 3–5
Table 6
Summary of the predicted optimal physicochemical parameters of the major natural tyrocidines for antibacterial growth inhibition, as determined from the fourth order
polynomial QSAR trends in Figure 3
Parameter M. luteus NCTC8340 L. monocytogenes B73 L. monocytogenes B73-MR1
Optimum R2 Optimum R2 Optimum R2
HPLC tR 8.89 (>12.05) 0.999 (0.993) 8.75 (>12.05) 0.997 (0.998) 8.75 (>12.05) 0.996 (0.930)
R lipophilicity 8.57 0.948 8.62 >0.999 8.50 0.992
R side-chain surface area 781.5 0.931 782.5 0.920 775.0 0.971
m/z 1327.8 0.973 1330.6 0.906 1332.8 >0.999
The R2 value is given for the ﬁt of each fourth order polynomial curve used for determining the speciﬁc optimum. The values in brackets for the optimal HPLC tR are those
determined with gramicidin S as part of the dataset.
B. M. Spathelf, M. Rautenbach / Bioorg. Med. Chem. 17 (2009) 5541–5548 5547the activity parameter for the QSAR analyses as insufﬁcient statisti-
cal differences between IC50 values were observed (Table 4). The
lipophilicity and HPLC retention time were indicators of hydropho-
bic interaction and membrane activity (Fig. 5A and 4B), while SCSA
andm/zwere used as indicators of side-chain steric and charge fac-
tors that may inﬂuence target interaction (Fig. 5C and D).
Our correlation between antimicrobial activity, as reﬂected by
the ICmax values (‘MIC’), and the four structural parameters
(Fig. 5) were quite different from those observed by Rautenbach
et al.7 with P. falciparum infected erythrocytes as tyrocidine target
cells. Only fourth order polynomial equations could be ﬁtted for all
our datasets, however, remarkably similar trends were obtained
from correlations between ICmax and solution amphipathicity
(HPLC tR), lipophilicity, m/z and SCSA for the three Gram-positive
target cells (Fig. 5). The curve ﬁts also allowed us to predict optimal
structural parameters for the antibacterial activity of the natural
tyrocidine library. Similar optima were predicted for all the target
cells, indicating that the structural prerequisite for activity is inde-
pendent of the Gram-positive bacterial strain (Table 6).
The best fourth order polynomial correlations and curve ﬁts
were found between ICmax and HPLC retention time (Table 6,
Fig. 5A). This is most probably because the peptide conformation
inﬂuences the hydropathy, lipophilicity and accessible surface area
of the peptide, which will in turn inﬂuence the HPLC retention time
and antibacterial activity, while the calculated theoretical parame-
ters do not take the three-dimensional conformation of the peptide
into consideration. Optimal HPLC retention time (solution amphi-
pathicity) and m/z were predicted between that of tyrocidine B1
and C, and tyrocidine B1 exhibited optimal theoretical lipophilicity
(Tables 5 and 6). When we included GS in the QSAR analysis of
HPLC tR versus ICmax, two optima became apparent. The one opti-
mum still correlated with the tR near TrcB1 and C, whereas the sec-
ond optimum corresponds to near the tR of GS (Fig. 5A). The
predicted optimal side-chain surface area corresponded with that
of tyrocidine C (Tables 5 and 6).
In general, the optima, as expected, coincided with that of the
two most active peptides in terms of growth inhibition, namely
tyrocidine B1 and C. In general, tyrocidine C exhibits optimal SCSA,
while tyrocidine B1 exhibits optimal lipophilicity, m/z and HPLC
retention time. This suggests that TrcC may approach the optimal
structural characteristics for target interaction, whereas TrcB1
may have optimal amphipathicity for hydrophobic interaction
and membrane insertion.
In order to explain our QSAR results we needed to make some
assumptions. First, regardless of precise mechanism of action/
molecular target, initial membrane association is essential. Second,
the initial membrane association is governed primarily by electro-
static interactions, and is followed by membrane integration dri-
ven by hydrophobic interactions.39,40 The tyrocidines carry the
same charge with only small differences in m/z and should thus
all have a similar propensity for initial association. However, there
are two groups of tyrocidines, those with Lys and those with Orn as
cationic residue. Lys and Orn differ in their side chain with only aCH2 unit, but this small difference translates into different amino
group pKa’s (pKa = 10.54 and 10.76, respectively),40 and different
hydropathies (9.9 and 9.0, respectively).41 Also, it has been
shown that Lys, with a butylene moiety in its side chain, ‘snorkels’
into the membrane,7,42 which leads to a tighter membrane interac-
tion than Orn. Our results, however, show that the Lys-containing
tyrocidines are not necessarily more active.
The tyrocidines containing Trp (TrcC, TrcC1, TrcB and TrcB1)
were found to be more active than the more hydrophobic Phe-con-
taining (A and A1) peptides. A 2–4-fold increase in activity was
found between TrcA/A1 with a Phe in position 3 and TrcB/B1 with
a Trp in position 3. A similar increase 2–4-fold increase in activity
was found by Marques et al.12 when Phe3 in synthetic TrcA was re-
placed with a pentaﬂuoro-Phe residue which is larger but more
hydrophobic. Furthermore TrcB1 (containing one Trp and one
Phe), was found to be more active than TrcC1 (containing two
Trp residues), while TrcB and C have similar activities. Substituting
D-Phe4 to D-Trp4 (TrcB/B1 vs TrcC/C1) had a minor inﬂuence on
activity. These results indicated that the aromatic residue on posi-
tion 3 has a major inﬂuence on activity. However, the two most ac-
tive peptides, TrcB1 and C differ from each other at two residues.
TrcB1 contains Lys and TrcC Orn as the cationic residue, while TrcB1
contains D-Phe and TrcC D-Trp in the position 4 of aromatic dipep-
tide moiety.
The aromatic residues (Trp, Phe and Tyr), two of which are
found in the variable aromatic dipeptide unit, have a considerable
impact on the hydrophobicity of the tyrocidines and are expected
to be responsible for/contribute to integration into the membrane.
The efﬁcacy with which the tyrocidines lead to cell death is deter-
mined, at least in part, by the efﬁciency of the initial membrane
association and integration and/or translocation steps. As the Tyr
residue is constant for all investigated tyrocidines, differences in
efﬁcacy of membrane integration may be contributed to the Trp
and/or Phe residues of the dipeptide unit. The greater lipophilicity,
indicative of the preference for the water–phospholipid interface,
of the Phe residue suggests that peptides containing Phe rather
than Trp will be more active if activity only depended on the mem-
brane interaction. Phe was found to insert much deeper into the
membrane than Trp.43,44 However, previous research has shown
that the size of the residue is important with larger (Trp) residues
having good anchoring properties.45 Despite Trp’s shallow mem-
brane insertion, the anchoring is probably due to the formation
of hydrogen bonds via its NH-group with fatty-acyl carbonyl
groups.46 Overall, it is deduced that tyrocidines containing Lys
and Phe may undergo tighter membrane association than tyroci-
dines containing Orn and Trp. However, it should be kept in mind
that a stronger association with the cell membrane does not neces-
sarily lead to greater activity as the mechanism of cell death and/or
molecular target also plays a role. This result therefore suggests
that there is an optimal amphipathicity, in which Phe and/or Lys
is required for tighter binding, but Trp and/or Orn modulates this
binding, possibly by reduction of peptide trapping and allowing
for the most efﬁcient membrane integration and self-assembly into
5548 B. M. Spathelf, M. Rautenbach / Bioorg. Med. Chem. 17 (2009) 5541–5548active lytic complexes and/or translocation to an internal target.
The tyrocidines have been shown to interfere with glucose metab-
olism6 as well as inhibition of RNA synthesis of B. brevis.47 The
tyrocidines may thus also interact with a molecular target, such
as DNA or RNA precursors. Marques et al.12 came to a similar
conclusion, namely that there is a ﬁne amphipathic balance that
must be maintained in order for their synthetic TrcA analogues
to remain active.
5. Conclusions
Investigation of the antibacterial activity of the tyrocidines
indicated that activity is (1) strain-speciﬁc and thus dependent
on properties of the target cell; and (2) dependent on peptide
structure. The greater sensitivity of L. monocytogenes B73-MR1
relative to L. monocytogenes B73 towards the tyrocidines and gram-
icidin S may be related to differences in membrane structure and/
or metabolic differences.
Although the natural library of tyrocidines that we analysed is
too small to draw ﬁrm conclusions on the QSAR of the tyrocidines,
we were able to determine a number of prerequisites for activity
towards Gram-positive bacteria. First, we found that the more
polar tyrocidines (B and C groups) were more active than the more
hydrophobic A group. Second, the more active B and C groups con-
tained at least one Trp residue, with position 3 being more sensi-
tive, which may point to the importance of this aromatic residue
in their activity. Third, there was no direct indication for a prefer-
ence for either Lys of Orn in the tyrocidine activity. However, an
optimal m/z of between 1333 and 1340 was observed, which indi-
cated activity was dependent on both charge and overall size.
Although the bacterial growth inhibition of the tyrocidines dis-
played a dependency on primary structure, pertaining primarily to
the aromatic dipeptide moiety, investigation of the lytic activity
indicated that lysis is independent of the speciﬁc tyrocidine struc-
ture. This suggests that the tyrocidines, apart from their membran-
olytic activity, may have a second target/mechanism of action. The
observed structural prerequisites for bacterial growth inhibition
are thus probably related to the ability of the different tyrocidines
to reach another target, associate with, or inﬂuence an alternative
internal (such as RNA or DNA)47 or membrane bound target (such
as autolysins6,48or phosholipases49) and not only their ability to in-
duce overt membrane lysis.
Research concerning the tyrocidines may play an important role
in future combating of infections caused by treatment-resistant
food-borne bacteria. The development of novel therapeutic agents
or bio-preservatives based on the tyrocidines, however, requires
consideration of several safety considerations and technical difﬁcul-
ties. These include selectivity, toxicity and sensitivity to physiologi-
cally relevant ionic strength, pH and serum conditions. Further
research regarding the basis of selectivity, the role of speciﬁc amino
acid residues inbacterial growth inhibitionandelucidationofmech-
anism of action may allow for the development of more efﬁcacious
molecules, improved selectivity and reduced toxicity. Furthermore,
investigation of the role of environmental conditions, such as
changes in ionic strength and pH, on antilisterial activity may pro-
vide valuable information for development of bio-preservatives.
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Addendum (Chapter 5)  
Correlations between tyrocidine self-assembly and 
antilisterial activity  
 
Background 
Following publication of the antilisterial activity and structure activity-relationships of 
the six major tyrocidines (Chapter 5), indicators of peptide conformation and 
self-assembly were derived from circular dichroism data (Chapter 3). Peptide 
self-assembly is expected to influence antibacterial activity by modulating membrane 
interaction. β-sheet peptides, such as the tyrocidines, are likely to undergo 
superstructure organisation upon membrane interaction [1], and such multimer 
formation has been suggested to play a key role in the cytolytic activity of β-sheet 
peptides [2-6]. However, self-assembly in aqueous solution is expected to impact 
membrane interaction and reduce antibacterial activity [5-8]. Insight regarding the 
structure-activity relationships and mode of action of the tyrocidines may thus be gained 
by investigating correlations between self-assembly and antilisterial activity.  
Correlations between tyrocidine self-assembly and antilisterial activity 
Circular dichroism (CD)-derived parameters, negative ellipticity minima ratios in water 
(θ205/θ216, water) and TFE (θ204/θ214, TFE), were chosen as indicators of conformation and 
self-assembly in an aqueous and membrane environment, respectively (Refer to 
Chapters 3 and 4 for more detail). Correlations between antibacterial activity toward L. 
monocytogenes B73 and CD-derived parameters (Table 1) were investigated in order to 
determine the role of tyrocidine self-assembly in the modulation of antibacterial 
activity.  
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Table 1  Summary of antilisterial activity and selected CD-derived parameters of 
self-assembly of the purified tyrocidinesThe identity of the variable 
amino acid residues in positions 3, 4 and 9 are given, with Phe = F; Trp = 
W; Lys = K; and Orn = O, and D-amino acids indicated by lower case 
letters.  
 
Peptide 
Antilisterial activity 
(µM)1 
Variable residue 
 identity 
θ205/ θ216 
in water2 
θ204/ θ214 
in TFE2 
 IC50 ICmax    
TrcA 13 ± 0.49 25 ± 0.54 F3f4-O9 0.92 ± 0.0077 1.11 ± 0.078 
TrcA1 18 ± 0.94 38 ± 1.0 F3f4-K9 0.94 ± 0.077 0.93 ± 0.062 
TrcB 10 ± 0.46  15 ± 0.41 W3f4-O9 1.15 ± 0.040 1.51 ± 0.038 
TrcB1 8.1 ± 0.19 15 ± 0.47 W3f4-K9 1.14 ± 0.037 1.49 ± 0.155 
TrcC 9.5 ± 0.73 13 ± 0.32 W3w4-O9 1.15 ± 0.026 1.74 ± 0.117  
TrcC1 9.3 ± 0.25 22 ± 0.54 W3w4-K9 1.03 0 ± 0.025 1.68 ± 0.168 
 1
 Refer to Chapter 5 
 2
 Refer to Chapter 3 
 
Strong exponential correlations were observed between antilisterial activity and the 
CD-derived parameters of self-assembly. For all the tyrocidines, an increase in 
antilisterial activity (against L. monocytogenes B73) correlated exponentially with an 
increase of the ellipticity ratio θ204/θ214 in the membrane-mimetic TFE (Figure 1). It is 
important to note that, although the IC50 values are not all statistically different (refer to 
Chapter 5 [9]), they follow the same trend as the statistically different ICmax values. In a 
membrane environment, the Trp-containing tyrocidines (TrcC, C1, B and B1) exhibit 
greater β-sheet structure/self-assembly than the Trp-lacking tyrocidines (TrcA and A1) 
(Refer to Chapter 3). As discussed in Chapter 5 [9], the Trp-containing tyrocidines 
(TrcC, C1, B and B1) exhibited greater antilisterial activity than the Trp-lacking 
tyrocidines (TrcA and A1). Activity as characterised by IC50 and ICmax therefore 
correlated with the ability to self-assemble in membrane environments and are probably 
related to the lytic activity of the tyrocidines towards L. monocytogenes.  
 As discussed in Chapter 3, the Phe3-containing tyrocidines (TrcA and A1) probably 
form more/larger higher-order structures (β-sheet formation) than the Trp3-containing 
tyrocidines (TrcC, C1, B and B1) in an aqueous environment. Such self-assembly in an 
aqueous environment corresponds to the observed antilisterial activity as the 
Phe3-containing tyrocidines A and A1 were found to be significantly less active than the 
Trp3-containing tyrocidines C, C1, B and B1 [9] (Chapter 5). These results indicate that 
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enhanced self-assembly in aqueous solution leads to reduced antilisterial activity, 
probably due to reduced efficiency of membrane interaction and/or integration. 
However, as discussed in Chapter 5 [9], the six major tyrocidines exhibited similar lytic 
activities, which suggests that the correlation between enhanced self-assembly within a 
membrane-environment and enhanced antilisterial activity may be related to the manner 
in which/the extent to which the peptides translocate to the cytoplasm or cause 
membrane leakage, rather than the induction of overt lysis. It should also be kept in 
mind that the methodology used to characterise membrane lysis is only 
accurate/sensitive enough to indicated overt/extreme lysis and would not provide an 
indication of the ability of the tyrocidines to induce membrane leakage. 
 
 
 
 
 
 
 
 
 
 
Figure 1  Correlations between antilisterial activity (ICmax and IC50) and the 
 CD-derived descriptor of self-assembly in a membrane-mimetic 
 environment (θ204/θ214 in TFE). Each data point represents the mean of 
 at least three determinations ± standard error of the mean (SEM). 
Conclusion 
Enhanced self-assembly in aqueous solution was found to be associated with reduced 
antilisterial activity, which suggests that premature self-assembly reduces target 
membrane interaction, integration and/or translocation to reach a cytoplasmic target. 
Enhanced self-assembly in a membrane environment was found to be associated with 
enhanced antilisterial activity, which suggests that self-assembly into active lytic 
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complexes within the target cell membrane and/or complexes than can traverse this 
barrier may be critical for the antilisterial activity of the tyrocidines.  
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 Chapter 6  
 A non-lytic mode of action towards Listeria 
monocytogenes depends on the complexation of the 
natural tyrocidines with Ca2+  
 
6.1 Introduction 
Listeriosis, a severe disease with high hospitalisation and case fatality rates, is caused 
by Listeria monocytogenes, a food-borne pathogen that has drawn the interest of food 
manufacturers and government bodies [1-3]. Since the isolation of the first 
multi-resistant stain of L. monocytogenes in 1988 [4] numerous strains of 
L. monocytogenes exhibiting resistance to antimicrobial agents [5-8] and disinfectants 
[9-11] have been reported, which necessitates the development of new preservatives. 
Naturally occurring preservatives, such as small organic biomolecules and membrane or 
cell wall perturbing proteins and peptides have been receiving mounting interest from 
the food industry [2, 12, 13]. The broad spectrum antibacterial activity, speed of action 
and reduced likelihood of resistance development toward antimicrobial peptides suggest 
that these compounds may be useful as bio-preservatives [14]. Nisin and pediocin, 
bacteriocins produced by lactic acid bacteria (LAB), have been shown to effectively 
inhibit L. monocytogenes growth in various food products and are currently accepted for 
use as food preservatives [2, 13, 15-18]. Unfortunately, L. monocytogenes strains that 
exhibit resistance toward nisin and pediocin have been reported [2, 18-20]. In addition 
to the challenge of resistance-development, control of L. monocytogenes in food is 
complicated by its high temperature, salt and pH tolerance [1, 21, 22]. The ability of 
L. monocytogenes to grow under high salt conditions pose a significant problem for the 
application of antimicrobial peptides as bio-preservatives since the activity of most 
antimicrobial peptides is reduced by the presence of cations such as Na+, Mg2+ and Ca2+ 
[23-27]. Divalent cations, especially Ca2+, lead to a dramatic reduction in antibacterial 
activity of various antimicrobial peptides, including nisin and pediosin [16, 24-29]. The 
inhibition of antimicrobial peptide activity by cations may be due to either increased 
aggregation induced by cations [24, 30], which would decrease the number of “active” 
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peptide, or inhibition of membrane-binding, probably by shielding electrostatic 
interaction between the peptide and the target membrane [16, 24, 31]. The tyrocidines, a 
group of cyclic antimicrobial peptides produced by Bacillus aneurinolyticus, have been 
shown to possess significant antibacterial activity toward L. monocytogenes [32]. 
Furthermore, the tyrocidines were found to possess enhanced antilisterial activity 
toward L. monocytogenes B73-MR1, a leucocin A (a pediocin-like bacteriocin) resistant 
strain [32, 33], relative to the leucocin A-sensitive L. monocytogenes B73 [32, 34], 
which suggests that the tyrocidines may be useful bio-preservatives. Investigation of the 
influence of cations on the antilisterial activity of the tyrocidines may thus provide 
valuable information for development of the tyrocidines for use as bio-preservatives.  
6.2 Materials  
Tyrothricin (commercial extract from B. aneurinolyticus), gramicidin S, trifluoroacetic 
acid (TFA, >98%), trifluoroethanol (TFE), Corning Incorporated® cell culture cluster, 
non-pyrogenic polypropylene 96-well microtiter plates, bisbenzimide and propridium 
iodide was supplied by Sigma (St. Louis, USA). The microtiter plates (NuncTM-Immuno 
Maxisorp) and culture dishes were supplied by AEC Amersham (Johannesburg, South 
Africa) and Lasec (Cape Town, South Africa), respectively. The CellTiter-BlueTM Cell 
Viability Assay kit was supplied by Promega (Madison, USA). The diethyl ether, 
acetone, butan-1-ol, acetic acid, propan-2-ol, agar powder and NaCl were supplied by 
Saarchem (Krugersdorp, South Africa). Acetonitrile (ACN) (HPLC-grade, far UV cut-
off) and was supplied by Romill Ltd. (Cambridge, UK). Biolab Diagnostics (Midrand, 
South Africa) supplied the brain heart infusion broth (BHI) and BHI agar. Bovine milk 
casein and was supplied by Fluka Chemicals (Buchs, Switzerland). The Na2HPO4 and 
KH2PO4 and ethanol (>99.8%) were supplied by Merck (Darmstadt, Germany). Capital 
Enterprises (Hillcrest, South Africa) supplied the KCl. Analytical grade water was 
prepared by filtering water from a reverse osmosis plant through a Millipore Milli-Q® 
water purification system (Milford, USA). 
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6.3 Methods 
6.3.1 Peptide preparation 
Peptides were isolated from commercially obtained tyrothricin and purified by 
semi-preparative reverse-phase high-performance liquid chromatography (RP-HPLC), 
as previously described by Rautenbach et al. (2007) [35] and Spathelf and Rautenbach 
(2009) [32]. Stock solutions of the purified peptides of 2.00 mg/mL were analytically 
prepared in ethanol:water (1:1, v/v). For dose-response experiments, the stock solution 
was diluted to 500 µg/mL in the appropriate solvent (water or salt solution) and used to 
construct a doubling dilution series in polypropylene 96 multi-well plates using the 
same solvent. For the single-concentration experiments, the stock solution was 
analytically diluted to 125 µg/mL or 0.100 mM in the appropriate solvent.  
6.3.2 Culturing of bacteria 
L. monocytogenes B73 was cultured, using normal sterile techniques, from freezer 
stocks on BHI agar at 37°C for 24 hours. Selected colonies were cultured overnight at 
37°C in BHI broth (37 g in 1L water) or BHI broth supplemented with 7.5 mM CaCl2. 
The overnight cultures were sub-cultured in standard BHI broth or BHI broth 
supplemented with 7.5 mM CaCl2 at 37°C to an OD620 of 0.4 for use in activity 
determinations, dose-response assays and live-cell fluorescent microscopy. 
6.3.3 Cell viability assays  
Suspensions for the cell viability assays were prepared by diluting the mid-log phase 
cultures (OD620 of 0.4) of L. monocytogenes B73 in standard BHI broth or BHI broth 
supplemented with 7.5 mM CaCl2 to an OD620 of 0.20 (determined as 6.7x108 
CFU/mL). The cell viability assays were performed in 96-well microtiter plates that 
were sterilised with 70% isopropanol and blocked with sterile 0.5% casein in 
Dulbecco’s phosphate buffered saline (PBS) [36] prior to use. A 90 µL of cell 
suspension was added to the microtiter plates, followed by 10 µL of peptide solution. 
After the addition of the peptides, the microtiter plates were incubated at 37°C for 2 or 
16 hours, after which 10 µL of the CellTiter-BlueTM reagent was added to each well and 
incubated for a further hour. Cell viability was determined using the CellTiter-BlueTM 
Cell Viability Assay in which resazurin (blue, absorption maximum at 605nm) is 
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reduced to resofurin (pink, absorption maximum at 573nm) in actively respiring cells 
[37]. The light absorption of each well was spectrophotometrically determined at 490 
and 595 nm using a Biorad microtiter plate reader and percentage inhibition calculated 
according to equation 1: 
 
backgroundofAAveragewellsgrowthofAAverage
backgroundofAAveragewellofAinhibition
595/490595/490
595/490595/490 )(100100%
−
−×
−=
 (1) 
6.3.4 Cell survival assays  
Cell suspensions (OD620 of 0.20, 6.7x108 CFU/mL) were prepared as for the cell 
viability assays. A 10 µL of the diluted peptide solution was added to 90 µL of cell 
suspension and incubated at 37ºC for 2 and 16 hours. Culture samples were 
subsequently diluted in sterile PBS, plated onto BHI agar plates and incubated at 37ºC 
for 24 hours after which colony forming units (CFU) were counted. Cell survival was 
calculated as the percentage of CFUs relative to the growth control. 
6.3.5 Data analysis 
Dose-response curves were plotted using GraphPad Prism® 3.01 and 4.00 (GraphPad 
Software, San Diego, USA). The dose-response data was analysed by performing 
nonlinear regression and sigmoidal curves (with variable slope and a constant difference 
of 100 between the top and bottom plateau) were fitted according to Rautenbach et al. 
(2006) [38].  IC50 is defined as the concentration of peptide required to induce 50% 
inhibition; and the activity slope, which is related to the Hill slope, defines the slope of 
the curve [38]. ICmax, related to the maximum inhibitory concentration (MIC), was 
calculated from the x-values at the intercept between the slope and the top plateau, as 
described by Du Toit and Rautenbach (2000) [39]. ICmin, the minimum inhibitory 
concentration, was calculated from the x-values at the intercept between the slope and 
the bottom plateau. ICF-values were calculated according to equations 1-4 from 
Rautenbach et al. (2006) [38].  
ICF = ICmax/ICmin    (1) 
ICF = (IC50/ICmin)2    (2) 
ICF = (ICmax/IC50)2    (3) 
ICF = 0.25 × (IC50/ICmin + ICmax/IC50)2 (4) 
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All four equations were used to calculate an average ICF in order to minimize the 
overall error by considering the whole dose-response curve. For single concentration 
experiments and CFU, percentage inhibition/survival and the standard error of the mean 
was determined using GraphPad Prism® 4.00 (GraphPad Software, San Diego, USA). 
6.3.6 Fluorescent microscopy 
Mid-log phase cultures (OD620 of 0.4) of L. monocytogenes B73 was washed in sterile 
NaCl (0.9% m/v) and resuspended to an OD620 of 0.20 in sterile NaCl (0.9% m/v). For 
each sample, 200 µL cell suspension was incubated with 2 µL bisbenzamide (a 
membrane permeable DNA chelator) and 2 µL propridium iodide (a membrane 
impermeable DNA chelator) at room temperature for 15 minutes. 10 µL of peptide 
solution was added to 90 µL of the stained cells (final peptide concentration of 
6.25 µg/mL). Image acquisition was performed on an Olympus CellR system attached to 
an IX 81 Inverted fluorescence microscope equipped with an F-view-II cooled CCD 
camera (Soft Imaging Systems). Using a Xenon-Arc burner (Olympus Biosystems 
GMBH) as light source, images were acquired using the 360 nm and 472 nm excitation 
filters. Emission data was collected using a UBG triple-bandpass emission filter cube 
(Chroma). Images were acquired using an Olympus Plan Apo N60x/1.4 Oil objective. 
The degree of membrane leakage/lysis was deduced from the fluorescent signal of the 
membrane impermeable propridium iodide. 
6.3.7 Circular dichroism and fluorescence spectroscopy 
Analytical stock solutions (2.00 mg/mL) of the purified tyrocidines were prepared in 
ethanol:water (1:1, v/v), and diluted to 10 µM in water, 2,2,2-trifluoroethanol (TFE), 
75 mM CaCl2 or 75 mM MgCl2 (final ethanol concentration was 0.5% v/v) for the 
circular dichroism, UV absorbance and fluorescence analyses. Circular dichroism scans 
were obtained on a Chirascan CD spectrometer (Applied Photophysics, UK) using a 
1.00 cm quartz cuvette. Three scans were collected between 200 and 250 nm with 0.1 
nm steps. UV-absorbance spectra were collected simultaneously with the CD spectra. 
Fluorescence measurements of the same peptide solutions were performed on a model 
RF-5301PC spectrofluorophotometer (Shimadzu, Japan). Emission spectra were 
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recorded between 280 and 450 nm, 0.2 nm steps, for excitation at 280 and 295 nm. Slit 
widths of 5 nm were used for both excitation and emission.    
 
6.3.8 Mass spectrometry 
Complexation between the tyrocidines and various cations was investigated by diluting 
the stock solution of tyrocidine complex to 12.5 µg/mL in 1.0 mM NaCl, KCl, MgCl2 or 
CaCl2. For investigation of complexation between the purified tyrocidines and divalent 
cations (Ca2+ and Mg2+) by mass spectrometry, the purified tyrocidine stock solutions 
were diluted to 10 µM in various CaCl2 or MgCl2 concentrations. Time-of-flight 
electrospray mass spectrometry (TOF-ESMS) analyses were performed using a Waters 
Q-TOF Ultima mass spectrometer fitted with an electrospray ionisation source. Ten µL 
of each peptide sample was injected into the ESMS and subjected to a capillary voltage 
of 3.5 kV. The source temperature and cone voltage was set at 100 ºC and 35 V, 
respectively. The data was collected in positive mode by scanning the first mass 
analyser (MS1) through m/z = 100–1999. 
 
6.4 Results and Discussion 
6.4.1 Influence of growth medium composition and cations on 
antilisterial activity 
The influence of growth medium on the reduction of cell viability by the tyrocidine 
complex, tyrocidine A (TrcA), tyrocidine B (TrcB) and tyrocidine C (TrcC), and 
gramicidin S toward L. monocytogenes B73 was investigated by pre-incubating the 
peptides in BHI growth medium. Reduction of cell viability by TrcA and TrcB was 
increased by 70 % and 120 %, respectively, upon pre-incubation in BHI growth medium 
(Table1), which indicates that the tyrocidines are sensitive to solvent composition. The 
activity of the tyrocidine mixture and TrcC was, however, not significantly increased 
(Table1), which indicates that the various tyrocidines have different sensitivities to BHI 
growth medium.  
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Table 1 Influence of solvent conditions on reduction of cell viability after 3 hours. The 
inhibition of cell viability was induced by 12.5 µg/mL (tyrocidine mixture) or 
10 µM (purified peptides) peptide diluted in water, BHI growth medium or salt 
solutions. The antilisterial activity is expressed relative to activity of peptides 
diluted in water.  
 Fold change in activity 
Modifier/solvent Trc mix Trc A Trc B Trc C GS 
Water 1.0 ± 0.049  1.0 ± 0.040 1.0 ± 0.020 1.0 ± 0.015 1.0 ± 0.035 
BHI medium 1.2 ± 0.034 1.7 ±0.076*** 2.2 ± 0.096*** 1.4 ± 0.077 1.02 ± 0.11 
7.5mM NaCl 1.0 ± 0.053 0.92 ± 0.076 0.93 ± 0.034 0.87 ± 0.080 ND 
15.0mM NaCl 1.1 ± 0.064 0.90 ± 0.061 0.91 ± 0.046 0.86 ± 0.078 ND 
7.5mM KCl 1.0 ± 0.045 0.78 ± 0.089 0.91 ± 0.021 0.84 ± 0.054 ND 
15.0mM KCl 1.1 ± 0.053 0.89 ± 0.090 0.98 ± 0.055 0.85 ± 0.053 ND 
7.5mM MgCl2 1.0 ± 0.050 1.0 ± 0.043 0.91 ± 0.048 0.93 ± 0.0.58 ND 
15.0mM MgCl2 1.1 ± 0.053 1.0 ± 0.073 0.92 ± 0.055 0.98 ± 0.056 ND 
7.5mM CaCl2 1.6 ± 0.021*** 1.8 ± 0.20*** 1.4 ± 0.030*** 1.3 ± 0.042* 1.0 ± 0.084 
15.0mM CaCl2 1.4 ± 0.048*** 1.6 ± 0.13*** 1.3 ± 0.039*** 1.0 ± 0.053 1.0 ± 0.039 
Fold change in inhibition of peptide with water as solvent ± standard error of the mean (N≥3);  
* P<0.05; ** P<0.01; *** P<0.001 
Components in the growth medium that may affect the activity of cationic membrane 
active peptides include metal cations (such as Na+, K+, Mg2+ and Ca2+), phosphate, 
amino acids, peptides, proteins, lipids and carbohydrates. The influence of the major 
biological alkali and earth metal cations on activity (reduction of cell viability) was 
determined by pre-incubating the natural tyrocidine complex, purified natural 
tyrocidines A, B and C, and gramicidin S in NaCl, KCl, MgCl2 and CaCl2 solutions. 
The results indicated that only CaCl2 influenced the activity of the tyrocidines, whereas 
the other cations investigated (Na+, K+ and Mg2+) did not significantly affect their 
inhibitory activity (Table 1). As seen for the influence of BHI growth medium, the 
different tyrocidines exhibit different sensitivities to CaCl2.  TrcA displayed the greatest 
increase in activity and was found to be more sensitive than TrcB, with the activity of 
TrcC the least sensitive (Table 1). The observation that the tyrocidines are relatively 
salt-insensitive and that CaCl2 increased activity indicates that calcium plays a major 
role in the modulation of tyrocidine anti-listerial activity. Furthermore, the activity of 
gramicidin S was not influenced by the presence of CaCl2 (Table 1), which suggest that 
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the CaCl2-induced increase in tyrocidine activity involves a process specific to the 
tyrocidines and not non-specific cell sensitisation. 
6.4.2 Investigation of tyrocidine-cation complexation by mass 
spectrometry 
Complex formation between the tyrocidines and the major biological alkali and earth 
metal cations (Na+, K+, Mg2+ and Ca2+) was investigated by TOF-ESMS. The degree of 
complex formation was deduced by monitoring the reduction of singly charged free 
peptide ions ([M+H]+). In general, the addition of cations was shown to reduce the 
detection/availability of free peptide ions (Figure 1), which may be a result of 
precipitation (“salting-out”), peptide-cation complexation or masking of the peptide ion 
by the chloride counterion. Different cations led to varying degrees of free peptide ion 
loss, suggesting that the tyrocidines have different affinities for different types of 
cations. Addition of divalent cations (magnesium or calcium) led to a greater loss of 
free peptide ions (approximately 80%) than the addition of monovalent cations (sodium 
or potassium), which may suggest that the tyrocidines have a greater affinity for 
divalent cations. However, the higher chloride ion concentration may also lead to this 
result. When the detection of free peptide in the presence of the monovalent cations is 
considered it is clear that the tyrocidine affinity for Na+ is greater than K+. Comparing 
the divalent ions, lower free peptide signal was detected for Ca2+ suggesting a higher 
affinity than for Mg2+.  In addition to each tyrocidine having different affinities for the 
various cations, the tyrocidines exhibit varying affinities for each cation, which suggests 
that peptide structure influences cation complexation. The six major tyrocidines 
exhibited similar affinities for sodium. In general, greater affinity for monovalent 
potassium is associated with greater HPLC retention time (solution 
amphipathicity/apparent hydrophobicity) and lower side-chain surface areas (results not 
shown). In contrast, greater affinity for divalent cations is associated with shorter HPLC 
retention time (solution amphipathicity/apparent hydrophobicity) and larger side-chain 
surface areas (results not shown).  
Complexation between the purified tyrocidines and divalent cations (Ca2+ and Mg2+) 
was further investigated by mass spectrometry. The degree of complex formation was 
deduced by monitoring the signal intensity of the cation adducts ([M+Ca]2+ or 
[M+Mg]2+) in the presence of various CaCl2 or MgCl2 concentrations and used to  
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calculate the apparent maximal Ca2+ or Mg2+ binding (maximal/plateau MS signal of 
complex, Smax) of the six major tyrocidines (Figure 2).  
 
 
  
 
 
 
 
 
Figure 1 Tyrocidine-cation complexation as determined by TOF-ESMS. TOF-ESMS 
signal of singly charged free peptide ions ([M+H]+) relative to ethanol:water 
(1:1, v/v) of tyrocidines in the tyrocidine complex prepared in solutions 
containing different chloride salts at 1 mM.  The average of triplicate 
determinations with the standard error of the mean is shown. 
The apparent maximal calcium binding of the tyrocidines was found to be related to 
their solution amphipathicity, as illustrated by the linear correlation (R2 = 0.82) between 
Smax for Ca2+ and HPLC retention time (Figure 3A), and suggests that increased 
amphipathicity allows for increased Ca2+-complexation. As increased amphipathicity is 
also expected to be associated with increased self-assembly in an aqueous environment, 
the increased apparent Ca2+-complexation may be related to incorporation of Ca2+ 
within the assembly. Some correlation was also observed between Smax for Mg2+ and 
HPLC retention time, but required segregation of the Lys9 and Orn9 containing 
tyrocidines (Figure 3B). These correlations indicate that increased amphipathicity also 
allows for increased Mg2+-complexation, possibly due to incorporation of Mg2+ with 
higher-order structures. However, the required segregation of the Lys9- and 
Orn9-containing tyrocidines, and the significantly lower Smax for Mg2+ of the 
Lys9-containing tyrocidines, indicate that the manner of Mg2+-complexation differs for 
these two groups, possibly due to differences in self-assembly (Discussed in Chapter 3).  
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Figure 2 Apparent (A) Ca2+-tyrocidine and (B) Mg2+-tyrocidine complexation as 
determined by TOF-ESMS. TOF-ESMS signal of tyrocidine-Ca2+ or -Mg2+ 
adducts ([M+Ca]2+ or [M+Mg]2+) relative to ethanol:water (1:1, v/v) of the 
purified major tyrocidines prepared in solutions of varying CaCl2 or MgCl2 
concentrations. Each data point represents the average of triplicate 
determinations ± SEM. 
 
 
 
 
 
 
Figure 3 Correlation between the apparent maximal (A) Ca2+ or (B) Mg2+ binding 
(Smax) and HPLC retention time of the tyrocidines. Each data point 
represents the average of triplicate determinations ± SEM. The dashed lines 
in A indicates the 95% confidence interval and the boxes in B shows the 
two tyrocidine groupings. 
As tyrocidine-Ca2+ complexation and/or induction of higher-order structures influences 
the antilisterial activity and mode of action, correlations between Smax for Ca2+ and 
antilisterial activity may provide insight regarding the structure-activity relationships 
and mode of action. With the exception of TrcC1, a strong linear correlation (R2 = 0.95) 
was observed between the Smax for Ca2+ and antilisterial activity of the tyrocidines 
(Figure 4), which suggest that increased calcium binding leads to reduced antilisterial 
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activity. However, TrcC1 does not follow the same trend. TrcC1 exhibited the lowest 
Smax for Ca2+ and reduced activity, which strongly suggest that an optimal amount of 
Ca2+-complexation is required for antilisterial activity. The loss of activity associated 
with increased Ca2+-binding may be related to increased self-assembly within solution 
leading to loss of peptide due to precipitation, whereas the reduced activity of TrcC1 
associated with low Ca2+-complexation indicates that a certain amount of Ca2+-binding 
is required for antilisterial activity. No clear correlations were observed between the 
antilisterial activity and Smax for Mg2+, which suggests that Mg2+-complexation is not a 
direct determinant of antilisterial activity. However, increased Mg2+-complexation may 
compete with Ca2+-complexation, indirectly influencing tyrocidine activity. These 
results suggests that the correlation between antilisterial activity and Smax for Ca2+ may 
be unique to this divalent cation, which corresponds to the earlier observations that only 
Ca2+ influences antilisterial activity (Table 1).  
 
 
 
 
 
 
Figure 4 Correlation between the apparent maximal divalent cation (Ca2+ in A and 
Mg2+ in B) binding (Smax) and antilisterial activity (ICmax and IC50) of the 
tyrocidines. Each data point represents the average of at least three 
determinations ± SEM. 
6.4.3 Influence of divalent cations on the conformation/self-assembly of 
tyrocidines A, B and C 
Circular dichroism (CD) spectroscopy was used to investigate the influence of calcium, 
magnesium and trifluoroethanol (TFE) on tyrocidine conformation and/or 
self-assembly. As discussed in Chapter 3, the CD spectra of tyrocidines A, B and C in 
an aqueous environment exhibit negative ellipticity minima at 205 (θ205) and 
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216 (θ216) nm. Although such CD spectra are reminiscent of an α-helical structure, 
previous research has indicated that these negative ellipticities are due to type II` β-turn 
(205 nm) and β-sheet (216 nm) structure [40-44]. It should, however, be noted that the 
shape and intensity of the minima are influenced by the aromatic amino acids, which are 
known to distort CD spectra, as well as the aggregation state of the peptide [44-46]. 
In the presence of Ca2+, the CD spectra of the Trp-containing tyrocidines B 
(Trp3-D-Phe4) and C (Trp3-D-Trp4) exhibited enhanced θ205 and θ216 (Figures 5A and 
B). The CD spectra of TrcB in the presence of Mg2+ also exhibited negative ellipticity 
minima at 205 and 216 nm, but with decreased intensity relative to water (Figure 5B). 
In contrast to the CD spectra of the Trp-containing tyrocidines, the CD spectra of 
tyrocidine A (Phe3-D-Phe4) in the presence of Ca2+ exhibited slightly red-shifted θ216 
minima at 218 nm, and generally reduced ellipticity (Figure 5C). These changes in 
negative ellipticity may be due to changes in backbone conformation, changes in the 
relative contribution of the aromatic amino acids and/or differences in self-assembly. 
Previous research indicated that the TrcB forms elongated aggregates in a salt-free 
environment [47], whereas micelle-like association leads to the formation of spherical 
aggregates in the presence of NaCl [48, 49]. The manner of self-assembly, the size of 
the formed aggregate/self-assembled structure and/or the relative orientation of the 
peptide molecules within the induced structure may affect CD spectra directly or 
indirectly due to the influence on the orientation/exposure/local environment of the 
aromatic amino acids. The reduced ellipticity of TrcA in the presence of Ca2+ may be 
related to loss of peptide due to settling out of higher-order structures.  
The CD spectra of TrcB and TrcC in TFE exhibited slightly blue shifted negative 
ellipticity minima with increased intensity at 204 nm and 214 nm, although the 
resolution of the latter was lost (Figure 5A and B). The CD spectra of TrcA in TFE also 
exhibited slightly blue shifted negative ellipticity minima with increased intensity at 204 
nm and 214 nm, as well as an additional negative band around 222 nm (Figure 5C). 
These changes in ellipticity may be attributed to the induction of significant changes in 
the self-assembly state, hydrogen bonding and the orientation/exposure/local 
environment of the aromatic amino acids. (Refer to Chapter 3). If it is assumed that the 
CD spectra in TFE represent self-assembled structures that may be found in membranes, 
6-13 
 
then the spectrum in CaCl2 represents self-assembled structures that are different from 
those in TFE (Figures 5A-C).  
Fluorescence spectroscopy was used to further investigate the influence of Ca2+ and 
Mg2+ on the conformation/self-assembly.  For TrcB and TrcC, photoselective excitation 
of Trp fluorescence (λex = 295 nm) indicated emission maxima at 350 nm in water and 
75 mM CaCl2, with greatly increased Trp fluorescence observed in the presence of Ca2+ 
(Figures 5D and E). These results suggest that the presence of Ca2+ leads to significant 
changes in the conformation/self-assembly of TrcB and C, which influence the 
exposure/local environment/quenching of the Trp residue(s). The fluorescence spectra 
of TrcB in 75 mM MgCl2 also exhibited increased Trp fluorescence, however, Ca2+ led 
to a 2.0 fold increase in Trp fluorescence yield, whereas Mg2+ only led to a 1.1 fold 
increase in Trp fluorescence yield. For TrcA, excitation of Tyr fluorescence 
(λex = 280 nm) indicated emission maxima at 305 and 340 nm in water (Figure 5F), 
which may be attributed to Tyr and tyrosinate fluorescence [50-52], respectively (Refer 
to Chapter 3). The presence of Ca2+ led to greatly increased Tyr fluorescence yield, but 
a loss of tyrosinate fluorescence yield (Figure 5F). These results suggest that the 
presence of Ca2+ leads to significant conformational changes of TrcA that influence the 
exposure/local environment/quenching of the Tyr residue and prevents tyrosinate 
formation.   
The CD and fluorescence spectroscopy results therefore indicate that Ca2+ induce 
distinct changes in the conformation/self-assembly of the tyrocidines, which supports 
the hypothesis that peptide-calcium complexes/aggregates represent the active form of 
the peptide. Further, comparison of the spectra of TrcB (Figures 5B and E) clearly 
shows that Ca2+ had a significantly greater influence than Mg2+, which explains the 
observation that Mg2+ does not induce similar changes in antilisterial activity. This 
result was confirmed by NMR titration studies on TrcC that suggested that an increase 
in Ca2+ causes a change in the TrcC structure while increasing Mg2+ does not have an 
effect on the Trc structure (personal communication, K. Köver). 
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Figure 5 Influence of solution composition/identity on the CD spectra A. TrcC,  B. TrcB 
and C. TrcA and fluorescence emission spectra of D.TrcC,  E. TrcB and F. 
TrcA. Each CD spectrum is depicted by a Lowess fit line (20 point smoothing 
window) for an average of triplicate determinations. 
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6.4.4 Influence of calcium on antilisterial activity of the tyrocidines  
The optimal calcium concentration for increased activity of the tyrocidine mixture was 
found to be at least 7.5mM CaCl2 (Figure 6). The undiluted tyrocidine mixture in 
37.5 mM CaCl2 (before 10 fold dilution in the assay) became visibly opaque, but a 
major loss of activity only occurred at 30 
0 mM CaCl2 (Figure 6). This loss of activity is due to visible precipitation (salting out) 
of the tyrocidine mixture in the undiluted stock.  When 75 mM CaCl2 (7.5 mM in assay) 
was added to the peptide solutions, the activity of the tyrocidine complex, as well as the 
three purified tyrocidines were significantly increased (Table 1, Figure 6).  
 
 
 
 
 
 
 
Figure 6  Effect of calcium concentration on the antilisterial activity of the tyrocidine 
mixture. The reduction of cell viability after 3 hours and 17 hours by 
12.5 µg/mL tyrocidine mixture diluted in different calcium concentrations 
was determined. The arrows indicate maximal activity, which was observed 
at 7.5 mM CaCl2. Each data point represents the mean of quadruplicate 
repeats, with ± standard error of the mean (SEM).  
As discussed above, the increased activity induced by 7.5 mM CaCl2 may be due to 
complexation between calcium and the tyrocidines inducing a more active conformation 
or formation of active complexes/higher-order structures. Alternatively, the increased 
activity in the presence of calcium may be due to increased calcium in the bacterial cell 
wall or membrane, which may serve as docking sites for the tyrocidines. In order to 
determine the mode in which calcium modulates antilisterial activity of the tyrocidines, 
the tyrocidine complex and TrcB were diluted in 75 mM CaCl2 (10× concentrate), 
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allowing pre-complexation before exposure to growth media and bacteria, and tested 
toward L. monocytogenes cultured in standard BHI growth medium. The second 
hypothesis was tested by culturing L. monocytogenes in BHI growth medium 
supplemented with 7.5 mM CaCl2, which would allow the influence of calcium-bacteria 
interaction on activity to be evaluated. It was assumed that bacteria grown in the 
presence of calcium would have a greater amount of calcium in their cell wall and 
membrane, possibly providing more binding sites for the tyrocidines. TrcB was chosen 
to evaluate this aspect as it is more sensitive to solvent composition than TrcC (refer to 
Table 1) and more active toward L. monocytogenes B73 than tyrocidine A [32].  The 
antilisterial activity of the tyrocidine complex and tyrocidine B was assessed by 
measurement of cell viability (cell reducing potential) and cell survival (CFU 
determination) after 2 to 3 hours (short-term effect) and 16 to 17 hours (long-term 
effect) of exposure and culturing (Figure 7).  
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Figure 7 Representative dose–response curves of TrcB toward L. monocytogenes. TrcB 
was either diluted in 75 mM CaCl2 (7.5 mM in assay) or water, or diluted in 
water and exposed to 7.5 mM CaCl2 in the bacterial culture. Each data point 
represents the mean of quadruplicate repeats ± SEM. The sigmoidal dose–
response curves fitted the experimental data with R2-values of >0.99. 
Investigation of the short term antilisterial activity indicated that both CaCl2 in the 
peptide solvent and in culturing medium of L. monocytogenes B73 led to an increase in 
activity, as reflected by significantly lower IC50-values and reduced cell survival (Table 
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2). With 75 mM CaCl2 as peptide solvent (7.5 mM in assay), the reduction of cell 
viability by the tyrocidine complex and TrcB increased with 2.6 and 1.9 fold, 
respectively, while cell survival was reduced by 40 and 67%, respectively. The 
reduction of cell viability by the tyrocidine complex and TrcB toward L. monocytogenes 
B73 cultured in BHI growth medium supplemented with calcium increased with 3.4 and 
3.1 fold, respectively, while cell survival was reduced by 24% and 45%, respectively. In 
contrast, with the longer exposure and culturing (16-17 hours) only 75 mM CaCl2 in the 
tyrocidine solvent led to an increase in tyrocidine activity (Table 2). The reduction of 
cell viability by the tyrocidine complex and TrcB increased with 1.5 and 2.3 fold, 
respectively, while cell survival was reduced by 38 and 25%, respectively. 
Table 2   Effect of peptide solvent on the antilisterial activity of the tyrocidine mixture 
and tyrocidine B. The antilisterial activity of the tyrocidine mixture and 
tyrocidine B (diluted in either water or 75 mM CaCl2) toward 
L. monocytogenes B73 (cultured in either standard BHI growth medium or 
BHI growth medium supplemented with CaCl2) reflected by inhibition of cell 
viability, was characterised in terms of IC50, given in µg/mL. Percentage cell 
survival after incubation with 6.25 µg/mL peptide, is given in terms of CFUs.  
 
 
 IC50 ± SEM (µg/mL) % Cell survival ± SEM 
 3 hours 17 hours 2 hours 16 hours 
Trc mix     
Water 7.1 ± 1.2 25 ± 0.40 40 ± 4.4 50 ± 6.0 
7.5 mM CaCl2 2.7 ± 0.42* 13 ± 0.0033*** 0.010 ± 0.010*** 12 ± 8.0* 
Calcium culture 2.1 ± 0.30* 28 ± 0.31***,††† 16 ± 2.1**,† 52 ± 10† 
TrcB     
Water 13 ± 1.1 25 ± 1.0 72 ± 2.5 56 ± 1.0 
7.5 mM CaCl2 6.8 ± 0.25** 11 ± 0.27** 5.3 ± 0.20*** 31 ± 4.8* 
Calcium culture 4.2 ± 0.077*** 30 ± 3.7†† 27 ± 2.5**,† 62 ± 10†† 
P-values were determined with Tukey’s multiple comparison test. For statistical difference of activity 
parameters from parameters for bacteria cultured in standard medium with water used as peptide solvent: 
*, P < 0.05; **, P < 0.01, ***, P < 0.001 (N≥3). For statistical difference of activity parameter from 
parameters for bacteria cultured in standard medium with 75 mM CaCl2 used as peptide solvent: †, P < 
0.05; ††, P < 0.01, †††, P < 0.001 (N≥3). 
The discrepancy between the results of short and long term activity toward 
L. monocytogenes cultured in calcium-supplemented growth media suggests that a 
concomitant tyrocidine challenge leads to reversible cell stress and/or damage. 
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Fluorescence microscopy with propridium iodide as membrane permeability indicator 
showed that the calcium exposed cultures exhibit greater intrinsic cell 
permeability/death (results not shown). The observed increase in short-term activity 
toward L. monocytogenes cultured in calcium-supplemented growth media may thus be 
attributed to cell damage, which leads to decreased redox potential, but translates to a 
bacteriostatic and not a bacteriocidal effect. The reduced cell survival seen under these 
conditions after two hours may be due to loss of damaged but viable cells during 
dilution of the cultures in PBS before plating-out. Overall, our results indicate that the 
increased bacteriocidal activity requires peptide-calcium pre-incubation which may lead 
to the formation of complexes (see discussion on the spectrophotometric analysis of 
TrcB). The different Ca2+-sensitivities of the various tyrocidines may be due to 
differences in peptide-calcium interaction and/or different propensities for aggregation. 
Differences in peptide-calcium complexation and/or aggregation may be related to 
structural differences of the tyrocidines. 
6.4.5 Influence of calcium on the mode of action of the tyrocidines  
Previous research has suggested that the antilisterial activity of the tyrocidines may 
involve a membranolytic as well as an additional/alternative mechanism of action [32]. 
Two activity parameters related to peptide mechanism of action were determined, 
namely inhibition concentration factor (ICF), which describes the increase in peptide 
concentration between minimum and maximum inhibition and the activity slope (AS), 
which is related to the Hill coefficient [38]. Furthermore, live-cell fluorescent 
microscopy with propridium iodide as permeability indicator was used to assess the 
microscopic influence of the different solvents and culturing conditions on the lytic 
activity of TrcB.  
In addition to changes in antilisterial activity (as described by IC50), changes in activity 
parameters indicative of mechanism of action (as indicated by ICF and AS) were induced 
by the use of 75 mM CaCl2 as peptide solvent (7.5 mM in assay). When water was used 
as peptide solvent, the tyrocidine mixture and TrcB both exhibit IC50s of 25 µg/mL; 
ICFs of 3.2 and 4.1, respectively; and AS of 3.6 and 4.7, respectively, toward L. 
monocytogenes B73 cultured in standard BHI growth medium (Table 3). The high AS 
(>1) suggests that, under these conditions, the peptides self-assemble into active lytic 
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complexes [38]. This is supported by the results of live-cell fluorescent microscopy, 
which indicated that TrcB (with water as solvent) induced membrane lysis/leakage of 
L. monocytogenes cultured in standard BHI growth medium, with an apparent lytic rate 
of 8.6 fluorescent units/min (R2 = 0.99) (Figures 8 and 9). The activity of the tyrocidine 
complex and TrcB toward L. monocytogenes B73 cultured in calcium-supplemented 
growth medium exhibited similar ICFs (2.6 and 3.4, respectively) and ASs (4.7 and 3.6, 
respectively) as toward bacteria cultured in standard growth medium
 
(Table 3). 
Furthermore, tyrocidine induced lysis/leakage of L. monocytogenes cultured in the 
presence of calcium had an apparent lytic rate of 7.3 fluorescent units/min (R2 = 0.99) 
which is equivalent to that induced toward L. monocytogenes cultured in standard BHI 
growth medium (Figures 8 and 9). 
Table 3   Effect of peptide solvent on the antilisterial activity after 17 hours growth in 
the tyrocidine mixture and TrcB. The antilisterial activity of the tyrocidine 
mixture and TrcB (diluted in either water or 75 mM CaCl2) toward 
L. monocytogenes B73 (cultured in either standard BHI growth medium or 
BHI growth medium supplemented with CaCl2) was characterised in terms of 
ICmin, ICmax, IC50, ICF and AS.  
 
 ICmin1 IC50 ICmax2 ICF3 ± SEM AS ± SEM 
Trc mix      
Water 14 (14) 25 45 (45) 3.2 ± 0.0041 3.6±0.76 
75 mM CaCl2 12 (11) 13*** 15 (14) 1.2 ± 0.024*** 18±1.6*** 
Calcium culture 20 (15) 28***,††† 52 (38) 2.6 ± 0.32†† 4.7±1.2††† 
TrcB      
Water 12 (13) 25 49 (52) 4.1 ± 0.076 2.8±0.35 
75 mM CaCl2 10 (8.8) 11** 14 (12) 1.3 ± 0.092*** 15±0.32*** 
Calcium culture 19 (15) 30†† 62 (48) 3.4 ± 0.35††† 3.6±1.6††† 
1
 From dose-response curves, values in parentheses calculated as ICmin = IC50/√ICF; ICF = (ICmax/IC50)2 
2
 From dose-response curves, values in parentheses calculated as ICmax = ICmin×ICF; ICF = (IC50/ICmin)2 
3
 Average of ICFs calculated according to equations (2)-(5) 
P-values were determined with Tukey’s multiple comparison test. For statistical difference of activity 
parameters from parameters for bacteria cultured in standard medium with water used as peptide solvent: 
*, P < 0.05; **, P < 0.01, ***, P < 0.001 (N≥3). For statistical difference of activity parameter from 
parameters for bacteria cultured in standard medium with 75 mM CaCl2 used as peptide solvent: †, P < 
0.05; ††, P < 0.01, †††, P < 0.001 (N≥3). 
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Figure 8 The influence of divalent cations on TrcB-induced leakage of propridium 
iodide into L. monocytogenes B73. A. A real time monitoring of propridium 
iodide fluorescence in the presence of 6.25 µg/mL TrcB either diluted in 
water or 75 mM CaCl2 (7.5 mM in assay); B. The lytic activity of 6.25 µg/mL 
TrcB (diluted in water, 75 mM MgCl2 or 75 mM CaCl2; 7.5 mM in assay) 
toward L. monocytogenes B73 (cultured in either standard BHI growth 
medium or BHI growth medium supplemented with CaCl2) was evaluated at 
different time points by fluorescence microscopy, using propridium iodide. 
The increase in fluorescent signal of propridium iodide is indicative of 
increased membrane leakage/lysis. 
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Figure 9 Fluorescent microscopy of L. monocytogenes using propridium iodide and bisbenzimide to 
assess the influence of TrcB, in the presence and absence of divalent cations, on cell integrity. 
Bisbenzimide (membrane permeable DNA marker) fluorescence (blue) indicates all L. monocytogenes 
cells, whereas propridium iodide (membrane impermeable DNA marker) fluorescence (red) indicates L. 
monocytogenes cells with compromised membrane integrity. The left hand panels show the overlay of 
bisbenzimide and propridium iodide fluorescence; the middle panels the bisbenzimide fluorescence and 
the right hand panels the propridium iodide fluorescence.  A: Untreated L. monocytogenes cultured in 
standard BHI growth medium; B: L. monocytogenes cultured in standard BHI growth medium and treated 
with 6.25 µg/mL TrcB diluted in water; C: L. monocytogenes cultured in standard BHI growth medium 
and treated with 6.25 µg/mL TrcB diluted in 75 mM MgCl2 (7.5 mM in assay); D: L. monocytogenes 
cultured in standard BHI growth medium and treated with 6.25 µg/mL TrcB diluted in 75 mM CaCl2 (7.5 
mM in assay); E: Untreated L. monocytogenes cultured in calcium-supplemented BHI growth medium; F: 
L. monocytogenes cultured in calcium-supplemented BHI growth medium and treated with 6.25 µg/mL 
TrcB diluted in water. 
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When 75 mM CaCl2 was used as peptide solvent (7.5 mM in assay), the tyrocidine 
complex and TrcB exhibit lower ICFs (1.2 and 1.3, respectively) and significantly 
higher AS (18 and 15, respectively) toward L. monocytogenes B73 cultured in standard 
BHI growth medium (Table 3). The low ICFs and very high ASs are indicative of either 
antimicrobial peptide self-assembly into active lytic complexes (as seen with water as 
peptide solvent) or a lethal cellular event at a threshold concentration [38]. Fluorescence 
microscopy results indicated a complete absence of lytic activity when 75 mM CaCl2 
was used as peptide solvent (Figures 8 and 9), which strongly suggests that these 
conditions lead to a non-lytic lethal cellular event. The specificity of the influence of 
calcium on the modulation of tyrocidine mode of action is supported by the observation 
that the use of 75 mM MgCl2 as peptide solvent did not significantly influence the 
membrane lysis/leakage by TrcB (Figures 8 and 9), exhibiting an apparent lytic rate of 
6.7 fluorescent units/min (R2 = 0.95). These results indicate that, in addition to 
improving antilisterial activity, peptide-calcium pre-complexation and/or induction of 
active complexes/higher-order structures changes the mechanism of action of the 
tyrocidines from a predominantly lytic to non-lytic mechanism of action.  
6.5 Conclusions 
The activities of tyrocidines were found to be highly sensitive to solvent composition in 
terms of solubility, aggregation/self-assembly and complexation with cations, however, 
they showed relatively good salt tolerance. The observed sensitivity is highly dependent 
on peptide structure and probably purity. Furthermore, the solvent composition leads to 
changes in both activity (characterised by IC50) and mechanism of action (reflected by 
ICF and AS). When considering the activity toward L. monocytogenes B73 cultured in 
standard BHI growth medium, the results suggest that when the tyrocidines are 
dissolved and diluted in water, they self-assemble to form active, bactericidal lytic 
complexes. As with most lytic antimicrobial peptides, the self-assembly of the 
tyrocidines probably occurs within the membrane, disrupting membrane integrity when 
a certain critical peptide concentration is reached. However, a novel result from this 
study indicated that calcium plays an important role in the antilisterial activity and mode 
of action of the tyrocidines. Correlations between apparent Ca2+-complexation and 
antilisterial activity of the tyrocidines further supported the hypothesis that 
Ca2+-complexation is an important modulator of tyrocidine antilisterial activity. The 
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spectrophotometric investigation indicated that Ca2+ has a significant influence on the 
self-assembly of the tyrocidines and that such self-assembly is distinct, possibly in 
terms of size and/or  the relative orientation of the peptide molecules with the assembly, 
from assemblies formed in a salt-free environment, and a membrane environment. We 
were able to show that calcium-peptide interaction is important in activity modulation, 
whereas calcium-bacteria interaction does not influence the long term activity or mode 
of action. When peptides are pre-incubated in 75 mM CaCl2, they form active 
complexes/higher-order structures, which lead to a non-lytic bacteriocidal cellular 
event.  Pre-incubation of the tyrocidines in 75 mM CaCl2 therefore not only increases 
the specific antilisterial activity of the tyrocidines, but also changes the mechanism of 
action of the tyrocidines from a predominantly lytic to an alternative/intracellular mode 
of action. Our results also strongly indicate that a novel antimicrobial peptide target 
may exist in L. monocytogenes.  
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 Chapter 7  
 Antiplasmodial activity and structure-activity 
relationships of the tyrocidines 
 
7.1 Introduction 
Malaria is one of the principal causes of morbidity and mortality worldwide, with 
nearly 250 million cases and one million deaths reported annually [1]. The majority of 
these fatal cases are caused by Plasmodium falciparum, the most virulent species [2, 3]. 
The prevalence of drug-resistant P. falciparum species [3, 4] necessitates the 
development of new antimalarial compounds. Various antimicrobial peptides have been 
shown to possess selective antimalarial activity. The modification of the host 
erythrocyte membrane by the infecting parasite may render it vulnerable to selective 
recognition and perturbation by membrane-active compounds, such as membrane active 
antibiotics, antimicrobial peptides and polymers. Membrane active polyene antibiotics, 
such as amphotericin B and nystatin [5], linear antimicrobial peptides, such as mellitin, 
magainin 2, cecropin B and cecropin-mellitin analogues [6, 7], dermaseptin S4 [8-10] 
and the cyclic antimicrobial peptide gramicidin S [11] have been shown to selectively 
lyse P. falciparum infected erythrocytes. However, antimicrobial peptides with 
alternative/internal targets have also been identified. Aminoacyl analogues of 
dermaseptin S4 inhibit P. falciparum by crossing several membranes to reach the 
intracellular parasite target [8-10]. A linear antimicrobial peptide representing the 
cationic core region of the lymphocytic effector protein NK-lysin, NK-2, exerts its 
antiplasmodial activity by permeabilising and transversing the erythrocyte membrane as 
well as the parasitophorous vacuole membrane to reach the intracellular parasite [12]. A 
small library of microheterogeneous cyclohexadepsipeptides has also been shown to 
inhibit the intraerythrocytic growth of P. falciparum, without lysis of erythrocytes [13]. 
Rautenbach et al. (2007) [11] previously reported selective inhibition of P. falciparum 
3D7 blood stages by the tyrocidines, a group of membrane active cyclic decapeptide 
antibiotics from Bacillus aneurinolytcus. Unlike the lytic mechanism of the analogous 
gramicidin S, the antiplasmodial activity of the tyrocidines was found to involve a 
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non-lytic mechanism of action focussed on the trophozoite developmental stage [11]. 
The reported selective antiplasmodial activity of the tyrocidines suggests that they may 
be promising compounds for the development of new antimalarial drugs.  However, the 
tyrocidines also exhibit haemolytic activity and toxicity toward certain human cell lines 
in vitro [11, 14]. In order to develop therapeutic agents based on the tyrocidines, insight 
regarding their structure-activity-toxicity relationships, formulation determinants of 
activity and mechanism of action is imperative. 
As described in Chapter 2, the six major tyrocidines (tyrocidines A, A1, B, B1, C and 
C1) and two minor tyrocidines (tyrocidines B` and B1`) were successfully purified. A 
further two minor natural tyrocidines (TpcB and TpcC) were partially purified. (Refer to 
Chapter 2 for more detail.)  The antiplasmodial and haemolytic activities of these 
purified peptides were investigated and correlated with selected physicochemical 
descriptors of hydrophobicity/amphipathicity, size and structure (Chapter 4) in order to 
gain insight regarding the structural features of the peptides that modulate activity. In 
addition to hydrophobicity/amphipathicity and size, peptide self-assembly in solution 
may influence antiplasmodial activity and insight regarding the structure-activity 
relationships and mode of action of the tyrocidines may thus be gained by investigating 
correlations between self-assembly and antiplasmodial activity. Furthermore, the 
bioactivity of antimicrobial peptides requires interaction with the target cell membrane 
[15-19] and correlations between changes in tyrocidine structure/aggregation state 
induced by a membrane-mimetic environment may thus advance our understanding of 
tyrocidine structure-activity relationships and mode of action. In addition to the role of 
peptide properties, the physiological salt and serum components, such as albumin, may 
influence the antiplasmodial activity of the tyrocidines [15, 20]. The observation that 
Ca2+ has significant influence on the antilisterial activity of the tyrocidines (Chapter 6) 
motivates investigation of the influence of divalent cations on antiplasmodial activity. 
7.2 Materials  
Tyrothricin (commercial extract from B. aneurinolyticus), gramicidin S, trifluoroacetic 
acid (TFA, >98%), Corning Incorporated® cell culture cluster, non-pyrogenic 
polypropylene 96-well microtiter plates, MalstatTM reagent and bisbenzimide and 
propridium iodide was supplied by Sigma (St. Louis, USA). The diethyl ether, acetone, 
butan-1-ol, acetic acid, and propan-2-ol were supplied by Saarchem (Krugersdorp, 
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South Africa). Acetonitrile (ACN) (HPLC-grade, far UV cut-off) and was supplied by 
Romill Ltd. (Cambridge, UK). Ethanol (>99.8%) was supplied by Merck (Darmstadt, 
Germany). Albumax II and RPMI-1640 were supplied by Scientific Group (Auckland, 
New Zealand). Analytical grade water was prepared by filtering water from a reverse 
osmosis plant through a Millipore Milli-Q® 58 water purification system (Milford, 
USA).  
7.3 Methods 
7.3.1 Peptide preparation 
Peptides were isolated from commercially obtained tyrothricin and purified by 
semi-preparative reverse-phase high-performance liquid chromatography (RP-HPLC) 
(Chapter 2), as previously described by Rautenbach et al. (2007) [11] and Spathelf and 
Rautenbach (2009) [21].  
Stock solutions of the purified peptides were prepared by dissolving the analytically 
weighed peptides in ethanol:water (1:1, v/v) to concentrations of 2.00 mg/mL. Stock 
solutions were diluted 1:1 in water to give peptide solutions of 1.00 mg/mL, which were 
subsequently used to construct quadrupling dilution series. The dilution series were 
constructed in polypropylene microtiter plates using supplemented RPMI-1640 culture 
medium (sans albumax II), used for P. falciparum culturing. The stock solutions and 
dilution series were prepared shortly before (<30min) before each assay. For 
investigation of the influence of peptide solvent, the peptide stock solutions 
(2.00 mg/mL, ethanol:water, 1:1 v/v) were diluted to 0.200 µM in RPMI-1640 culture 
medium (sans albumax II), 0.5% (w/v) albumax II  or 10 mM CaCl2.  
7.3.2 Antiplasmodial and haemolytic activity determination 
P. falciparum (D10 strain) was cultured under an atmosphere of 3% CO2, 4% O2 and 
93% N2 in RPMI-1640 medium supplemented with 50 mM glucose, 0.65 mM 
hypoxanthine, 25 mM HEPES, 0.2% (w/v) NaHCO3, 0.048 mg/mL gentamicin, 0.5% 
(w/v) albumax II and 2–4% (v/v) human O+ or A+ erythrocytes. Prior to each assay, a 
2% parasitemia and 2% haematocrit suspension was prepared by mixing culture-derived 
parasitised erythrocytes with fresh culture medium and erythrocytes. Dose-response 
assays were performed in sterile microtiter plates by adding 10 µL of the peptide 
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dilution series to 90 µL of the parasite suspension. For determination of total growth 
and total haemolysis, 10 µL culture medium and 10 µL 250 µg/mL saponin, 
respectively, was added to the parasite suspension. The microtiter plates were incubated 
at 37 °C for 48 h, after which 10 µL of the supernatant was removed and diluted 1:9 in 
water. The released haemoglobin in the supernatant was spectrophotometrically 
determined from their absorbance at 405 nm. The parasite viability in each well of the 
experimental microtiter plate was determined from the residual lactate dehydrogenase 
activity [22] after freeze-thawing. Briefly, 20 µL of lysate was removed from each well 
and added to 100 µL Malstat reagent, 10 µL nitroblue tetrazolium and 10 µL 
diaphorase, incubated at room temperature for 20 minutes and the absorbance at 600 nm 
measured. 
7.3.3 Analysis of dose-response data 
The percentage growth inhibition and haemolysis was calculated according to equations 
1 [23] and 2, respectively.  
backgroundofAAveragewellsgrowthofAAverage
backgroundofAAveragewellofAinhibitiongrowth
600600
600600 )(100100%
−
−×
−=
 (1) 
backgroundofAAveragewellshaemolysisofAAverage
backgroundofAAveragewellofAhaemolysis
405405
405405 )(100%
−
−
×=  (2) 
Dose-response curves were plotted using GraphPad Prism® 4.00 (GraphPad Software, 
San Diego, USA). The dose-response data was analysed by performing nonlinear 
regression and sigmoidal curves (with variable slope and a constant difference of 100 
between the top and bottom plateau) were fitted according to Rautenbach et al. (2006) 
[23].  
7.3.4 QSAR analyses 
The relationship between the antiplasmodial activity, apparent selectivity and molecular 
descriptors of amphipathicity/hydrophobicity, size, conformation and self-assembly of 
the tyrocidines was analysed. The HPLC retention times of the tyrocidines were 
obtained from the analytical HPLC chromatograms of the purified tyrocidines. 
Theoretical side-chain surface area (SCSA) and volume was calculated as the sum of 
the SCSA and volumes [24] of the constituent amino acids. Solvent-accessible surface 
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area and volume was determined from low energy models from homology modelling 
(Chapter 4). Descriptors of conformation and self-assembly were calculated from 
circular dichroism parameters (Chapters 3 and 4). The correlations between the 
molecular descriptors, antiplasmodial activity and selectivity were analysed by 
performing a linear/exponential regression using GraphPad Prism® 4.00 (GraphPad 
Software, San Diego, USA).  
7.3.5 Fluorescence microscopy 
For each sample, 10 µL of peptide solution (0.4 µM, final peptide concentration of 
40 nM) was added to 90 µL of parasite suspension (2% parasitemia, 4% hematocrit) and 
incubated for 24 hours. The samples were stained with 1 µL bisbenzamide (a membrane 
permeable DNA chelator) and 1 µL propridium iodide (a membrane impermeable DNA 
chelator) at room temperature for 15 minutes. For lytic controls, 90 µL of parasite 
suspension was treated with gramicidin S (final peptide concentration of 20 µM) fo 10 
minutes. Image acquisition was performed on an Olympus CellR system attached to an 
IX 81 Inverted fluorescence microscope equipped with an F-view-II cooled CCD 
camera (Soft Imaging Systems). Using a Xenon-Arc burner (Olympus Biosystems 
GMBH) as light source, images were acquired using the 360 nm and 472 nm excitation 
filters. Emission data was collected using a UBG triple-bandpass emission filter cube 
(Chroma). Images were acquired using an Olympus Plan Apo N60x/1.4 Oil objective. 
The degree of membrane leakage/lysis was deduced from the fluorescent signal of the 
membrane impermeable propridium iodide. 
7.3.6 Mass spectrometry 
For investigation of complexation between the tyrocidines and Ca2+ by mass 
spectrometry, stock solutions of the purified tyrocidines were diluted to 10 µM in 
various CaCl2 concentrations. Time-of-flight electrospray mass spectrometry 
(TOF-ESMS) analyses were performed using a Waters Q-TOF Ultima mass 
spectrometer fitted with an electrospray ionisation source. 10 µL of each peptide sample 
was injected into the ESMS and subjected to a capillary voltage of 3.5 kV. The source 
temperature and cone voltage was set at 100ºC and 35 V, respectively. The data was 
collected in positive mode by scanning the first mass analyser (MS1) through m/z = 
100–1999. Binding curves were plotted using GraphPad Prism® 4.00 (GraphPad 
Software, San Diego, USA) and analysed by performing nonlinear regression and the 
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curves were fitted according to Y = Smax*X/(Kd+X), where Smax represents the apparent 
maximal calcium binding (Smax) of the tyrocidines. 
7.4 Results and Discussion 
7.4.1 Antiplasmodial and haemolytic activity 
The activities of the purified tyrocidines and gramicidin S were determined toward 
normal and P. falciparum D10-infected human erythrocytes (Table 1). The 
antiplasmodial and haemolytic activities were characterised in terms IC50 or HC50 
(concentration that gives 50% inhibition or haemolysis) [23]. The observed IC50- and 
HC50-values (Table 1) were highly comparable to those reported by Rautenbach et al. 
(2007) [11], in which antiplasmodial activity of the six major natural tyrocidines 
towards the P. falciparum 3D7 strain was determined. This study indicated that the 
major tyrocidines were slightly less active toward P. falciparum D10 than toward 
P. falciparum 3D7, which is most probably due to small differences in cultures and 
assay.  
All the tyrocidines exhibited antiplasmodial activity in the nanomolar range (4.4 – 
490 nM), and were found to be significantly more active than GS (Table 1). Tyrocidine 
A was found to be the most active (IC50 = 4.4 nM), whereas tyrocidine C1 was the least 
active (IC50 = 490 nM). The minor tyrocidines B` (IC50 = 420 nM) and B1` 
(IC50 = 440 nM) were less active than the major tyrocidines B (IC50 = 110 nM) and B1 
(IC50 = 260 nM). TpcB(+TrcA) at 59 % purity and TpcC (+unknown) at 73 % purity 
exhibited low IC50-values of 60 ng/mL and 100 ng/mL, respectively. These two 
tyrocidines could, however, not be sufficiently purified and were therefore not included 
in the analyses of the structure-activity relationships. The relatively high activity of 
TpcB and TpcC may be due to the activity of the contaminant(s) or synergistic activity.  
The six major tyrocidines exhibited haemolytic activities toward normal human 
erythrocytes with HC50-values ranging between 3.1 and 6.1 µM, which is greater than 
the haemolytic activity of GS (Table 1). For the major tyrocidines, the Lys9-containing 
peptides were found to be slightly more haemolytic than their Orn9-containing 
analogues (Table 1), possibly due to tighter association of Lys with cell membrane than 
Orn [11, 25]. The minor tyrocidines B` and B1` (HC50 = 9.0 µM) were less haemolytic 
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than the major tyrocidines B (HC50 = 6.1 µM) and B1 (HC50 = 4.9 µM), with 
HC50-values similar to that of GS (Table 1). TpcB and TpcC exhibited HC50-values of 
4.9 µg/mL and 9.8 µg/mL, respectively.  
All the natural tyrocidines, with the exception of TrcC1, were found to be significantly 
more selective for infected erythrocytes than GS (Table 1).  Tyrocidine A exhibited the 
highest selectivity index (SI = 1100), whereas tyrocidine C1 had the lowest SI (9.5) 
(Table 1).  
Table 1  Summary of the antiplasmodial and haemolytic activity parameters of the 
tyrocidines in this study. For comparison the IC50 values of the major 
tyrocidines towards P. falciparum 3D7 from the study of Rautenbach et 
al. (2007) are given in parentheses. IC50-values are given in nM (the 
tyrocidine mixture, TpcB and TpcC given in ng/mL). Haemolytic activity 
was characterised in terms of HC50, given in µM (the tyrocidine mixture, 
Tpc B and Tpc C given in µg/mL). The apparent selectivity index (SI) 
was calculated as HC50/IC50. Each value represent the mean of at least 3 
biological repeats, with 3-5 technical repeats per assay ± standard error 
of the mean (SEM). Values are given to two significant digits.  
 P. falciparum D10 Human 
erythrocytes HC50/IC50 
Peptide IC50 ± SEM HC50 ± SEM SI ± SEM 
Trc mixture 410 ±  44 4.4 ± 0.059  11 ± 1.3 
Trc A 4.4 ± 0.16 (0.58) 4.7 ± 0.33 (4.5) 1100 ± 68 
Trc A1 36 ± 2.5 (4.4) 3.1 ± 0.38 (4.1) 82 ± 10 
Trc B 110 ± 8.1 (61) 6.1 ± 0.37 (2.6) 55 ± 5.9 
Trc B1 260 ±13 (310) 4.9 ± 0.89 (8.6) 20 ± 3.9 
Trc C 370 ± 27 (290) 5.5 ± 0.47 (3.2) 15 ± 0.86 
Trc C1 490 ± 6.0 (460) 4.6 ± 0.25 (5.4) 9.5 ± 0.43 
Trc B’ 420 ± 28 9.0 ± 0.65 21 ± 0.55 
Trc B1’ 440 ± 35 9.0 ± 0.091 19 ± 0.38 
Tpc B + TrcA 60 ± 10 4.9 ± 0.51 81 ± 20 
Tpc C  + unk 100 ± 16 9.8 ± 0.72 98 ± 9.6 
GS 1700 ± 160 (1300) 10 ± 0.14 (11) 6.6 ± 0.70 
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7.4.2 Structure-activity-selectivity relationships of the tyrocidines 
In order to identify structural features of the tyrocidines associated with antiplasmodial 
activity and selectivity, correlations between activity (IC50), apparent selectivity 
(HC50/IC50) and various physicochemical parameters (Table 2) of the eight purified 
tyrocidines were investigated. Previous research by Rautenbach et al. (2007) indicated 
strong correlations between the antiplasmodial activity, apparent selectivity, apparent 
hydrophobicity and theoretical side-chain surface area of the six major natural 
tyrocidines [11]. For this investigation RP-HPLC retention time was chosen as an 
indicator of solution amphipathicity/apparent hydrophobicity [11, 21]. As HPLC 
retention time is determined in vitro, the three-dimensional conformation and 
self-assembly are inherently taken into account (Refer to Chapter 4 for more detail). In 
silico solvent-accessible surface area (SASA) and in silico solvent-accessible volume 
(SAV) were chosen as indicators of peptide size. The theoretical parameters were 
omitted from this study as they only consider the amino acid composition, without 
taking the three-dimensional conformation or self-assembly into account. The in silico 
parameters are conformation-dependent, but also do not consider the influence of 
self-assembly.   
In order to determine the role of tyrocidine self-assembly in the modulation of 
antiplasmodial activity and selectivity, correlations between activity (IC50), apparent 
selectivity (HC50/IC50) and circular dichroism (CD)-derived indicators of peptide 
conformation and self-assembly (Table 2) were investigated. Negative ellipticity 
minima in water (θ205/θ216, water) and TFE (θ204/θ214, TFE) were chosen as indicators of 
conformation and self-assembly in an aqueous and membrane-like environment, 
respectively. Changes in negative ellipticity minima from water to TFE 
(∆θ205/θ216, water→TFE) were chosen as indicators of inducibility of secondary 
structure/self-assembly upon membrane interaction. (Refer to Chapters 3 and 4 for 
more detail). 
 
 
 
  7-9 
Table 2  Summary of selected physicochemical parameters of the purified 
tyrocidines The identity of the variable amino acid residues in positions 
3, 4 and 9 are given, with Phe = F; Trp = W; Lys = K; and Orn = O, and 
D-amino acids indicated by lower case letters.  
 
Peptide 
Variable 
residue 
identity 
HPLC RT1 
(min) 
SASA2 
(Ǻ2) 
SAV2 
(Ǻ3) 
θ205/ θ216 
in water3 
θ204/ θ214 
in TFE3 
∆ θ205/ θ216, 
water→TFE
3
 
Trc A F3f4-O9 11.81 1199 2680 0.92 1.11 21.4 
Trc A1 F3f4-K9 11.33 1207 2715 0.94 0.93 -1.21 
Trc B W3f4-O9 9.48 1216 2740 1.15 1.51 31.5 
Trc B1 W3f4-K9 9.24 1231 2776 1.14 1.49 30.3 
Trc C W3w4-O9 8.31 1267 2833 1.15 1.74 52.1 
Trc C1 W3w4-K9 7.90 1268 2854 1.03 1.68 63.8 
Trc B` F3w4-O9 8.98 1276 2808 0.85 1.67 95.9 
Trc B1` F3w4-K9 9.72 1253 2800 0.92 1.67 82.0 
1
 HPLC retention times were obtained from the analytical HPLC chromatograms of the purified tyrocidines.  
2
 Obtained from analysis of the low energy structures from homology modelling.  
3
 The ratios of the ellipticity minima were calculated from CD spectra of the tyrocidines. 
7.4.3 Structure-activity relationships of the tyrocidines 
A linear correlation was observed between antiplasmodial activity (P. falciparum D10 
strain) and HPLC retention time (R2 = 0.89) of the six major tyrocidines (Figure 1), 
which corresponds very well to previous research by Rautenbach et al. (2007) [11]. 
However, the two minor natural tyrocidines (TrcB` and TrcB1`) do not follow the same 
trend (Figure 1), which may be due to the influence of three-dimensional conformation, 
self-assembly and/or individual amino acid identity. Good linear correlations were 
observed between the antiplasmodial activity and in silico solvent-accessible surface 
area (R2 = 0.91) and volume (R2 = 0.91) of all eight tyrocidines (Figure 1). The 
modulation of antiplasmodial activity by solution amphipathicity, peptide size and the 
individual variable residues may be related to a direct influence on initial association 
with the erythrocyte membrane; integration into the erythrocyte membrane leading to 
haemolysis and/or membrane leakage; translocation to the intracellular parasite and 
association/integration with parasite membrane(s) leading to membrane leakage and 
lysis and/or interaction with parasite molecular target leading to growth inhibition 
(halting of parasite development in the late trophozoite stage). 
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 Figure 1  Correlation between the tyrocidine antiplasmodial activity and molecular 
descriptors of A. solution amphipathicity (HPLC RT) and B. size 
(solvent-accessible volume).  In A filled squares represent the six major 
tyrocidines, and clear squares represent the minor tyrocidines B` and B1` 
(excluded from linear regression). Each data point represents the mean of 
at least 3 biological repeats, with 3-5 technical repeats per assay ± SEM. 
 
Irrespective of mechanism of action (MOA), initial target membrane interaction is 
expected to be a central determinant of peptide activity. As initial membrane association 
is expected to be driven by electrostatic interaction and the cationic charge of the 
tyrocidines is carried by the Lys9 or Orn9 residue, these residues probably play an 
important role in initial membrane association. Lys has been found to interact more 
strongly with cell membrane than Orn [25], and such tighter association of Lys may 
improve lysis, but concurrently decrease the ability to translocate and reach an 
alternative internal target, thus decreasing activity. This hypothesis is supported by 
Lys9-containing tyrocidines exhibiting greater haemolytic activity, but reduced 
antiplasmodial activity and selectivity, relative to their Orn9-containing analogues 
(Table 1). Initial membrane association is followed by membrane integration driven by 
hydrophobic interactions [19, 26], possibly mediated by the aromatic residues in the 
variable dipeptide unit. In general, substitution of the Phe residues with Trp residues 
(Phe3→Trp3 and D-Phe4→D-Trp4) was found to lead to decreased antiplasmodial 
activity, which may be related to decreased amphipathicity, increased size, shallower 
membrane insertion and/or better membrane anchoring properties of Trp relative to Phe 
[27-29].  However, the influence of Phe→Trp substitution on antiplasmodial activity 
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was found to be sequence-dependent. For tyrocidines containing D-Phe4, Phe3→Trp3 
substitution leads to decreased activity (TrcA is 25 times more active than TrcB; TrcA1 
is 7 times more active than TrcB1). However, for tyrocidines containing D-Trp4, 
Phe3→Trp3 substitution does not influence activity. For tyrocidines containing Phe3, 
D-Phe4→D-Trp4 substitution led to decreased antiplasmodial activity (TrcA is 95 times 
more active than TrcB`; TrcA1 is 12 times more active than TrcB1`). For tyrocidines 
containing Trp3, Trp3-D-Phe4→ Trp3-D-Trp4 substitution also led to decreased 
antiplasmodial activity, but to a lesser extent (TrcB is 3 times more active than TrcC; 
TrcB1 is 2 times more active than TrcC1). These results emphasise the importance of 
position 4, which should ideally be D-Phe4, in antiplasmodial activity. 
Although solution amphipathicity and peptide size may directly modulate activity by 
influencing the productivity of membrane interaction, the observation that the minor 
tyrocidines B` and B1` do not follow the same trends and that the influence of Phe→Trp 
substitution is sequence-dependent suggest that alternative/additional factors are 
involved. We hypothesised that solution amphipathicity and peptide size indirectly 
modulates membrane interaction by influencing the manner and/or extent of peptide 
self-assembly. Although no clear correlations were observed between antiplasmodial 
activity and self-assembly in an aqueous environment, the major Phe3-containing 
tyrocidines (TrcA and A1) exhibit greater antiplasmodial activity than the 
Trp3-containing tyrocidines (TrcC, C1, B and B1) (Table 1). As discussed in Chapter 4, 
the Phe3-containing tyrocidines exhibit enhanced β-sheet/self-assembly relative to 
Trp3-containing tyrocidines in aqueous solution, which suggest that enhanced 
β-sheet/self-assembly in an aqueous environment leads to increased antiplasmodial 
activity. The same does, however, not apply for the minor Phe3-containing tyrocidines 
(TrcB` and B1`), which exhibit enhanced self-assembly in water, but reduced activity. 
This result again indicates the importance of D-Phe4 in antiplasmodial activity.  
Good exponential correlations were observed between antiplasmodial activity and 
θ204/θ214, TFE of the Orn9- (R2 = 0.84) and Lys9- (R2 > 0.99) containing tyrocidines 
(Figure 2A), which suggest that the extent and/or manner of tyrocidine self-assembly in 
a membrane environment is a major determinant of antiplasmodial activity, with 
enhanced β-sheet/self-assembly in a membrane environment related to reduced activity. 
Furthermore, the Trp-containing tyrocidines (C and B groups) were less active than the 
Phe-containing tyrocidines (A group) (Table 1). As discussed in Chapter 4, decreased 
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solution amphipathicity, greater solvent-accessible surface area and the presence of a 
Trp residue (irrespective of position) is associated with enhanced β-sheet 
structure/self-assembly in a membrane environment. In addition to self-assembly in a 
membrane environment, enhanced inducibility of secondary structure/self-assembly 
upon membrane interaction (∆θ205/θ216, water→TFE), was generally associated with reduced 
antiplasmodial activity (Figure 2B). The Trp4-containing tyrocidines (TrcC, C1, B` and 
B1`) were less active than the Phe4-containing tyrocidines (TrcA, A1, B and B1), 
following a sigmoidal relationship between (∆θ205/θ216, water→TFE) and antiplasmodial 
activity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2  Correlation between the tyrocidine antiplasmodial activity and CD-
derived descriptors of A. self-assembly in a membrane environment 
(θ204/θ214, TFE) and B. inducibility of self-assembly upon membrane 
interaction (∆ θ205/θ216, water→TFE ). Each data point represents the mean of 
at least 3 biological repeats, with 3-5 technical repeats per assay ± SEM.  
As discussed in Chapter 4, inducibility of β-sheet structure/self-assembly upon 
membrane interaction is associated with decreased solution amphipathicity, greater 
solvent-accessible surface area, and Trp4-containing tyrocidines (TrcC, C1, B` and B1`) 
exhibit enhanced inducibility of β-sheet structure/self-assembly relative to 
Phe4-containing tyrocidines (TrcA, A1, B and B1). The results therefore suggest that the 
reduced antiplasmodial activity associated with decreased solution amphipathicity and 
increased size may be an indirect result of the enhanced self-assembly in a membrane 
environment/inducibility of self-assembly upon membrane interaction leading to a 
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membrane associated MOA. The sigmoidal trend may also indicate a switch in MOA 
between a pure non-membrane associated MOA for TrcA and A1, a mixed MOA for 
TrcB and B1 (slope of curve) and a pure membrane associated MOA for TrcC, C1, B` 
and B1` (Figure 2B). 
7.4.4 Structure-selectivity relationships of the tyrocidines  
Excellent exponential correlations were observed between apparent selectivity for 
infected erythrocytes and in silico solvent-accessible surface area (R2 = 0.95, results not 
shown) and in silico solvent-accessible volume (R2 = 0.98) (Figure 3A), indicating that 
solution amphipathicity and peptide size are major determinants of selectivity, which 
corresponds to previous research by Rautenbach et al. (2007) [11]. However, 
correlation between apparent selectivity and HPLC retention time required segregation 
of the Orn9- (R2 = 0.99) and Lys9- (R2 = 0.94) containing tyrocidines, suggesting that the 
identity of the cationic residue in position 9 may have an important influence on 
selectivity (Figure 3B).  
As discussed for antiplasmodial activity, increased solution amphipathicity and 
decreased peptide size may increase selectivity (1) directly by modulating the 
productivity of membrane interaction and/or (2) indirectly by modulating the manner 
and/or extent of peptide self-assembly. Good exponential correlations were observed 
between apparent selectivity for infected erythrocytes and θ204/θ214, TFE of the Orn9- 
(R2 > 0.99) and Lys9- (R2 = 0.91) containing tyrocidines (Figure 4).  
These results suggest that the extent and/manner of tyrocidine self-assembly in a 
membrane environment is a major determinant of selectivity, with enhanced β-
sheet/self-assembly in a membrane environment related to reduced selectivity. The 
required segregation of the Orn9- and Lys9-containing tyrocidines is probably related to 
the influence of these cationic residues on the extent of self-assembly (size of self-
assembly structures) and/or the orientation of the peptide molecules within the 
higher-order structures (Discussed in Chapter 4).  
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Figure 3  Exponential correlation between apparent selectivity (SI) for P. 
falciparum-infected erythrocytes and molecular descriptors of A. size (in 
silico solvent-accessible volume) and B. solution amphipathicity (HPLC 
RT) of the tyrocidines. Each data point represents the mean of at least 3 
biological repeats, with 3-5 technical repeats per assay ± SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4  Correlation between apparent selectivity for P. falciparum-infected 
erythrocytes and CD-derived descriptors of self-assembly in a membrane 
environment (θ204/θ214, TFE) of the tyrocidines. Each data point represents 
the mean of at least 3 biological repeats, with 3-5 technical repeats per 
assay ± SEM. 
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Overall, these results indicate a central role for self-assembly in antiplasmodial activity 
and selectivity, and suggest that the structural requirements of activity and selectivity 
are, at least in part, related to the propensity for self-assembly in different environments. 
Tyrocidines with a higher propensity for self-assembly in an aqueous environment were 
in general more active and selective, while the inverse was observed for membrane 
associated self-assembly.  
7.4.5 Modulation of antiplasmodial activity by solvent 
conditions/formulation 
From the above correlations it is clear that the activity of the tyrocidines is very 
sensitive in terms of self-assembly and the formulation/solvent environment, such as 
ionic strength and the presence of serum proteins such as albumin [15], of the 
tyrocidines may therefore have a major influence on their activity. 
7.4.5.1 Tyrocidine-Ca2+ complexation and antiplasmodial activity 
The antibacterial activity of the tyrocidines was found to be relatively salt-insensitive, 
but calcium was found to play a major role in antilisterial activity modulation 
(Chapter 6). Investigation of the influence of calcium on the antiplasmodial activity of 
tyrocidine A (the most active antiplasmodial peptide) indicated that 1.0 mM CaCl2 led 
to a 50% decrease in the activity of tyrocidine A. The observed loss of activity may be 
related to the precipitation of the TrcA-Ca2+ complexes. For antilisterial activity, a 
peptide-to calcium ratio of 1:750 (10 µM peptide:7.5 mM CaCl2) led to optimal activity. 
Peptide-to-calcium ratios greater than 1:3000 led to reduced antilisterial activity, 
attributed to precipitation of active tyrocidine-Ca2+ complexes (refer to Chapter 6). The 
high peptide-to-calcium ratio (1:68 750; 20 ng/mL:1.375 mM CaCl2) may therefore 
have lead to precipitation of TrcA-Ca2+ complexes and loss of antiplasmodial activity. 
However, the role of Ca2+ in the antiplasmodial activity of the tyrocidines cannot be 
fully ruled out as the RPMI culture medium contains approximately 375 µM CaCl2 (15 
ppm as determined with elemental analysis)
 
 leading to the an 1:18750 ratio at 20 ng/mL 
tyrocidine. As normal parasite development, as well as erythrocyte invasion by 
P. falciparum merozoites, is highly dependent on extracellular and intraparasitic Ca2+ 
[30-37], the influence of lower calcium concentrations could not be investigated. 
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The apparent maximal Ca2+ binding (maximal/plateau MS signal of complex, Smax) of 
the six major tyrocidines was calculated from TOF-ESMS data (Figure 5A). In 
Chapter 6, a linear correlation (R2 = 0.82) was reported between the Smax for Ca2+ and 
HPLC retention time, which indicates that tyrocidine-Ca2+ complexation is related to 
solution amphipathicity. This correlation may also imply that greater self-assembly in 
aqueous solution (as seen for TrcA and A1, refer to Chapter 3 ) allows for greater Ca2+ 
binding, possibly due to incorporation of Ca2+ in higher-order structures. 
A strong exponential correlation (R2 = 0.96) was observed between apparent maximal 
Ca2+ binding (Smax) and antiplasmodial activity (Figure 5B), which supports the 
hypothesis that Ca2+-tyrocidine complexation plays an important role in antiplasmodial 
activity.  The results indicate that increased Smax is associated with increased 
antiplasmodial activity, which may be related to induction of active 
conformations/higher-order structures by increased Ca2+-complexation. Tyrocidine-Ca2+ 
complexation may interfere with calcium homeostasis, which is required for normal 
development of the parasite.  
 
 
 
 
 
 
 
  
Figure 5 A. Apparent tyrocidine-Ca2+ complexation as determined by TOF-ESMS 
and B. Correlation between apparent maximal Ca2+ binding (Smax) and 
the antiplasmodial activity (IC50) of the six major tyrocidines. Data 
points are the mean of at least three determinations ± SEM.  
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7.4.5.2 The influence of serum albumin on antiplasmodial activity 
The potential influence of albumin on the antiplasmodial activity of the tyrocidines was 
evaluated diluting the peptides in RPMI culture medium or albumax II (human serum 
albumin preparation used as serum substitute). Albumax II did not influence the activity 
of tyrocidines A and A1, but led to a significant loss in activity of tyrocidines B, B1, C, 
C1 and gramicidin S (Figure 6). The loss of gramicidin S activity, which acts mostly via 
a lytic mode of action [11], suggests that the presence of/binding to albumin reduces its 
specific lytic activity. The observed loss of activity of tyrocidines B, B1, C and C1, with 
B1 the least affected of this group, may be related to the loss of lytic activity due to 
binding to albumin. In contrast, the more active peptides, tyrocidines A and A1, did not 
exhibit reduced activity in the presence of albumin, which suggests that either these 
peptides do not associate with albumin or their mode of action is not influenced by such 
interaction.  
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Figure 6  Influence of pre-incubation conditions on the antiplasmodial activity of 
the tyrocidines. The bars indicate inhibition of P. falciparum (% 
inhibition ± SEM, n = 5) by 20 ng/mL purified tyrocidine with RPMI 
culture medium (clear bars) or albumax II (grey bars) as peptide 
per-incubation solvent.  
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 Results from fluorescent microscopy (see discussion below), as well as previous 
research, indicated that TrcA does not induce overt lysis, but rather acts via an 
alternative mode of action, halting parasite development in the late trophozoite stage 
[11]. Such an alternative mode appears to be unaffected by association with albumin. 
7.4.6 Influence of tyrocidine A on membrane integrity 
The previous study by Rautenbach et al. (2007) [11] indicated that the tyrocidines act 
by a non-lytic mode of action. In order to investigate this observation further, the 
influence of tyrocidine A on membrane integrity was visualised by live cell fluorescent 
microscopy. Bisbenzimide, a membrane permeable DNA marker, was used to visualise 
all P. falciparum nuclei, whereas propridium iodide, a membrane impermeable DNA 
marker, was used to identify nuclei of P. falciparum cells with compromised membrane 
integrity. As expected, the control cultures only exhibited bismenzamide fluorescence, 
especially in the vicinity of the hemozoin crystal (Figure 7A), indicating that membrane 
integrity is not compromised.  The TrcA-treated P. falciparum-infected erythrocytes 
also did not exhibit propridium iodide fluorescence, indicating that TrcA does not 
compromise parasite membrane integrity within a 24 hour period, which corresponds to 
previous research by Rautenbach et al. (2007) [11]. Only cultures lysed with 20 µM 
gramicidin S indicated propridium iodide fluorescence (Figure 7C) in correspondence 
with previous results by Rautenbach et al. (2007) [11]. 
As seen for the control cultures, the bismenzamide fluorescence of the TrcA-treated 
cultures was found localised around the hemozoin crystal (Figure 7B). However, the 
hemozoin crystals of the treated cultures were generally found to be smaller, and in 
some cases unobservable (Figure 7B), than those of the control cultures. These results 
correspond to previous research, which found delayed growth (smaller trophozoites) in 
TrcA-treated cultures [11].  
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Figure 7  Fluorescence and light microscopy of P. falciparum-infected erythrocytes 
incubated with propridium iodide and bismenzamide. Bisbenzimide 
(membrane permeable DNA marker) fluorescence (blue) indicates all P. 
falciparum nuclei, whereas propridium iodide (membrane impermeable DNA 
marker) fluorescence (red) indicates nuclei of P. falciparum cells with 
compromised membrane integrity. In A: untreated P. falciparum-infected 
erythrocytes after 24 hours, B: P. falciparum-infected erythrocytes treated 
with 40 nM TrcA for 24 hours, and C: P. falciparum-infected erythrocytes 
treated with 20 µM gramicidin S for 10 minutes. The left hand panels show 
the overlay of bisbenzimide fluorescence (blue), propridium iodide 
fluorescence (red) and light (transmission) microscopy; the middlle panels 
show bisbenzimide fluorescence, and the right hand panels show propridium 
iodide fluorescence. 
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7.5 Conclusions 
As was observed for antilisterial activity (Chapters 5 and 6), the antiplasmodial activity 
of the tyrocidines was found to be sensitive to solution composition and peptide 
identity, in particular the aromatic dipeptide unit identity. The manner in which 
different pre-incubation solutions modulate antiplasmodial activity is possibly related to 
self-assembly/aggregation. The QSAR analyses indicated a central role for tyrocidine 
self-assembly in antiplasmodial activity and selectivity, with reduced propensity for 
self-assembly in a membrane environment associated with enhanced antiplasmodial 
activity. Furthermore, the observed structural requirements (increased solution 
amphipathicity, reduced peptide size) for enhanced activity and selectivity are probably, 
at least in part, related to the propensity for self-assembly.  
 
A non-lytic antiplasmodial MOA was confirmed for TrcA with live cell fluorescence 
microscopy and correlates with the Ca2+- associated non-lytic antilisterial activity of the 
tyrocidines. Correlation between activity and Ca2+ binding also indicates that Ca2+ may 
play a role in the tyrocidine antiplasmodial activity, possibly due to interference of  
tyrocidine with Ca2+-homeostasis. Previous research has shown that, although lysis may 
contribute to tyrocidine activity, the antiplasmodial activity of the tyrocidines does not 
depend on overt lysis, but rather inhibition of parasite development [11]. The loss of 
activity of lytic GS and tyrocidines B, B1, C and C1 in the presence of albumin strongly 
indicated that these tyrocidines share a lytic MOA with GS. The anti-plasmodium 
activity of the most active peptides, TrcA and A1, were unaffected by albumin and 
indicates an alternative MOA. This result correlates with our finding that there is a 
sigmoidal trend between SI (selectivity towards P. falciparum) and the propensity of the 
tyrocidine to self-assemble in a membrane environment. As with this trend, the 
influence of albumin also points to a switch in MOA between a pure non-membrane 
associated MOA to a lytic MOA that is sequence dependent. As the lytic action of the 
tyrocidines have been associated with the VO(K)LFP pentapeptide unit, [11], the 
generally lower activity of the Lys9-containng tyrocidines, relative to their Orn9 
counterparts may be ascribed to differences in initial membrane association leading to 
different propensities for membrane integration and induction of lysis. On the other 
hand, the variable pentapeptide unit (F/W)(f/w)NQY may allow for the alternative, non-
lytic mechanism of action [11], with particular emphasis on the sequence and identity of 
the aromatic dipeptide unit. The importance of the aromatic amino acid sequence within 
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the dipeptide unit is illustrated by the reduced antiplasmodial activity of tyrocidines B` 
and B1` (Phe3-D-Trp4) relative to tyrocidines B and B1 (Trp3-D-Phe4). Optimal 
antiplasmodial activity was found to be mediated by Phe3-D-Phe4 (TrcA and A1). 
Incorporation of a Trp residue in either position 3 or 4 led to reduced activity, which 
may be related to enhanced self-assembly in a membrane environment. Position 4 was, 
however, found to be significantly more sensitive to Phe→Trp substitution, which 
suggests that D-Phe4 plays an important role in antiplasmodial activity. As D-residues 
are scarce, D-Phe4 may be involved in interaction with a stereospecific target. 
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 Chapter 8 
 Conclusions and recommendations  
for future studies 
 
This study represents the first detailed investigation of the self-assembly, bioactivity 
and structure-activity relationships of the purified natural tyrocidines produced by 
Bacillus aneurinolyticus. Investigation of the structure-activity relationships and 
modulation of tyrocidine bioactivity was motivated by their possible application as 
novel therapeutic agents and bio-preservatives. The objectives of this study included 
purification of tyrocidines from the natural tyrothricin complex of B. aneurinolyticus; 
investigation of conformation, physicochemical character and self-assembly of the 
purified tyrocidines; investigation of the antibacterial, antiplasmodial, and haemolytic 
activity and selectivity; elucidation of the structure-activity-selectivity relationships; 
and evaluation of modulation of bioactivity by environmental conditions. 
The complexity of tyrocidine chemistry and biochemistry became apparent during the 
purification process and initial bioactivity determinations, which indicated that the 
tyrocidines are extremely sensitive to solution composition and handling. Such 
sensitivity was found to be a result of their tendency for self-assembly. The 
spectrophotometric investigation of the tyrocidines was also complicated by their 
tendency for self-assembly, as well as their high aromatic content.  
This study is the first reported study in which eight tyrocidines were successfully 
purified to >95% purity from the natural tyrothricin complex (Chapter 2), which 
allowed investigation of the physicochemical character, conformation, self-assembly 
and bioactivity (Chapters 3-7).  
8.1 Experimental conclusions 
8.1.1 Structural investigation 
Spectrophotometric analyses of the tyrocidines indicated that the manner and/or extent 
of tyrocidine self-assembly are highly dependent on peptide identity and solvent 
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composition (Chapter 3). This observation corresponds to previous research, which 
indicated that the tyrocidines undergo extensive, stable aggregation/self-assembly in 
aqueous solution [1-6], and that such self-assembly is highly dependent on amino acid 
sequence, conformation and proper spatial orientation of the amino acid residues [1, 2, 
6] and sensitive to solvent composition [3, 5]. The results of this study indicated that the 
variable cationic residue (Orn9/Lys9) and the variable aromatic dipeptide moiety 
(Phe3,4/Trp3,4) have a significant influence on the manner/extent of tyrocidine 
self-assembly, as well as the orientation/exposure/local environments of the aromatic 
amino acids. Such differences in self-assembly are likely to influence the bioactivity, 
and possibly the mode of action, of the tyrocidines. The manner in which the variable 
residues modulate self-assembly may be related to differences in molecular properties, 
such as hydrophobicity, amphipathicity, available surface area, and/or the spatial 
orientation of the amino acid side-chains. In an aqueous environment, the 
Phe3-containing tyrocidines (TrcA, A1, B` and B1`) exhibited greater 
self-assembly/β-sheet stability than the Trp3-containing tyrocidines (TrcC, C1, B and 
B1), and such differences in self-assembly were shown to be related to differences in the 
solvent-accessible surface areas of the Phe3- and Trp3-containing tyrocidines. 
Furthermore, we concluded that the relative positioning of the aromatic residues within 
the dipeptide moiety influences the manner/extent of self-assembly of the tyrocidines, 
which may be explained by the segregation of the two residues in the aromatic dipeptide 
moiety on opposite faces of the molecule. The results also suggested that self-assembly 
in an aqueous environment involves shielding of the aromatic residue in position 4 from 
the solvent, while the aromatic residue in position 3 remains exposed. In a 
membrane-mimetic environment, the Trp-containing tyrocidines (B and C group) 
exhibit greater self-assembly/β-sheet stability than the Trp-lacking tyrocidines (TrcA 
and A1), indicating that the presence of Trp (irrespective of position) is associated with 
enhanced β-sheet structure/self-assembly. Furthermore, decreased solution 
amphipathicity and greater solvent-accessible surface area were shown to be associated 
with enhanced β-sheet structure/self-assembly, in a membrane-mimetic environment. 
The results also suggested that the arrangement of peptide molecules within the 
higher-order structures in an aqueous and membrane-mimetic environment differ, with 
increased exposure of residue 4, which was “buried” in water-induced self-assembly, in 
a membrane-mimetic environment. 
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The differences in the manner of association of the tyrocidines/arrangement of peptide 
molecules within the higher-order structures in an aqueous and membrane-mimetic 
environment may be attributed to differing driving forces for association. Previous 
research suggested that tyrocidine aggregation/self-assembly in an aqueous environment 
is mediated by hydrophobic side-chain interactions [1-3, 5], and self-assembly in an 
aqueous environment will thus involve association of the hydrophobic regions of the 
peptides in order to shield them from the polar solvent. In contrast, self-assembly in 
membrane-mimetic environment is expected to be mediated by other forces, and the 
results suggested that higher-order structures formed in the presence of TFE are 
probably stabilised by intermolecular hydrogen bonding. Self-assemblies in a 
membrane-mimetic environment will preferentially shield the polar regions from the 
hydrophobic solvent, while exposing the hydrophobic portions. The results also 
indicated that the structure of the predominant self-assembled species formed in a 
membrane-mimetic environment differ from, and are probably larger than, the 
higher-order structures formed in aqueous solution, which indicates that β-sheet 
peptides are likely to form superstructures upon membrane interaction [7].  
Due to the limited amount of available peptide and the lack of 13C enriched tyrocidines, 
nuclear magnetic resonance (NMR) spectroscopy could not be employed in this study 
for complete determination of the three-dimensional structure of the tyrocidines. 
Furthermore, NMR structure determination of the tyrocidines is complicated by their 
propensity for self-assembly. We therefore used a molecular model of tyrocidine C, 
modelled using NMR constraints for homology modelling, which indicated that the 
eight investigated tyrocidines adopt similar β-sheet backbone conformations (Chapter 
4). However, unlike gramicidin S, the tyrocidines do not exhibit segregated 
hydrophobic and polar faces. Instead, an aromatic residue extends from each face of the 
peptide. Also, in contrast to previous predictions suggesting that the D-Phe1 and Orn9 
side-chains extend from the same face [8], our modelling results correspond well to a 
previous report by Marques et al. (2007) [9].  The aromatic residues of the variable 
dipeptide unit were shown to extent to opposite sides of the tyrocidine structure, with 
residue 3 (Phe3/Trp3) extending to one side while residue 4 (Phe4/Trp4) and the cationic 
residue (Orn9/Lys9) extend toward the opposite side. Such segregation of the variable 
aromatic residues may have important implications for tyrocidine self-assembly and 
membrane interaction.  
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8.1.2 Bioactivity and selectivity  
The antibacterial activity of the tyrocidines was found to be (1) strain-specific and thus 
dependent on properties of the target cell; (2) dependent on peptide identity/structure; 
and (3) sensitive to environmental/solvent conditions. The tyrocidines were found to be 
selective for Gram-positive bacteria, which may be attributed to differing cell walls of 
Gram-positive and Gram-negative bacteria. Due to the lack of activity toward 
Gram-negative bacteria under our assay conditions, this study focussed on the activity 
of the tyrocidines toward Gram-positive bacteria. Further evidence for the influence of 
target cell properties was gained from the observation that L. monocytogenes B73-MR1 
is more sensitive to the tyrocidines than L. monocytogenes B73, which may be related to 
differences in membrane structure and/or metabolic differences [10-12] (Chapter 5). In 
addition to the role of the target cell, antibacterial growth inhibition induced by the 
tyrocidines was found to be dependent on peptide structure. QSAR analyses allowed 
prediction of optimal physicochemical parameters for antibacterial activity of the 
natural tyrocidine library (Chapter 5). In general, TrcC exhibited optimal side-chain 
surface area, while TrcB1 exhibited optimal solution amphipathicity (HPLC RT). 
Although these optimal physicochemical characteristics may be directly related to target 
cell membrane interaction/integration/translocation or interaction with alternative 
targets, such structural requirements may also be related to the propensity for tyrocidine 
self-assembly, as peptide self-assembly may impact membrane interaction, cytolytic 
activity and/or transport across biological barriers [7, 13-19]. We found that the 
Trp-containing tyrocidines (B and C groups) were more active towards Gram-positive 
bacteria than the Trp-lacking tyrocidines (A group). The reduced antibacterial activity 
seen for TrcA and A1 was found to be associated with enhanced self-assembly in 
aqueous solution, which suggests that premature self-assembly reduces target 
membrane interaction, integration and/or translocation to reach a cytoplasmic target. 
The greater antilisterial activity of the Trp-containing tyrocidines C, C1, B and B1 
corresponds to enhanced self-assembly in a membrane environment, which suggests 
that self-assembly into active bactericidal lytic complexes within the target cell 
membrane may be critical for the antilisterial activity of the tyrocidines.  
In addition to the roles of the target cell and peptide structure/self-assembly in 
antibacterial activity modulation, a novel result from this study indicated that 
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tyrocidine-Ca2+ complexation plays an important role in the antilisterial activity and 
mode of action of the tyrocidines (Chapter 6). Spectrophotometric investigation 
indicated that Ca2+ has a significant influence on the self-assembly of the tyrocidines 
and that such self-assembly is distinct, possibly in terms of size and/or  the relative 
orientation of the peptide molecules with the assembly, from assemblies formed in a 
salt-free environment and a membrane environment. Such formation of higher-order 
structures leads to a non-lytic bacteriocidal cellular event. Tyrocidine-Ca2+ 
complexation and the concomitant induction of higher-order structures therefore not 
only increase the antilisterial activity of the tyrocidines, but also change the mechanism 
of action of the tyrocidines from a predominantly lytic to an alternative/intracellular 
mode of action.  
As was observed for antilisterial activity, the antiplasmodial activity of the tyrocidines 
was found to be sensitive to peptide identity and solvent composition and the QSAR 
analyses indicated a central role for tyrocidine self-assembly in antiplasmodial activity 
and selectivity (Chapter 7). However, contrasting structural and self-assembly 
requirements were observed for antilisterial and antiplasmodial activity. While 
enhanced self-assembly in a membrane-environment was shown to be associated with 
improved antilisterial activity, reduced propensity for self-assembly in a membrane 
environment associated with enhanced antiplasmodial activity. This study confirmed a 
non-lytic antiplasmodial mode of action (MOA) for TrcA, supporting the observation 
that, although lysis may contribute to tyrocidine activity, the antiplasmodial activity of 
the tyrocidines involves inhibition of parasite development and not overt membrane 
lysis [20]. Correlations between self-assembly and antiplasmodial activity, as well as 
observations regarding the influence of serum albumin, strongly indicated that the 
Trp-containing tyrocidines share a lytic MOA with gramicidin S, whereas the most 
active peptides, TrcA and A1, act via an alternative MOA. The influence of albumin 
suggested a sequence-dependent switch in MOA between a pure non-membrane 
associated MOA to a lytic MOA. As seen for antilisterial activity, an alternative non-
lytic mode of action may also be related to tyrocidine-Ca2+ complexation, as indicated 
by the correlation between enhanced Ca2+ binding and antiplasmodial activity. The 
(F/W)(f/w)NQY may allow for the alternative, non-lytic mechanism of action [20], with 
particular emphasis on the sequence and identity of the aromatic dipeptide unit. Optimal 
antiplasmodial activity was found to be mediated by Phe3-D-Phe4 (TrcA and A1) and 
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incorporation of a Trp residue in either position 3 or 4 led to reduced activity, which 
may be related to enhanced self-assembly in a membrane environment. Position 4 was, 
however, found to be significantly more sensitive to Phe→Trp substitution, which 
suggests that D-Phe4 plays an important role in antiplasmodial activity, possibly by 
interacting with alternative, stereospecific target.  
8.2 Hypotheses 
This study indicated contrasting structural and self-assembly requirements for 
antilisterial and antiplasmodial activity, which may be related to the different target cell 
types – bacterium or parasite – or target cell locations – extracellular or intracellular. If 
the effects of peptide self-assembly are due to the localisation of the pathogen, 
differences may be ascribed to the mechanism of peptide uptake and delivery to the 
(molecular) target. Higher-order structures may translocate to the cytoplasm (possibly 
via endocytosis) to reach an internal target more effectively than monomers/low-order 
structures, which may become trapped by interacting too strongly with the cell 
membrane. Furthermore, peptides that form larger assemblies (eg more hydrophobic 
peptides) may be delivered to an internal target in higher concentrations. A preliminary 
investigation, in which the tyrocidine complex was formulated in PheroidTM vesicles (in 
collaboration with A. Fourie, University of the North West), lipid based carriers that 
promote transfer across membranes, indicated that antiplasmodial activity was enhanced 
by >100%. This result strongly suggests that antiplasmodial activity requires the 
peptides to transverse the erythrocyte and parasite membranes, indicating that the 
tyrocidines may have an internal target. In the event that the effects of peptide 
self-assembly are modulated by target cell type, differences may be ascribed to different 
membrane compositions or different mechanisms of action. The influence of peptide 
organisation on activity is expected to be related to the type and/or efficacy of 
membrane interaction. The different responses of antibacterial and antiplasmodial 
activity may thus be related to different membrane types/compositions, which may have 
a preference for different peptide aggregation states. Alternatively, different organisms 
may require different interaction efficacies due to different mechanisms of action/target 
sites.  
The results presented in this thesis suggest that the antilisterial and antiplasmodial 
activity of the tyrocidines is likely to be mediated, at least in part, by a non-
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membranolytic mode of action. As the tyrocidines have been shown to inhibit RNA 
synthesis by binding to DNA [21-23], such a non-lytic mode of action may be related to 
tyrocidine-DNA interaction. Previous research has suggested that, at low 
concentrations, tyrocidine-DNA interaction involves intercalation of the aromatic 
side-chains between DNA bases, leading to unwinding of superhelical DNA [22]. At 
higher peptide concentrations, interaction between DNA and tyrocidine aggregates 
induces DNA packaging, and therefore inhibition of transcription [22]. The role of 
tyrocidine self-assembly in activity modulation may thus be related to the influence on 
DNA packaging. The role of Ca2+ in tyrocidine antilisterial activity may also be related 
to a DNA-associated mechanism of action, as the higher-order tyrocidine structures 
induced upon Ca2+ may favour tyrocidine-DNA interaction.  The observation that 
antiplasmodial activity is associated with enhanced self-assembly of the tyrocidines in 
solution, as well as enhanced Ca2+ binding (TrcA and A1), suggests that the same may 
apply for the antiplasmodial activity of the tyrocidines.     
In addition to the possible DNA-related mode of tyrocidine action, the role of Ca2+ in 
tyrocidine activity suggests that the antilisterial and antiplasmodial activity of the 
tyrocidines may be due to disruption of Ca2+ homeostasis. As most cell types rely on 
calcium signalling to regulate cell function, interference with Ca2+ homeostasis may led 
to lethal disruption of normal cell functions. The vital importance of both intracellular 
and extracellular calcium for plasmodium invasion of erythrocytes and the normal 
development of the parasite have been widely documented [24-32], and interference 
with Ca2+ homeostasis is expected to disrupt normal parasite development and prevent 
re-invasion of erythrocytes. Disruption of Ca2+ homeostasis by the tyrocidines may thus 
contribute to their antiplasmodial activity, which has been shown to involve inhibition 
of parasite development [20]. 
8.3 Recommendations for future studies 
This study only investigated tyrocidine activity toward L. monocytogenes in culture. 
L. monocytogenes is, however, an intracellular pathogen, which infects the mammalian 
cell by phagocytosis and, once released from the membrane-bound vacuole, starts to 
multiply [33]. A preliminary investigation into the activity of TrcC and TrcA towards 
intracellular Mycobacterium tuberculosis indicated selective low µM activity  
(IC50< 1.25 µM). The possibility that the tyrocidines may be active toward intracellular 
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L. monocytogenes, potentially by a mechanism related to antiplasmodial/ 
antimycobacterial activity, should be investigated. Conversely, the activity of the 
tyrocidines toward L. monocytogenes in culture suggests that they may be active toward 
extracellular blood-borne parasites. This possibility should be investigated by 
determining the activity of the tyrocidines toward, for example, Trypanasoma brucei. 
Furthermore, investigation of the nature of the effect of peptide self-assembly on 
activity toward intracellular L. monocytogenes, M. tuberculosis and extracellular 
T. brucei may allow us to determine whether the effect of peptide self-assembly is 
related to target cell location or type.  
Information regarding the interaction of peptides/peptide complexes with the target cell 
membrane may contribute to understanding the manner by which self-assembly 
influences activity. The ability of different self-assembly states of the tyrocidines to 
induce cell lysis or to translocate to the target cell cytoplasm may be investigated using 
model membrane systems composed of different phospholipids. The processes involved 
in tyrocidine/tyrocidine complex uptake and delivery may be further be elucidated by 
investigating the role of endocytosis and phagocytosis in the uptake of the tyrocidines in 
P. falciparum and intracellular L. monocytogenes, respectively.  
In order to gain a better understanding of tyrocidine mode of action, the contribution of 
membrane interaction, self-assembly in membranes and lysis to their antimicrobial 
activity needs to be determined. The ability of the different tyrocidines to interact with 
membranes, self-assemble and induce cell lysis and/leakage can be evaluated by making 
use of model membrane systems. Unfortunately, our access to a fluorometer and 
circular dichroism spectrometer was limited and the available infrastructure did not 
allow such investigations using liposomes. In addition to providing information 
regarding the contribution of membrane activity to mechanism of action, selectivity 
between anionic and neutral liposomes, representative of bacterial and eukaryotic cell 
membranes respectively, will provide insight regarding the role of target cell properties 
in activity modulation. Gaining a better understanding of the manner in which the target 
cell modulates activity may provide valuable insight regarding the structure-activity 
relationships and mode of action of these peptides, as well as the foundation for 
optimising tyrocidine selectivity.  
 8-9 
In order to evaluate the hypotheses regarding the mechanism(s) of action, investigation 
of the influence of the tyrocidines on DNA structure and gene expression of Listeria 
and Plasmodium may be investigated by DNA footprinting and microarray gene 
expression studies. Further, the possible influence of the tyrocidines on Ca2+ 
homeostasis and/or distribution within the target cells may be investigated by 
fluorescence microscopy using Ca2+ indicators. 
Furthermore, the influence of the target cell and the central role of self-assembly in 
tyrocidine bioactivity motivates further research regarding the manner of 
tyrocidine-tyrocidine association in both aqueous and membrane environments. 
Analytical techniques, such as Fourier transform infrared spectroscopy and nuclear 
magnetic resonance, can be applied to elucidate these molecular interactions. Also, 
tyrocidine C1 formed fibre-like structures in TFE, and microscopic/physical properties 
of such macromolecular structures may be investigated by scanning electron 
microscopy.  
Shortly prior to submission of this manuscript, our collaborator, Prof. Graham Jackson 
(University of Cape Town) provided us with a dimer model of TrcC, stabilised by four 
intermolecular hydrogen bonds formed between the backbone carbonyl- and amino-
groups of Orn9 and D-Trp4 (Figure 1). Comparison of the Yasara refined low energy 
dimer model with the monomer, indicated that the TrcC dimer has substantially lower 
potential energy than the TrcC monomer. This finding may explain the propensity for 
self-assembly and role of the variable cationic and aromatic residues in self-assembly. 
Further insight regarding possible dimer and higher order structure formation of the 
tyrocidines may thus shed light on the role of the variable residues in self-assembly and 
bioactivity. 
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Figure 1 Model of tyrocidine C dimer refined by Yasara 9.10.5©; original model 
courtesy of Prof Graham Jackson (University of Cape Town). 
8.4 Preliminary results pertaining to potential application as 
a bio-preservative  
L. monocytogenes has drawn the interest of food manufacturers and government bodies 
due to food-borne outbreaks [34], with milk and milk products being particularly 
susceptible to contamination by L. monocytogenes [34-37]. As discussed in Chapter 5, 
the tyrocidines have been shown to possess significant antibacterial activity toward 
L. monocytogenes [38], as well as enhanced antilisterial activity toward 
L. monocytogenes B73-MR1, a leucocin A (a pediocin-like bacteriocin) resistant strain 
[38, 39], relative to the leucocin A-sensitive L. monocytogenes B73 [38, 40]. 
Furthermore, although the activity of most antimicrobial peptides (including nisin and 
pediosin) is reduced by the presence of cations such as Na+, Mg2+ and Ca2+ [41-48], the 
tyrocidines were found to be reasonably salt-tolerant. These results suggest that the 
tyrocidines may be useful bio-preservatives. However, activity of antimicrobial agents 
may be influenced by additional food components, such as fat and protein [49] and the 
antilisterial activity of nisin has been shown to decrease in milk, largely due to the milk 
fat content [50]. Preliminary investigation indicated that L. monocytogenes growth in 
milk may be successfully inhibited by the presence of 100 µg/mL tyrocidine complex 
(Figure 2), which prompts further investigation.  
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Figure 2 Protective influence of the tyrocidine complex. Blue wells indicate the 
absence of viable cells, while pink wells indicate the presence of viable 
L. monocytogenes. A doubling dilution series of the tyrocidine complex 
was added to store-bought skim milk (highest concentration = 
0.10 mg/mL), followed by inoculation with L. monocytogenes B73 
(6.7x107 CFU/mL). The inoculated plate was left at room temperature for 
two days, after which viability of L. monocytogenes was assessed using 
the CellTiter-BlueTM Cell Viability Assay.  
 
8.5 Last word 
Overall, it may be hypothesised that tyrocidine activity and mode of action is modulated 
by a critical play-off between self-assembly, cation-complexation and 
membrane-interaction. As these modulators of activity are highly dependent on 
tyrocidine sequence/structure, the wide variety of tyrocidines found in the natural 
complex may allow for optimal interaction with and activity toward a variety of 
microbes.  
Research concerning the tyrocidines may play an important role in future combating of 
the spread of treatment-resistant food-borne bacteria, as well as treatment-resistant 
infections. However, as a consequence of their toxicity and the expense of synthesis of 
non-toxic alternatives they may find their primary applicability as bio-preservatives and 
for the treatment of serious bacterial and plasmodium infections that are resistant to 
conventional antibiotics.  
100 µ g/ml Trc
complex 
Doubling 
dilution series 
Blank Growth 
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